








Equine Grass Sickness has traditionally been known as a dysautonomia,
principally affecting parasympathetic neurons in the enteric nervous system.
Studies of central neuropathology have been cursory and conflicting, examining
different and occasionally poorly defined central structures in variable numbers
of cases and control animals. There was no agreement on the association or
severity of clinical signs with the severity of central pathological changes.
This study accurately describes the distribution of pathology in the brain of EGS
cases. Chromatolytic neurons have a highly specific distribution which is unlike
that reported in any other equine or human disease, but is apparently the same as
in cats, dogs and hares with primary dysautonomias. The involvement of somatic
efferent lower motor neurons suggests that EGS may be more correctly classified
as a multisystem disease. This is a further incentive to search for a common
aetiologic agent and may decrease the number of candidates under consideration.
The nature of the pathological insult to the central neurons remains undetermined
but, unlike peripheral neurons, central neurons do not appear to be dying; this
study was unable to demonstrate evidence of neuronal apoptosis, axonal
pathology or muscle fibre type grouping in muscles innervated by chromatolytic
neurons. Phosphorylated neurofilament epitopes were labelled in the soma of
somatic and visceral lower motor neurons indicating an axonal transport problem,
but no consistent expression of the cell stress protein ubiquitin was evident.
Smaller, CGRP-expressing dorsal root ganglia neurons are more likely to be
chromatolytic than large neurons and may contribute to the observed rhinitis
sicca. Electron microscopy revealed classical chromatolytic changes and no
inclusion bodies.
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Electrodiagnostic examination of the blink reflex did not reveal a functional
deficit of the facial nerve, and the characteristic ptosis of EGS cases was
determined to be an expression of Horner's syndrome secondary to pathology to
postganglionic sympathetic neurons. The response of the equine eyelid to alpha
agonist eyedrops was defined and a significant difference found between control
animals and EGS cases. The technique has been developed further as a useful
non-invasive adjunct diagnostic test in Grass Sickness.
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Equine Grass Sickness (EGS) is a disease of horses kept at grass with lesions of
neuronal chromatolysis and loss principally in postganglionic sympathetic and
parasympathetic neurons (Obel, 1955; Chandler and Brownlee, 1967; Barlow, 1969;
Gilmour, 1975; Doxey et al, 1992; Pogson et al, 1992). Classical clinical signs include
dysphagia, gut stasis, tachycardia, inappropriate sweating, trembling of axial and
appendicular muscles, rhinitis sicca and ptosis. There are no non-invasive, simple
diagnostic tests, clinical diagnosis being based on assessing the combination of
demographic data, history and clinical signs.
EGS is prevalent in the UK, in restricted Northern areas of continental Europe and in
Patagonia, South America (Uzal et al, 1991), and has not been reported in Australasia
(Wood et al, 1997). Clinical cases of EGS in North America (P. Johnston, U. of
Missouri, personal communication) and Finland (Riitta-Mari Tulamo, University of
Helsinki, personal communication) were recently confirmed by histopathology
(C.N. Hahn, unpublished observations).
The disease is known as a dysautonomia (Doxey et al, 1991b) but clinical signs of EGS
do not fit clearly into an uncomplicated picture of autonomic disease. Cases usually do
not have alterations in pupillary diameter, enophthalmos, corneal ulceration due to
decreased tear production or overt orthostatic hypotension. There is no good human
model of the disease although some histopathologic and clinical signs are shared with
acute autonomic neuropathy (Hart and Kanter, 1990), idiopathic orthostatic hypotension
(Roessmann et al, 1971) and particularly familial dysautonomia (Pearson et al, 1971;
Tonholo-Silva et al, 1994).
Despite the recognition of EGS since the early part of this century and over 100
associated publications, the aetiology of EGS remains an enigma. Neither the restricted
geographical and age distribution, nor the occurrence of primary dysautonomias with
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markedly similar enteric and sympathetic ganglionic lesions in cats (Pollin and
Griffiths, 1992), dogs (Schultze et al, 1997) and hares (Whitwell, 1991) have helped
elucidate the pathogenesis or aetiology of this disease, nor has the correlation of
pathological findings with the non-enteric clinical signs, specifically muscle trembling,
ptosis and rhinitis sicca, been addressed in detail. The basis of this project came from
discussions undertaken in 1995 at the first international workshop on equine
neurodegenerative diseases (Hahn et al, 1997). The editorial prologue and epilogue are
attached in appendix 1 as an introduction to the topic.
2. LITERATURE REVIEW
a) Neuroanatomy of the general visceral efferent system
A basic understanding of the anatomy of the autonomic nervous systems ([Gr] auto -
self, nomos - law) is fundamental to a discussion of EGS and a brief review is
warranted.
There are a number of semantic controversies (Anthoney, 1993) in defining the anatomy
of the autonomic nervous system (ANS). Specifically, there is no consensus as to
whether it consists of strictly a lower motor neuron (LMN) visceral efferent system
(Peele, 1977), a motor system with central control (Jenkins, 1978) or whether it also
includes afferent pathways in addition to central regulatory centres (de Lahunta, 1983).
In addition, there is no agreement on whether the enteric nervous system is part of the
ANS, consisting of parasympathetic postganglionic neurons, or whether it is a part of
the ANS but separate from the sympathetic or parasympathetic system. The following
description is limited to efferent and central components.
The ANS is a physiologic and anatomic system that includes the only motor system
innervating those structures whose functions are primarily outside voluntary control. It
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is divided into sympathetic (thoracolumbar) and parasympathetic (craniosacral)
divisions on the basis of physiologic, anatomic and pharmacologic differences of
component neurons. The general visceral efferent (GVE) system is the lower motor
neuron portion of the ANS and unlike the general somatic efferent (GSE) system consist
of two neurons, pre and postganglionic, between the central nervous system (CNS) and
the organ to be innervated. See Table 1-1 for a summary of the classification of
functional systems.
Integrative centres are situated in the midbrain, pons, medulla and particularly the
hypothalamus. The rostral and caudal portions of the hypothalamus are associated with
the parasympathetic and sympathetic systems respectively and receive afferent input
from the cerebrum, thalamus and general visceral afferent system. In turn the
hypothalamus influences metabolic centres in the brainstem which affect GVE neurons
in cranial and spinal nerves.
The sympathetic nervous system ([Gr] svm - with, pathos - emotion) has preganglionic
cell bodies situated in the intennediolateral grey column in approximately the first
thoracic to fifth lumbar spinal cord segment. Axons leave the cord via a spinal nerve
and white rami communicantes to join the paravertebral ganglionated sympathetic chain
which run3 from the fust cervical to the caudal vertebrae. The sympathetic trunk
contains ganglia of postganglionic neurons and is separated into three distinct ganglia
cranially, the cranial cervical, middle cervical and cervicothoracic ganglia, and more
diffuse ganglia associated with the thoracic, lumbar and sacral vertebrae. In the horse
the middle cervical and cervicothoracic ganglia are closely apposed and traditionally
referred to as the stellate ganglion. It is unclear whether authors always include the
middle cervical ganglion when discussing pathology to the stellate ganglion so the word
'stellate' is still used unqualified throughout this review.
On entering the sympathetic trunk, the route of the preganglionic neuron varies. Some
synapse with a multipolar post ganglionic neuron in a paravertebral ganglion, either
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with the first one they encounter or, by turning within the trunk, with a more cranial or
caudal ganglion. The postganglionic axon exits the trunk via a grey ramus communicans
and spinal nerve to innervate smooth and cardiac muscles and glands. Other
preganglionic neurons leave the sympathetic chain directly via thoracic or splanchnic
nerves to synapse in a prevertebral ganglion, principally the coeliacomesenteric and
caudal mesenteric ganglia. Parasympathetic axons pass through the prevertebral ganglia
but do not synapse there. The paravertebral ganglia principally contain vasomotor,
sudomotor and pilomotor neurons while prevertebral ganglia innervate the viscera of the
abdomen. Neurons in the paravertebral ganglia of the thoracic and cervical regions
however serve a dual function due to the absence of prevertebral ganglia in those
regions. The prevertebral ganglia are connected by a myriad of nerve fibres forming
plexuses. Caudal to the caudal mesenteric ganglion, sympathetic postsynaptic axons
make up the hypogastric nerve to anastomose with rami of the parasympathetic pelvic
nerves as well as sympathetic postganglionic axons from sacral paravertebral ganglia to
form a dense pelvic plexus.
The activity of the parasympathetic nervous system ([Gr]: para - next to) is much more
restricted than the sympathetic nervous system as preganglionic fibres terminate mostly
in ganglia associated with the organ innervated. Preganglionic parasympathetic neurons
are also located in the neuraxis, separated into cranial and caudal divisions.
In the cranial division, preganglionic parasympathetic neurons in the medulla oblongata
are associated with cranial nerves (CN) III, VII, IX, X and XI in a nuclear column, the
GSE column, dorsolateral to nuclei containing neurons innervating skeletal muscles
and ventral to the fourth ventricle (see Figure 1-1). The ganglia containing
postganglionic neurons innervated by preganglionic axons in cranial nerves III, VII, IX,
and XI are collectively called cephalic ganglia, whereas preganglionic vagal axons
synapse in cell bodies in the wall of the viscera innervated. Locations of the pre and
postganglionic cranial outflow components and the structures innervated are outlined in
Table 1-2.
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In the caudal division, preganglionic neurons are found in the lateral intermediate grey
columns of sacral segments of the spinal cord. Axons exit the cord with the ventral roots
at these levels to join the spinal nerves, and then separate as ventral branches that unite
to form a pelvic nerve on each side. Axons in the pelvic nerve synapse with
postganglionic neurons in the pelvic or hypogastric plexuses, or terminal ganglia within
walls of thoracic and abdominal viscera. The majority of neurons within the pelvic
plexus are thought to be parasympathetic.
Table 1-1: Functional classification of the nervous system
Functional System Components
General Somatic Afferent (GSA) Pain, temperature, touch, (spinal
nerves, CN V)
Special Somatic Afferent Vision (CN II), hearing (CN VIII)
General Visceral Afferent Organ content and displacement,
chemical changes. (Spinal nerves, CN
VII, IX, X)
Special Visceral Afferent Taste (CN VII, IX, X), Smell (CN 1)
General Proprioception Muscle and joint movements (spinal
nerves, CN V)
Special Proprioception Vestibular system, balance (CN VIII)
General Somatic Efferent (GSE) Striated skeletal muscle (spinal
nerves, CN III, V, VII, IX, X, XI)
General Visceral Efferent (GVE) Smooth and cardiac muscle, glands,
(sympathetic - spinal and splanchnic
nerves, parasympathetic - CN III, VII,
IX, X, XI)
From de Lahunta (1983, p310).
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Figure 1-1: Functional organisation of cranial nerve nuclei in the
brainstem.
Modified from de Lahunta (1983, p96).
7
















































Modified from Jenkins (1978, p310).
b) Clinical categories of equine grass sickness
Historically the classification of cases into the three categories, acute (AGS), subacute
(SGS) and chronic (CGS) grass sickness, were defined strictly by duration of disease
(Gilmour, 1988; Doxey et al, 1991b). Since this classification relies on the somewhat
variable level of owner observation, a classification by clinical severity was used for
purposes of this study.
AGS cases are defined as animals with severely decreased gut motility leading to small
intestinal distension and gastric reflux in addition to the classical signs of EGS, and
horses are invariably euthanised on humane grounds within 48 hours of first showing
clinical signs. Subacute cases have somewhat milder clinical signs and a characteristic
'tucked up' stance, do not present with distended small intestines but have colonic
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impactions. These are usually euthanised within one week of showing clinical signs.
Chronic cases are defined as horses with EGS but without profound changes on rectal
examination and milder dysphagia and ileus. Evidence of rhinitis sicca is very common
in this group and a small proportion of the chronic cases recover with intensive nursing
care.
c) Equine grass sickness neuropathology
The first comprehensive histopathological examination of a case of EGS was published
by Holman et al (1944), reviewing cases sent to the Moredun Research Institute over
the previous 20 years. A detailed examination of the nervous system was carried out,
including midbrain, pons and medulla, vagus, splanchnic and phrenic nerves, spinal
cord and coeliacomesenteric, thoracic, jugular (proximal GSA CN X) and spinal
ganglia. No signs of pathology were found in the central nervous system (CNS) or
peripheral nerves, however nor were significant lesions noted in any of the autonomic
ganglia.
A detailed histopathological description of grass sickness was reported by Obel in 1955.
The sympathetic trunk, prevertebral ganglia, vagal-glossopharyngeal nucleus in the
medulla oblongata, the nodose plexus and the spinal cord were examined. The most
marked changes were found in the cranial cervical ganglia and the stellate ganglia,
while caudal mesenteric ganglia were often affected to a lesser degree. In the more
severe, acute cases, swollen, chromatolytic neurons in sympathetic ganglia with
eccentrically placed enlarged nuclei and nucleoli were noted in sympathetic ganglia.
Chromatolytic and vacuolated neurons lacking nuclei were also sometimes seen in
spinal cord lateral and ventral horns. Some soma contained small vacuoles that
progressed to making the cell appear enlarged and spongy, either peripherally, centrally
or in alternating zones. Karyopyknosis or karyolysis was described in the same cells.
There appeared to be no reaction by surrounding satellite cells but these were noted to
have proliferated into nodules of Nageotte where neurons had entirely disappeared.
9
Enlarged axons and eosinophilic granules resembling inclusion bodies were observed in
some cells but inflammation was conspicuously absent. In less severe, chronic, cases
damage to neurons was thought to be as extensive as in acute cases but sympathetic
ganglia were greatly depleted. Extensively vacuolated, chromatolytic 'cell shadows' and
shrunken neurons with pyknotic nuclei were described in ganglia. The histopathological
similarity to changes associated with poliomyelitis, that unlike grass sickness results in
inflammation, and scrapie, that does not, was considered. Clinical signs of EGS were
attributed to increased sympathetic activity.
In 1959 Brownlee and Mahaffey described degenerative changes of neurons in the
coeliacomesenteric ganglia characterised by chromatolysis, the presence of small and
occasionally large vacuoles and nuclear pyknosis in acute and subacute cases of grass
sickness as well as in 3 out of 15 control horses. Brownlee (1965), remarked on the
relative paucity of neuronophagia of degenerating neurons. Howell et al (1974) noted
the numerous degenerate, foamy and necrotic neurones in the coeliacomesenteric
ganglia of cases of grass sickness which were not present in horses that died from other
causes. Vacuoles, pyknotic nuclei and some lymphocytes and macrophages were also
observed. Very similar changes have been described in the coeliacomesenteric ganglia
of cases of mal seco (Uzal et al, 1992).
A number of other publications have addressed the central histopathological changes
found in EGS and in mal seco. Barlow (1969) examined a limited number of brain
nuclei in two acute, three chronic and one case that had clinical sings of acute grass
sickness but no pathological changes in any of the tissues examined. The facial, lateral
vestibular, hypoglossal and dorsal motor vagal nuclei were normal in the acute cases but
showed some pathological changes in the chronic cases. Similarly, the oculomotor
nucleus was affected in the three chronic cases but not in one of the acute cases. No
pathology was noted in dorsal root ganglia, but abnormal nuclei in the spinal cord
ventral horns were seen in two out of three acute cases. Lipofuscin granules were
present in normal and abnormal neurons and neuronophagia was not observed. It was
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concluded that the CNS changes may be a specific part of the pathology of grass
sickness with the extent depending on the duration of clinical signs.
A more extensive survey, looking at 35 cases of EGS, was performed by Gilmour
(1973b) who concluded that lesions were more extensive and severe in acute and
subacute cases than in chronic cases. Specifically, pathological changes were seen in all
cases in the stellate, coeliacomesenteric, ciliary and dorsal root ganglia, the thoracic
sympathetic chain, oculomotor nuclei and intermediolateral horns of the spinal cord. 26
of 32 cases had abnormalities noted in CN VII and other nuclei, including the nuclei of
CN V, VI, VIII, GVE X, XII and the accessory cuneate nucleus were noted to be
affected in some cases but this was not quantified. The very extensive changes found in
autonomic neurons present in acute cases was felt to indicate that damage to extra-
enteric tissue precedes, or occurs coincidentally with, alimentary dysfunction.
Wright and Hodson (1988) on the other hand could not correlate the extent of central
changes with the clinical severity i.e. an acute versus chronic clinical course. Ten EGS
cases (2 AGS, 5 SGS, 34 CGS) and one laminitic horse were examined. A number of
nuclei and structures were specified as containing lesion. These include the nuclei of
CN III, VI, VII, VIII, GVE X, XII as well as the spinal trigeminal and primary sensory
nucleus of V, red nucleus and a number of structures and in the prosencephalon and
brainstem. The neuroanatomical accuracy of this study might be questioned however as
neurons were noted in the medial longitudinal fasciculus and the 'fields of forel', both
of which are white matter tracts. Few structures were examined in all the horses.
Lesions were noted to consist of a loss of cytoplasmic staining within the cytoplasm
resulting in a homogenous ground glass appearance. Pathology in the reticular
formation was most consistent, changes being present in seven of the eleven horses. In
only two horses were abnormal neurons found in the ventral horn of the spinal cord,
however the spinal cord segment and number of spinal cord sections examined was not
detailed. Two of eleven nuclei examined in the laminitis case also contained abnormal
neurons. The authors concluded that given the diversity of the nuclei involved and since
11
only two to three neurons per nucleus were affected, CNS involvement was likely to be
non-specific.
This supposition was supported by Hodson et al (1984b) who, unlike Gilmour (1973b)
argued that cytopathological changes in non enteric neurons appear to be similar to
retrograde degenerative lesions after axotomy and could therefore be a secondary
phenomenon following alimentary damage. This would lend weight to the concept that
the CNS changes are non specitic (Wright and Hodson, 1988). No effort was made to
establish whether chromatolytic central neurons, be they somatic or visceral, were
pathologically affected in the same manner as peripheral visceral neurons and go on to
die. Secondary axonal or muscle pathology of structures innervated by cranial nerves
have not been investigated.
In a histopathological study of the brain stem nuclei of 3 horses with mal seco, changes
were found that consisted of chromatolysis, cytoplasmic vacuoles, eosinophilic
spheroids, and pyknotic and eccentric nuclei. These changes were most severe in the
nuclei of CN III, VI and VIII (Uzal et al, 1994). It was suggested that the results
provided further evidence that mal seco and grass sickness may be the same disease.
Gilmour (1975) undertook a detailed light and ultrastructural examination of the stellate
ganglion. Pyknosis and cytoplasmic vacuolation, possibly originating from granular
endoplasmic reticulum was pi eminent, along with increased microtubules with an
absence of normal endoplasmic reticulum. Mitochondrial structure was similar to that
found in control samples. Numerous 5-15 pm, round, argyrophilic, eosinophilic bodies
surrounded by satellite cell processes were seen by light and electron microscopy in
perineuronal supporting tissue and in recesses in perikarya of normal and degenerate
neurons. These neurons contained mitochondria and vacuoles in vesiculotubular
material and were surrounded by a single limiting membrane and a sheath of satellite
cell processes. They were thought to represent dystrophic axons as similar changes had
been described in experimental and infantile neuraxonal dystrophy (Cowen and
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Olmstead, 1963). Hodson et al (1987) and Hodson and Wright (1984b) described three
types of neurons ultrastructurally in the coeliacomesenteric ganglia of 15 EGS cases.
The most common were chromatolytic neurons with marginated Nissl substance,
crenated and peripheral nuclei and dense bodies in cytoplasm. Many abnormal axons
were observed which were enlarged and showed accumulations, indicative of axonal
flow disruption. In addition there were neurons which appeared to be undergoing
dissolution with prominent dilations of cistemae and a crenated nucleus, while another
type was thought to be showing signs of recovery, containing aggregations of dense
bodies and neuronal autophagic vacuoles. The overall pathology was felt to be
compatible with retrograde lesions secondary to pathology of axons.
Primary morphological damage to axons was also suspected in work identifying
accumulations of nor-adrenaline in nerve fibre tracts within the stellate ganglion of
affected horses (Gilmour, 1976). These accumulations conformed with focal axonal
fragmentation and formation of argyrophilic fibrillar tangles seen in silver-stained
sections. This was supported by work showing that affected neurons have a marked
increase in dopamine-beta-hydroxylase, an enzyme associated with noradrenaline
synthesis, which may indicate a failure to be transported down the axon with resultant
accumulation in the perikaryon (Griffiths et al, 1993).
Transmission studies in which blood or serum from grass sickness cases was
administrated intraperitoneally to experimental ponies resulted in prevertebral ganglia
pathology and unspecified brainstem nuclear pathology indicated that the suspected
toxin was contained in a plasma protein fraction of molecular weight of 30,000 Da or
greater (Gilmour and Mould, 1977). Its identity however has not been determined as
toxicity appears to be inactivated during extraction procedures (Johnson, 1985) and
could not be detected by polyacrylamide gel electrophoresis (Johnson et al, 1983) or
thin layer chromatography (Pemberton et al, 1990).
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In order to demonstrate that a causative agent of EGS may reach neurons by retrograde
axonal transport, pooled sera from two acute cases of EGS were injected into the parotid
salivary gland of ponies (Griffiths et al, 1994a). The parotid salivary gland receives its
sympathetic innervation from the ipsilateral cranial cervical ganglion. Seven days later a
few neurons in the cranial cervical ganglia were found to be chromatolytic in four out of
five cases injected with acute serum. No clinical signs were apparent. Stellate and
coeliacomesenteric ganglia, which would have a haematogenous connection, were
unaffected however the otic ganglion, which supplies parasympathetic axons to the
parotid gland, was not examined. No chromatolysis was noted in the one subject
injected with serum from a chronic case, but a severe inflammatory infiltrate and
neuronophagia was apparent which was speculated to be attributable to antibodies
formed by the chronic cases. One further pony received serum fractionated to a
molecular weight of above or below 30 KD into the left and right parotid glands.
Chromatolysis was only observed in the ganglion on the side of the sample of the
greater molecular weight. The paucity of numbers of neurons affected was attributed to
the small percentage of cranial cervical axons which innervate the parotid salivary gland
and it was concluded that retrograde axonal transport of the neurotoxin is likely.
Rodents have been shown to retrogradely transport toxin at a rate of 180mm/day
(Stockel et al, 1975), Thus an intestinal toxin could reach enteric neurons very quickly
and theoretically reach all other ganglia within one to two days.
The search for potential aetiologic agents in grass sickness has been hampered by the
lack of a consensus of the pathogenesis. A limited amount of work has addressed the
associated cytopathology in EGS, and has focused on peripheral GVE neurons
(reviewed further in chapter 3). Pathology was marked by a reduction in neuropeptide-
containing ganglionic and mucosal endocrine cells (Sabate et al, 1983; Bishop et al,
1984) and changes to a wide array of cytoskeletal elements and an apparent absence of
Golgi apparatus (Griffiths et al, 1993). The authors commented that a complete loss of
the Golgi apparatus is very unusual in neuropathology but is not a known consequence
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of axonal disease. Neurons from experimental ponies to whom grass sickness serum
was administered by intraperitoneal injection (Gilmour, 1973a) had similar lectin -
immunohistochemical profiles (1R Griffiths, unpublished observations).
d) Clinicopathological correlates in Equine Grass Sickness
Very little progress has been made correlating the clinical signs of EGS with the
neuropathology since Grcig (1928) postulated that the majority of clinical signs in EGS
such as sweating, tachycardia and constipation were an expression of sympathicotonia.
The levels of plasma adrenocorticotropic hormone (ACTH), Cortisol and catecholamines
in cases of grass sickness and stressed and non stressed control horses (Hodson et al,
1984a; 1986) were assessed to try to support this hypothesis. Statistical evaluation
determined differences in hormone levels between groups of seven horses with EGS
(one acute, five subacute and one chronic), six horses with colic and 16 control horses
before and after mild stress. Plasma levels of the hormones were higher in horses with
acute and subacute grass sickness than in the other groups. It could not be concluded
whether the hyperactivation of the sympathetic system was caused by stress as a result
of the severity of the disease, or whether it also played a role in the aetiology.
Unfortunately only one sample from a chronic case was analysed and pertinent clinical
details, such as the presence of muscle fasciculation and heart rate, were not provided.
In an effort to further investigate eosphageal malfunction, that can be associated with
dysphagia in EGS cases, the passage of a barium bolus from pharynx to stomach in 25
cases was monitored by image intensification radiography (Greet and Whitwell, 1987).
A defect in oesophageal motility was detected in all 18 horses in which grass sickness
was later confirmed at post-mortem. Chromatolysis in brainstem nuclei was noted but
not detailed. Chromatolytic neurons were only occasionally observed in the oesophageal
myenteric plexus and the severity of eosphageal dysfunction was not correlated with
severity of neuronal pathology.
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The only attempts made to associate clinical signs and pathology are related to the
gastrointestinal tract. Scholles (1993) noted that the neuronal lesions of the small
intestine may explain the intractable gastrointestinal propulsive deficit that characterises
EGS, however severity assessment of the lesions was subjective. Quantitative work
(Doxey et al, 1992; Pogson et al, 1992) has been carried out to establish whether a
relationship exists between clinical severity and the extent of enteric neuronal
pathology, damage to neurons in the small intestine and selected para and prevertebral
ganglia. No connection between the clinical severity of acute or subacute dysautonomia
and the amount of neuronal damage in the cranial cervical, stellate and
coeliacomesenteric ganglia could be demonstrated. However a higher number of
neurons and a lower proportion of damaged neurons were found in chronic cases.
Similarly, in the jejunal submucosal and myenteric plexuses, chronic cases tended to
have a greater number and percentage of healthy neurons. A related study focusing on
the morphology of the enteric nervous system noted severe enteric neuropathy in all the
cases with EGS but a widespread distribution in the acute cases versus more focal
pathology in the distal intestine in chronic cases (Scholes et al, 1993).
Further work demonstrated that severe and extensive neuronal damage and loss
occurred in the ileum irrespective of the severity of clinical signs (Doxey et al, 1995)
and that the same pattern was seen in the small colon but it was always less obvious
than in the jejunum. In no cases was enteric neuronal damage and loss seen without
significant neuronal disruption also occurring in the coeliacomesenteric ganglia.
Conversely, attempts at experimental transmission by the intraperitoneal injection of
serum from horses with acute grass sickness into four ponies resulted in prevertebral
ganglionic pathology in the absence of enteric neuronal changes (Gilmour, 1973a).
Spinal cord intermediolateral horn and brainstem nuclei were also affected however
clinical signs did not develop in any of the cases. This was thought to indicate a
neurotoxic factor in the blood of horses with acute grass sickness possibly of an
insufficient dose icquired for the production of clinical disease.
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A functional in vitro study to investigate isometric motility of equine intestine from
horses with and without EGS was performed using strips of smooth muscle from the
small intestine of EGS-affected and control horses taken immediately post mortem
(Murray et al, 1994). Tissues obtained from horses suffering from acute grass sickness
had the longest latency before a measurable response could be obtained and the ileum
appeared to be damaged by EGS to a greater extent than the duodenum. By
investigating the in-vitro response to bethanechol, a muscarinic receptor agonist,
hypersensitivity was suggested in cases of acute grass sickness (Murray et al, 1994)
while latency measurements following exposure to physostigmine suggested that the
ileum of the EGS cases had a decreased number of active cholinergic neurons (Murray
et al, 1997).
Despite the widespread central pathology associated with EGS noted in several papers
(Barlow, 1969; Gilmour, 1973b; Wright and Hodson, 1988; Uzal et al, 1994), there are
no clinical signs reported or discussed which could be correlated to the specific lesions,
nor has correlating the non-enteric clinical signs such as dysphagia, trembling, rhinitis
sicca and ptosis with specific pathologic lesions been attempted. Lesions in a number of
structures might help explain some of the major clinical findings, but these have not
been considered specifically and it is likely that functional systems other than the GVF
system are involved in the aetiopathogenesis of some or all of these signs. These
structures could include the basal nuclei, oltactory system, oesophagus, trigeminal
ganglion and GVE lower motor neurons in the medulla that may be involved with
dysphagia, as well as spinal cord LMNs, peripheral nerves and appendicular muscles
that could be associated with trembling, and structures innervating the nasal mucosa that
could explain the rhinitis sicca.
Knowledge of neuroanatomy and neuropathology is paramount for reliable
interpretation of morbid entities involving the nervous system (Dexler, 1899) and
therefore the close examination of forebrain, brainstem, spinal cord and peripheral
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nervous system structures is required to establish the underlying pathology of these
common and often severe clinical signs in EGS.
e) Dysautonomia in other species
Dysautonomia appeared in cats in the early 1980s (Key and Gaskell, 1982) as abruptly
as it had done in horses over 70 years previously. These feline patients presented with
signs consistent with autonomic failure including persistent bilateral pupillary dilation,
dryness of the oral mucosa and reduced tear production, constipation, urinary
incontinence, regurgitation, megaoesophagus and prolapse of the third eyelid (Sharp et
al, 1984). Other aspects of neurological examination were reported to be normal but
Griffiths (1982) noted slowed proprioceptive test responses in some cases.
Chromatolytic neurons and neuronophagia were characteristically present in the
autonomic ganglia and the enteric nervous system of the cats, as well as GSE LMNs in
the ventral horn of the spinal cord and CN III, V, VII and XII, and GVE neurons in
CN X (Griffiths et al, 1982; Pollin and Griffiths, 1987). Feline dysautonomia has been
reported in a number of countries in northern Europe, as well as in New Zealand and the
United States (Edney and Gaskell, 1988), countries in which EGS is not documented.
The disease was not uncommon for several years but now appears to be confined to
sporadic clusters (Symonds et al, 1993). Very similar clinical signs and pathological
changes have been reported in a smaller number of dogs (Rochlitz and Bennett, 1983;
Longshore et al, 1996).
Whitwell ( 1991) reported several cases of hares that had been found dead with gross
PM changes reminiscent of grass sickness including marked cachexia, a distended
stomach, colonic impaction and mucus in the rectal lumen. Leporine dysautonomia was
confirmed in further animals (Griffiths and Whitwell, 1993; Whitwell, 1994) with
peripheral histopathological and ultrastructural changes apparently identical to those in
horses, cats and dogs. Similar lesions have been noted in wild rabbits (K.E. Whitwell,
personal communication) and a recent report (Kik and van der Haage, 1999) recorded a
18
case of a llama (Llama glama) with clinical, gross and histopathological changes
compatible with dysautonomia. The only lesions noted in the brain of that animal were
chromatolytic neurons in the lateral cuneate nucleus.
f) Neurodegenerative diseases
The neurodegenerative disorders are slowly progressive diseases that lead to loss of
specific neuronal populations and processes (Waggie et al, 1999) and are often
classified as such on the basis of not fitting overtly into the categories of infectious,
inflammatory, neoplastic or toxic disorders (Oliver et al, 1997). The use of this tenn
appears to currently be out of favour with neuropathology text books (Graham and
Lantos, 1997). Nevertheless the classification has merit in that it groups together some
of the most devastating neurological diseases with unknown aetiologies. EGS may be
included as a neurodegenerative disease (Gruys et al, 1994) on the basis of the death of
defined groups of neurons, even though the disease can be rapidly progressive and does
not invariably lead to the death of the animal.
A limited number of diseases of unknown aetiology leading to a loss of a defined group
of neurons have been documented in horses. Premature early degeneration is
exemplified by the cerebellar abiotrophies, known to be familial in Arahian, Gotland
and Oldenberg breeds and present in Eriskay ponies (Hahn et al, 1999). Histologic
abnormalities of the cerebellar cortex are principally a diffuse reduction of neurons in
the granular and molecular layers, as well as degeneration and disorientation of Purkinje
cells. A further disease with a familial component is equine degenerative
myeloencephalopathy, characterised clinically by quadripedal ataxia and pathologically
by prominent neuronal fibre degeneration in the spinal cord and brainstem and
neuroaxonal dystrophy in the nucleus thoracicus and lateral cuneate nucleus (Mayhew et
al, 1977). The exact pathogenesis of EDM is unknown however deficiency of vitamin E
is a causative factor. Low dietary alpha tocopherol has similarly been shown to be of
major importance in equine motor neuron disease (EMND), a disease resulting in
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profound weakness and degeneration of alpha motor neurons in the spinal cord and
specific, brainstem nuclei (Cummings et al, 1990). It has a striking resemblance to
progressive muscular atrophy, one of the forms of human motor neuron disease.
Objective
The objective of this work was to investigate the central nervous system pathology in
cases of equine grass sickness, and to determine the neuropathological correlates of
some of the characteristic clinical signs.
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1. INTRODUCTION
The clinical and gross pathological picture of 'Grass disease' has been noted in the
literature since 1927 , but it was Obel (1955), who published the first comprehensive
review of the pathology of EGS. The morphology of neurons in the intestines and
sympathetic ganglia were emphasised, but the appearance of'ganglia cells' in the
medulla oblongata and spinal cord was also referred to (Figure 2-1). These were
described as being chromatolytic and containing vacuoles and eosinophilic granules
resembling inclusion bodies.
Four publications have addressed the central nervous system (CNS) pathology in grass
sickness and mal seco (Barlow, 1969; Gilmour, 1973b; Wright and Flodson, 1988; Uzal
et al, 1994), examining different, and occasionally poorly defined, central structures and
variable numbers of cases and control animals. The central neuronal changes were
described as being degenerative in character, involving initial central chromatolysis and
eccentric, pyknotic nuclei. There was no agreement on the association or severity of
clinical signs with the severity of central pathological changes. Barlow (1969) noted
specific pathological changes correlated with disease duration, Gilmour (1973b) found
more severe lesions in the more severe (acute) cases, and Wright (1988) concluded that
the pathology was non-specific with no correlation to disease severity or duration. The
latter paper also noted that in two instances abnormal neurons were also found in an
orthopaedic control case. Gilmour (1973b) suggested that the very extensive changes
found in peripheral autonomic neurons of acute cases indicated that damage to central
tissue preceded, or occurred coincidentally with, alimentary dysfunction.
The disease is generally classified as a dysautonomia (Sharp, 1987) with some of the
histopathological changes resembling human familial dysautonomia. The recognition of
lower motor neuron (LMN) changes in the spinal cord of some cases however, has
posed the question whether EGS could represent an overlap syndrome of equine motor
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neuron disease (EMND) (Gerber and Gerber, 1997; Vandevelde, 1997), as has been
proposed with some human neurodegenerative diseases (Hart and Kanter, 1990).
There has been no attempt to correlate any GSE central changes with somatic clinical
signs. Muscle trembling is a prominent clinical sign of EGS (Pool, 1927; Holman et al,
1944) but its aetiology has not been addressed, nor has the correct descriptive
terminology been resolved. Pathological fasciculations are commonly seen in human
diseases of the lower motor neuron and are frequently found in patients with
amyotrophic lateral sclerosis (Conradi et al, 1982). The presence of benign
fasciculations and cramps in subclinical ALS patients implicates anterior hom cell
dysfunction in the pathogenesis of muscle fasciculation-cramp syndromes (Fleet and
Watson, 1986) and Sharp (1984) speculated that the muscle trembling see in EGS may
be related to ventral hom cell involvement. It is thus relevant to detemiine if spinal cord
LMN chromatolysis is correlated with trembling in EGS.
A thorough description of the central neuroanatomical distribution and severity of
lesions in EGS is fundamental to further investigations into the pathogenesis of the
cytopathology and the aetiology of clinical signs, and is the basis of this study.
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The hypoglossal nucleus. The majority of the nerve cells
are subject to chromatolysis (C) and a number of these are
also subject to shrinking and basophilia (B). At N there is
a normal ganglion cell.
Figure 2-1: From Obel, L. Studies on Grass Disease. J. Comp. Path. 1955.
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2. MATERIALS AND METHODS
a) Case material
The brains of 72 horses (28 AGS, 15 SGS, 17 CGS cases and 12 non-neurological
control animals) were obtained between 1995 and 1998 (Appendix 2). Animals were
euthanised with a mixture of quinalbarbitone and cinchocaine (Somulose, Arnolds,
UK). The head was disarticulated at the atlanto-occipital articulation and the brain was
collected by sawing through the calvarium to harvest the brain as soon as possible after
euthanasia, usually within 20 minutes.
For harvesting and processing the spinal cord tissue see section g below.
b) Tissue materials and methods
An incision was made at the level of the basal nuclei of the brain to allow fixative to
enter the ventricles, and the brain and spinal cord were immersed in a large volume of
4% neutral buffered formaldehyde. After fixing for at least one week, the brain was
blocked for processing. 4 mm blocks were taken at the level of the basal nuclei,
hypothalamus, rostral colliculus, caudal colliculus and confluence of the peduncles, and
the entire medulla oblongata was blocked to 1 cm caudal to the obex. Transverse blocks
of tissue were labelled according to the nomenclature of Singer (1962) and embedded
into paraffin blocks. The tissues were routinely processed and one 5 micron thick
section was cut from the rostral surface of each block and processed to haematoxylin
and eosin slides by the Moredun Research Institute. This one section from each block,
was the only one where analysis was carried out, avoiding any problems with possible
multiple counting of single neurons
c) Nuclear regions examined
Slides were examined blinded by the principal observer on a Nikon Optiphot-2
microscope. The entire section was surveyed for signs of pathology and special
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attention was paid to the structures and nuclei in Table 2-2, present in most of the cases.
Additional structures, such as central axons of cranial nerves and the parasympathetic
nuclei of CN III, VII, and IX (rostral GVE column), were examined when available.
Each structure was identified and significant lesions were recorded. A pilot study
indicated that chromatolysis of neurons (somata) in specific brainstem nuclei was a
feature of EGS cases, and subsequently the proportion of chromatolytic neurons in
affected nuclei was recorded in the majority of affected nuclei. For each nucleus in each
section on which chromatolytic neurons were noted, the number of chromatolytic and
normal cells examined was recorded. In a minority of sections (<20%) this proportion
was estimated. The estimation of proportions was substantiated by counting a number of
samples until the observer was confident that estimations were comparable to counted
proportions. Neurons were only counted in fields in which there was evidence of
chromatolysis. If the nucleus was bilateral, the combined data from both nuclei were
included in the analysis, the validity of assuming symmetry of the proportions of
chromatolytic neurons between nuclei on left and right sides of the brain having been
determined (Wilcoxon Signed Rank Test, p > 0.05, Figure 2-2).
Neurons within a nucleus were counted using an eye-piece graticule (100 pm squares,
Graticules, Pyser-SGI ltd) with neurons at the edges of the nucleus being included if the
majority of the soma was within the giid. All neurons were included regardless of
whether they contained a nucleus because of the concern that the number of
chromatolytic neurons, with their characteristically swollen soma and eccentrically
placed nucleus (Summers et al, 1995), would be underestimated if they were only
included when a nucleus was present on the section. Also, a pilot study had determined
that there was no significant difference in the proportion of chromatolytic neurons
determined when counting neurons with or without nuclei (18 nuclei, Student's t-test,
p>0.95). Data were entered into a customised database (Access, Microsoft Inc).
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Summary statistics were calculated and displayed using statistical software (SigmanStat
and SigmaPlot, SPSS Science).
Right
Figure 2-2: Proportion of neurons chrcmatolytic, left and right sides of
brain.
Scatter plot of data with simple regression line from185 sections containing left
and right nuclei. Regression line slope = 0.4.
d) Consistency of pathology
(i) Agreement of the presence of pathology between repeated
sections through a nucleus
Due to the regular blocking method, individual nuclei were examined on multiple
occasions depending on the length of the nucleus. Data from the nuclei of CN 111, V,
VII, XII or the parasympathetic nucleus of the vagus nerve (CiVE X), were
systematically examined to determine the proportion of cases in which an individual
nucleus within a case was noted to contain chromatolytic neurons (somata) on at least
one section, and to be unaffected on other sections.
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(ii) Consistency of the proportion of chromatolytic neurons noted
on repeated sections through a nucleus
To further evaluate repeatability, repeated sections of three nuclei were made and the
percentage of chromatolytic neurons in the nuclei of GVE X and CN XII were evaluated
in one case and the nucleus of CN VII was determined in another by counting the
neurons in those nuclei on each section.
Data were analysed using a Kruskal-Wallis One Way Analysis of Variance on Ranks
and the Kappa value of spatial repeatability was calculated.
(iii) Consistency of pathology within the general visceral efferent
functional system
Similarly, the uniformity of pathology within a defined functional system (de Lahunta,
1983), the GVE column, was assessed by determining if the presence or absence of
neuronal chromatolysis in the portion of the GVE column rostral to the nucleus of CN
XII (GVE nuclei of CN III, VII and IX) was in agreement with pathology in the caudal
portion (GVE X). Neurons in the nucleus of CN III were defined as being part of the
GSE column if they were on the same section as neurons of the red nucleus and of a size
similar to other somatic neurons. Small neurons in the sections further rostrally were
defined as being part of the GVE column.
e) Severity of brainstem somatic lower motor neuron pathology
A pilot study determined that the somatic nuclei of CN III, V, VII and XII were the
nuclei most consistently included with the strategic blocking method used in this study,
and the severity of brain pathology was assessed by focusing on the these nuclei.
Severity of pathology was assessed by determining the proportion of those nuclei
affected in individual cases, the proportion of neurons chromatolytic in those nuclei and
the proportion of sections containing these four nuclei examined in each case which
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contained chromatolytic neurons. The proportion of cases with abnormalities noted in
the nuclei of CN 111, V, VII and XII in AGS, SGS and CGScases was determined and
the 95% confidence intervals (CI) calculated from the Binomial distribution(Rohlf and
Sokal, 1981).
Data of the proportion of chromatolytic nuclei of CN III, V, VII and XII, the proportion
of chromatolytic neurons in those nuclei and the proportion of sections with
chromatolylie neurons were initially examined using descriptive statistics of the raw
data. Figure 2-3 shows an example of summary data. Pseudoreplication of data and the
use of multiple data entries per animal precluded effective interpretation of the material.
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To avoid pseudorcplication, the total number of chromatolytic and normal neurons for a
specific nucleus in an individual case was calculated by adding all the data from
different sections of that nucleus. Since there was no evidence of neuronal death in
nuclei in which chromatolysis was noted, the median total number of neurons counted
in affected nuclei was used to estimate the number of neurons present on the small
proportion of normal sections on which the neurons had not been counted. This
assumption was checked by repeating the analyses with the 25th and 75th percentiles and
was found not to affect the results.
In order to determine which of the explanatory variables (diagnostic category, days
affected and age) were important, and exactly how these variables were related to the
severity of central pathology, data from the 58 EGS cases in which the majority of the
four nuclei were available were analysed using generalised linear models and the
software package GLIM 3.77 (Royal Statistical Society, London 1985). Generalised
linear models were considered to be an appropriate tool for the analysis of the data in
this study since, unlike standard linear regression models, they allow the inclusion of
variables with normal and non-normal distributions. Models with binomial error
structures were used to analyse proportion data without loss of statistical power and all
predictor variables were fitted along with interaction terms. Overdispersion was
corrected for using Williams correction (Crawley, 1993). For the proportion of nuclei,
neurons and sections affected, variables investigated were the age of the animal, the
diagnostic category of EGS and the duration of disease in chronic cases. The
significance of model terms was assessed by stepwise removal from the corrected
maximal model, comparing the change in residual variance to the Chi-squared
distribution with the appropriate degrees of freedom. In order to determine which
diagnostic categories had an effect on the model, the analysis was first repeated
excluding data from AGS cases, and then repeated comparing data from SGS and CGS
cases together with data from AGS cases. Data were analysed for all four nuclei
together giving equal weights to all four nuclei.
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f) Sensitivity of strategic central neuropathology as a post mortem
diagnostic test
All data was re-evaluated to determine the sensitivity of a complete neuropathology
examination of the brain when used as a post-mortem diagnostic test for EGS.
g) Spinal cord neuropathology and the correlation between muscle
trembling and LMN chromatolysis in EGS
A subjective grade on a scale of 0 (no trembling) to 4 (severe) was assigned to eight
EGS cases, focusing on the appendicular musculature of the thoracic limb. Since the
degree of trembling shown by a case at a particular time was found to be very variable,
the greatest severity noted was used in the analysis.
At least one section of spinal cord, either CI or C8, was removed from EGS 49 cases by
isolating the vertebral column and exposing the spinal cord with parasagittal cuts using
a band saw (Bursgreen, Wadkin ltd.). The spinal cord cervicothoracic intumescence was
isolated and sectioned at it widest point, corresponding to the C8 segment. All
multipolar cells with 3-5 concave sides and densely stained Nissl substance in the
cytoplasm in both ventral horns were counted as lower motor neurons. In addition, all
chromatolytic cells in the ventral horn were counted and noted as a proportion of all
LMNs, The ventral horn was defined as the grey matter ventral to a straight horizontal
line through the central canal (Polack et al, 1998).
The number of chromatolytic LMN neurons was reviewed in the eight cases in which a
trembling score had been detennined in order to determine if there was an association.
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h) Lateral cuneate nuclei
The lateral cuneate nuclei had been noted to contain prominent spheroids in a pilot
study, and have been reported to be involved in EGS (Gilmour, 1973b). Sections
containing the lateral cuneate nucleus were re-examined in 13 EGS cases (7 AGS, 5
SGS and 1 CGS) and four control animals by two blinded observers and scored
according to the degree of pathology. If the scores from the left and right lateral cuneate
nuclei were different the higher score was used. Pathology was graded 0 (one or two
isolated spheroids), 1 (more than two isolated, small spheroids), 2 (several large
spheroids), 3 (substantial spheroid formation with vacuolation or fragmentation) or 4
(substantial spheroid formation with vacuolation and fragmentation, loss of cell bodies,
prominent astrocytosis and lipofuscin deposits).
3. RESULTS
a) Case material
A significantly larger proportion (Chi Square: p <0.003, Table 2-1) of cases included in
this database had acute grass sickness compared to cases presented to the R(D)SVS in
the previous 10 years. The proportion of chronic cases examined however was not
significantly different (P=0.14). The true EGS case distribution is unknown, but it is
likely that chronic cases at the R(D)SVS are over represented since these would be
viewed as potentially treatable by referring practitioners.
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Table 2-1: Proportion of cases (N) in the three clinical categories of EGS
included in this study










Over 2000 observations were entered into the data base for analysis. Significant
pathology was restricted to changes of the neuronal somata, which were swollen with
pale pink cytoplasm lacking apparent Nissl substance and (often) containing a central or
eccentric 'open faced' nucleus (Figure 2-4). An occasional chromatolytic neuron was
seen in the reticular formation on some sections. More significantly, a proportion of
LMN neurons in specific GSE and GVE nuclei in the brain (Figure 2-5) and spinal cord
appeared markedly chromatolytic. Occasional neurons appeared to be undergoing
central chromatolysis and rarely the nucleus was pyknotic. Evidence of neuronophagia
or glial scarring was no more prominent in sections examined from EGS than in control
cases. Small and medium sized axonal spheroids were frequently observed in the lateral
cuneate nucleus. Three acute cases and one subacute case of confirmed EGS had no
evidence of pathology noted in the brainstem, and in one further acute and one chronic
case no central somatic neuronal pathology was noted. The material from these cases
was re-examined but no further sections were cut. The occurrence of neuronal pathology
is summarised for all cases of EGS in Table 2-1.
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Figure 2-4: Normal (A) and chromatolytic (B) lower motor neurons,
nucleus of CN XII, CGS
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Figure 2-5: Diagram of the distribution of chromatolytic neurons in the
nuclei of cranial nerves at representative levels of the brain. The proportion
of neurons affected is not represented. Modified from de Lahunta (1983).
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Table 2-2: Summary of neuronal pathology in EGS cases
Nucleus or Structure Affected Total Prop Affected
(95% CI)
Olfactory bulb 0 11 0 (0 - 0.28)
Temporal lobe cortex 0 34 0(0-0.10)
Cerebellum 0 40 0 (0 - 0.09)
Basal nuclei - caudate, putamen, pallidum 0 34 0(0-0.10)
Thalamus 0 31 0(0-0.11)
GSE nucleus of CN III 36 62 0.58 (0.45-0.70)
GVE nuc. of CN III (Rostral GVE column) 7 16 0.44 (0.20 - 0.70)
Red nucleus 0 46 0 (0 - 0.08)
Substantia Nigra 0 38 0 (0 - 0.09)
Mesencephalic nucleus of CN V 2 60 0.03 (0 - 0.06)
Pontine Nuclei 0 42 0 (0 - 0.08)
Motor nucleus of V 21 54 0.39 (0.26-0.53)
Nucleus of CN VI 10 32 0.31 (0.16-0.50)
Cochlear nucleus 0 18 0(0-0.19)
Vestibular nuclei 3 57 0.05 (0.01 -0.15)
GSE nucleus ofCN VII 28 55 0.51 (0.37 -0.65)
Nucleus of the Trigeminal tract 0 52 0 (0 - 0.07)
Reticular formation 3 42 0.07 (0.01 -0.19)
Olivary nucleus 0 33 0(0-0.11)
Nucleus of GVE X (Caudal GVE column) 16 58 0.28 (0.17-0.41)
Nucleus of CN XII 20 58 0.34 (0.22 - 0.48)
Nucleus of the Solitary Tract 0 18 0(0-0.19)
Lateral Cuncatc nucleus 0 42 0 (0-0.08)
Spinal cord LMNs 17 49 0.35 (0.22 - 0.50)
Spinal cord ILH Neurons 15 18 0. 83 (0.59-0.96)
Total = number of cases in which the nucleus or structure was examined.
The 95% confidence intervals (CI) were calculated from the Binomial
distribution (Rohlf and Sokal, 1981).
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c) Control animals
Very few lesions were recognised in control animals. Spheroids were occasionally noted
in the reticular formation and particularly the lateral cuneate nucleus, and shrunken or
dark staining neurons and neuropil vacuoles were infrequently described but were
concluded to be processing artefact. A few small accumulations of mononuclear cells
('glial scars') were seen in the grey matter of the cortex of one case. With the exception
of two chromatolytic cell bodies in the red nucleus of one control animal, no nuclear
regions examined were found to contain chromatolytic neurons.
d) Consistency of pathology
(i) Agreement of the presence of pathology between repeated
sections through a nucleus
A total of 185 sections containing more than one section each of the nucleus of CN III,
V, VII, XII or GVE X were examined, of which 33 sections were classified as
unmatched. There was no significant difference in the proportion of cases in which there
was disagreement in the pathology of individual nuclei when either the data of different
nuclei in all cases of grass sickness (p >0.25), or the different severity categories of
grass sickness for all the nuclei (p >0.5) were compared by a Kruskal-Wallis one way
analysis of variance on ranks. To evaluate the proportion agreement beyond chance, all
the disagreement data were combined giving a moderate Kappa value for spatial
repeatability of 0.59 (95% CI 0.45 to 0.74).
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(ii) Consistency of the proportion of chromatolytic neurons noted
on repeated sections through a nucleus
The proportion of chromatolytic neurons was determined on 28 repeated sections of four
blocks of the nuclei of CN X and CN XII on one case, and from 19 sections of three
blocks of the nucleus of CN VII from another (Figure 2-6). MannWhitney Rank Sum
Tests comparing the first section in each block, the result of which were initially noted
in the database, with the subsequent sections through that block, showed no significant
difference in the 11 blocks examined (p>0.1). The data between blocks was compared
using a one way analysis of variance on ranks and was not significantly different for the
nucleus of GVE X (p> 0.1) or CN VII (p>0.5), but was significantly different for CN
XII (p> 0.02). Tukey's multiple comparison procedures indicated that in that in the




GVE X CN XII CN VII
Figure 2-6: Repeated sections summary data
Key: The ends of the boxes define the 25 and 75th percentiles with a line at
the median and error bars defining the 1(jh and 90th percentiles.
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(iii) Consistency: GVE column
The number of neurons in the rostral GVE column was probably underestimated as it is
likely that a number of the chromatolytic neurons noted as GSE in the oculomotor
nucleus, are actually part of the Rostral GVE column. For the sake of consistency
however only neurons in the very rostral part of the mesencephalon were included as
part of the rostral GVE column.
There was poor agreement (Kappa = 0.23) between the presence of neuronal
chromatolysis in the rostral and caudal portions of the GVE column, with disagreement
on the presence of pathology (present in the caudal portion and absent in the rostral
portion, or vice versa) in 11/13 cases.
e) Severity of brainstem somatic lower motor neuron pathology
Data from the somatic nuclei of CN III, V, VII and XII from 59 horses were thus
analysed using general linear models. A total of 9319 neurons on 472 sections were
examined. Data for all four nuclei were not available for each animal with 76%, 17%
and 7% of cases having four, three and two nuclei noted respectively.
(i) Proportion of nuclei affected
Summary data of the proportion of cases with chromalulytic neurons noted in the nuclei
of CN III, V, VII or XII for AGS, SGS and CGS cases are given in Figure 2-7. The
proportion of the four nuclei containing chromatolytic neurons in cases included in the
model differed significantly (pO.OOl) between the diagnosis categories (Figure 2-8),
and varied inversely and significantly (p<0001) with the age of the animal (Figure 2-9).
The interaction between these terms was not significant (p>0.05) showing that the effect
of age was similar in all three diagnosis categories. Further analysis revealed that the
proportion of nuclei affected did not vary between SGS and CGS cases (p>0.05), and
the proportion of nuclei affected in SGS and CGS cases was significantly (p<0.001)
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higher than that in AGS cases. Duration of illness was analysed only for chronic cases,
since acute and subacute cases were in the hospital for only short durations. This had a
significant negative effect (p<0.05), but this was small compared to the effect of age.
(ii) Proportion of chromatolytic neurons
The proportion of all chromatolytic neurons in the nuclei of CN III, V, VII and XII
differed significantly (p<0.001) between the diagnosis categories (Figure 2-8), and
varied significantly (p<0001) and inversely with the age of the animal (Figure 2-9). The
interaction between these terms was not significant (p>0.05). The proportion of nuclei
affected did not vary between SGS and CGS cases (p>0.1), but was significantly higher
than that in AGS cases (p<0.005). In a separate model containing only CGS cases, age
had a marginally significant effect (0.1>p>0.05) and duration did not have a significant
effect on the proportion of chromatolytic neurons present.
(iii) Proportion of sections with chromatolytic neurons
Both the diagnosis (p<0.001, Figure 2-8) and age (p<0.001, Figure 2-9), but not their
interaction (p>0.1), showed a significant influence in the model. All the diagnosis
categories were significantly different from each other (AGS, p<0.001; SGS and CGS,
p<0.05). When only chronic cases were considered, age again had a significant negative














Figure 2-7: The proportion of cases with chromatolytic neurons noted in
the nuclei of CN III, V, VII or XII for AGS, SGS and CGS cases.
Model mean plus 95% CI. The number of cases examined are given below the
x axis.
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(i) Proportion of nuclei




















(iii) Proportion of sections
AGS SGS CGS
Figure 2-8: The proportion of neurons (i) nuclei (ii) and sections (iii) of CN
III, V, VII and XII with chromatolytic neurons in AGS, SGS and CGS cases.
Data plotted are model estimates + 1 S.E. The difference between different
letters is statistically significant, p < 0.001.
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(i) Proportion of nuclei
(ii) Proportion of neurons
Aae
0 5 10 15 20
Age
(iii) Proportion of sections
Age
Figure 2-9: Influence of age on the proportion neurons (i) nuclei (ii) and
sections (iii) of CN III, V, VII and XII with chromatolytic neurons in AGS,
SGS and CGS casess. Points are model estimates.
Key: AGS - • , SGS - ° , CGS - •
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f) Sensitivity of strategic central neuropathology as a post mortem
diagnostic test
When all CNS sections from 58 EGS cases and 12 control animals were considered, 54
EGS cases had chromatolytic neurons noted on at least one CNS section in the GVE or
GSE nuclear columns whereas four cases did not. No control animal had chromatolytic
neurons noted in these nuclei. A sensitivity of 93% and specificity of 100% was thus
derived for diagnosing EGS following a complete CNS histopathologic investigation.
g) Spinal cord pathology and the correlation between muscle trembling
and LMN chromatolysis in EGS
Chromatolysis of preganglionic sympathetic neurons in the intermediolateral horn was
noted in 83% of the 18 cases examined. GSE LMN chromatolysis was present in 35%
of the 49 cases in which at least one section of spinal cord had been examined
(Table 2-2).
The median trembling score was 2, range 1-3. Seven of the eight cases had no evidence
of spinal cord LMN chromatolysis noted. One case showed evidence of chromatolysis
in a small proportion of LMNs (0.06) and had a low trembling score (1). There
appeared to be no correlation between trembling scores and spinal cord LMN
chromatolysis.
h) Lateral cuneate nuclei
Case and severity score summaries are given in Table 2-3. If the scores from the left and
right lateral cuneate nuclei were different the higher score was used. There was no
statistical difference between the scores of EGS cases and control animals (Mann-
Whitney Rank Sum Test, p=0.1).
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EGS 13 3 (2-5) 0(0-2)
Control 4 7.5 (2-8) 2 (0-1)
Key: 0 = one or two isolated spheroids, 1 = more than two isolated, small
spheroids, 2 = several large spheroids
4. DISCUSSION
The distribution of central lesions in EGS appears to be very specific and repeatable, to
the extent that strategic central neuropathology could be used as a sensitive and specific
post mortem diagnostic test. This agrees with Barlow (1969) but contradicts the
conclusions drawn by Wright (1988). The latter study, although it examined 11 cases,
did not assess all nuclei in each case and may have been confounded by the nuclei not
being diffusely affected throughout the GVE or GSE column. All previous studies that
examined the brain of grass sickness (Barlow, 1969; Gilmour, 1973b; Wright and
Hodson, 1988) and mal seco (Uzal et al, 1994) cases , reported pathology in one of the
vestibular nuclei. Only three cases in the current study had a few chromatolytic neurons
noted in the vestibular nuclei on careful examination of 58 cases, the neuroanatomic
identity of affected nuclei having been confirmed by specialists in the field. It may be
that the authors of the previous papers had mistaken neurons of the motor nucleus of
CN V for a vestibular nucleus, since the former have similar sized neurons and are
placed only slightly further rostral to the latter.
The distribution of central pathology in EGS in this study is unlike that reported in any
other equine or human disease, however it appears to he the strikingly similar to that in
cats (Griffiths et al, 1982), dogs (Schultze et al, 1997) and hares (unpublished
observations) with primary dysautonomias. Unlike the horses in this study however,
chromatolytic neurons were not seen in cases of cats with dysautonomia with disease
duration of longer than 2 weeks.
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Similarly to EGS, the nuclei of the hypoglossal, facial and trigeminal motor nuclei are
also regularly affected in amyotrophic lateral sclerosis in humans (Blackwood et al,
1964; Esiri, 1996) but the oculomotor, trochlear and abducens nuclei are not. It has been
observed however that in cases in which respiratory support has prolonged life of
human patients by delaying death from respiratory failure, nuclei regarded as resistant to
disease, including the oculomotor nuclei, have been found to be affected. This may
imply that the selective vulnerability of a functional system is a relative phenomenon
and, given time, the changes become more widespread (Ince et al, 1998). A similar
process may account for the finding that the somatic nucleus of CN X was not noted to
contain chromatolytic neurons, despite representing a large portion of the caudal
somatic efferent column and being affected in cats (Pollin and Griffiths, 1987) and
hares (unpublished observations) with dysautonomia. The 'nucleus ambiguus' is
notoriously difficult to distinguish from other nuclei in the reticular formation, however
it would have been registered if chromatolytic neurons had been present.
A specific anatomic distribution of neuropathology is a feature of a number of human
and animal neurodegenerative diseases, suggesting that the neurons in affected nuclei
share a common factor making them sensitive to specific insults. Individual neurons
differ greatly from each other in architecture, neurotransmitter production, state of
functional activity and metabolic requirements. A specific shared feature, such as
metabolic activity, unique to a pool of neurons, may make these neurons selectively
vulnerable to a particular insult (Waggie et al, 1999) and solving this intriguing
question may greatly improve the opportunity to determine the respective aetiologies.
Lesions in the motor nuclei of the trigeminal, facial and hypoglossal nerves are also a
consistent features of EMND (Cummings et al, 1990), however the lack of pathology in
the nucleus of CN III in that disease and the absence of the punctate eosinophilic
neuronal inclusions (Cummings et al, 1993) or evidence of neuronal death in the CNS
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Figure 2-10: Chromatolytic motor neuron, equine motor neuron disease.
Note cytoplasmic inclusions in the soma of the nucleus of cranial nerve VII next
to an accumulation of glial cells removing the remainder of a necrotic neuron
(H&E x 400).
A further feature dividing EGS from classical human neurodegenerative diseases
(Schwartz et al, 1999), is the absence of an invariable increase in severity of pathology
and clinical signs with increased duration of disease. The changes in central neuronal
pathology in EGS cases have been described as being degenerative in character and to
become more severe with increasing duration (Barlow, 1969). However the current
study does not support this. The small statistical trend for decreasing severity of brain
pathology with increased duration of disease may siggest somatic neurons are
recovering from the initiating insult. In the absence of a clinical model however it is not
possible to determine whether those animals had less severe disease from the outset.
Sections from the brain of one animal examined many )ears after recovering from EGS
(unpublished observations), had a marked depletion of peripheral postganglionic
sympathetic neurons but did not have evidence of loss of central neurons or formation
of glial scars, as was also the case in this study, suggesting that central neuronal
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(unpublished observations), had a marked depletion of peripheral postganglionic
sympathetic neurons but did not have evidence of loss of central neurons or formation
of glial scars, as was also the case in this study, suggesting that central neuronal
recovery occurs in time. The presence of degenerating neurons and neuronophagic
nodules however has been reported in cats with dysautonomia (Pollin and Griffiths,
1987), which implies a difference in the cellular pathology despite the similarity in the
distribution of affected neurons.
More difficult to explain is the clear association in this study between increased severity
of central neuronal pathology and less severe clinical disease; AGS cases having fewer
chromatolytic central neurons than CGS cases. This opposes observations by Gilmour
[11] who recorded a greater severity in acute cases. The durations of disease were not
equivalent between diagnostic categories and it would be interesting to establish
whether acute cases with longer durations have a severity of central neuropathology
equivalent to chronic cases at the same duration of disease. This study would be
extremely difficult to perform because determining the severity of enteric neuronal
pathology necessitates early euthanasia in the former group of cases.
The inverse association of age and severity of brain pathology by all criteria examined
had not been recugnised prior to obtaining the results of the statistical models. It is
known that younger adult animals are predisposed to EGS (Gilmour and Jolly, 1974;
Doxey et al, 1991a; Wood et al, 1998) with a later comprehensive epidemiological
study (Wood et al, 1994) finding that 56% of EGS cases were five years or younger.
However, there is no difference in ages between animals affected with acute, subacute
or chronic disease which have been presented to the University of Edinburgh in the last
ten years, suggesting that age is not associated with the clinical severity of peripheral
neuronal pathology.
The lack of correlation between trembling and spinal cord lower motor neuron soma
pathology in EGS implies that this clinical sign is unlikely to be due to LMN paresis but
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may be a physiological tremor. The characteristics of the trembling differs from those
invariably seen in equine motor neuron disease (Divers et al, 1992; Kuwamura et al,
1994), the tremors in EGS consisting of finer, higher frequency fasciculations extending
over the axial musculature and continuing when the horse is recumbent. Fasciculations
can be caused by a variety of lesions to peripheral structures from the nerve root to the
neuromuscular junction (Lance, 1988; Desai and Swash, 1997, Layzer, 1994). Higher
frequency physiological tremor such as 'essential tremor' is common in humans and can
be modified by cortical input (Teravainen and Larsen, 1984; Comby et al, 1992) but the
anatomical origin of the abnormal discharges is not known (Simpson and Thomaides,
1988). Electrodiagnostic techniques may be required to determine if the trembling is
due to the activity of individual muscle fibres (fibrillations), whole motor units
(fasciculations) or consists of undulation of entire muscle bellies (myokymia) (Lance,
1988) and to attempt to determine where they originate (Behnia and Kelly, 1991;
Layzer, 1994).
A structure frequently reported to be abnormal in EGS cases is the lateral cuneate
nucleus. The abnormalities noted were almost certainly spheroids, which represent focal
distensions of axons with organelles that normally are in transit away from or towards
the soma and are a non-specific response to many diverse insults. They are encountered
with increasing frequency with progressive age (Summers et al, 1995) and are a
diagnostic characteristic of equine degenerative myeloencephalopathy (Mayhew et al,
1977), a disease that is associated with vitamin E deficiency and may have a familial
component (Beech, 1994). An increased frequency of spheroids in the lateral cuneate
nucleus has also been noted in cases of equine idiopathic laryngeal hemiplegia, a
disease characterised by distal axonopathy of the recurrent laryngeal nerve (Cahill and
Goulden, 1989). In the absence of a case control study however, as was undertaken here,
it can be difficult to determine if the presence of spheroids is within normal ranges for
the age of the animal, and this may account for the observation of pathology in this
structure by previous authors.
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In conclusion, the consistent finding of somatic neuronal chromatolysis in EGS suggests
that, despite the lack of apparent somatic neuronal cell death or overt clinical evidence
of clinical somatic involvement, this disease should be classified as a multiple system
disorder. The involvement of multiple systems is increasingly found to be a feature of
distinct human neurodegenerative disorders, such as Parkinson's disease (Braak et al,
1995), and it has been speculated that the involvement of multiple systems may be
inevitable if the disease process is of a sufficiently long duration (Takahashi et al, 1993;
Sato et al, 1995). In familial dysautonomia however, a human disease which appears to
share many characteristics of EGS, there in no evidence of specific brainstem somal
neuronal pathology (Fogelson et al, 1967; Pearson et al, 1971) despite clinical
(Tonholo-Silva et al, 1994) and electrodiagnostic (Lahat et al, 1992) evidence of motor
and brainstem dysfunction. The similarity of the distribution of central neuropathology






1. INTRODUCTION TO CYTOPATHOLOGY IN EGS
The morphology of neurons in EGS was comprehensively described in Obel's seminal
description of'Grass Disease' in 1955 . Ultrastructural studies followed (Chandler and
Brownlee, 1967; Gilmour, 1975; Hodson et al, 1984b) but little molecular work
detailing the cytopathology has been accomplished and has focused solely on enteric and
peripheral sympathetic neurons.
Sabate et al (1983) investigated gut regulatory peptides in EGS and found a great
reduction in the numbers of nerves containing VIP, substance P, bombesin and
enkephalin, particularly in the ileum, and fewer than normal somatostatin and
enteroglucagon containing cells. Very similar changes were noted by Bishop et al
(1984). Murray et al (1994), in a functional study, recorded muscarinic receptor
hypersensitivity to bcthanechol by strips of smooth muscle from AGS cases. Peripheral
sympathetic ganglia were studied by Griffiths et al (1993), noting a marked
disturbances in neurofilament proteins and beta-tubulin with severely reduced staining
for neuron-specific enolase, the catecholaminergic enzyme tyrosine hydroxylase and an
increase in dopamine-beta-hydroxylase, another enzyme associated with noradrenaline
synthesis. Membranes of the Golgi apparatus were histochemically stained and revealed
a profound loss of a recognisable Golgi structure in affected neurons. Postganglionic
sympathetic ganglia in EGS and mal seco cases were additionally shown to contain
neurons staining for whole horse serum, which may occur non-specifically following
damage to the cell membrane (Griffiths et al, 1994b; Giruaudo Conesa and Uzal, 1996).
The principal abnormality noted in central neurons in EGS is chromatolysis, with an
extensive loss of defined Nissl substance (Nissl, 1894), often an eccentric nucleus with a
large nucleolus and a marked enlargement of the perikaryon. The latter is unlike neurons
in ALS, in which chromatolytic motor neurons have been found to be about 50% smaller
than those in non-ALS patients with chromatolysis due to nerve root pathology
52
(Wakayama, 1992). Classically, chromatolysis is seen a few days after axonal
transection and appears to be a regenerative response coinciding with an increase of
protein synthesis and axonal regeneration (Weller, 1984). The hallmark appearance of
the cytoplasm is due to dispersal of Nissl bodies, stacks of rough endoplasmic reticulum
and intervening groups of polyribosomes present in perikarya and dendrites (Peters et al,
1976). The nature of the trigger is controversial (Thomas et al, 1993).
The term 'chromatolysis' (chrom- [Gr] colour) is by some authors defined strictly as a
decrease or loss of cytoplasmic basophilia in the perinuclear region of the neuron
associated with axonal injury, while neurons that are pale and swollen for other reasons
have been referred to as 'ballooned' neurons or neurons showing achromasia (Greenfield
et al, 1988). Examples of diseases marked by the presence of ballooned neurons are
relatively rare in human and veterinary neuropathology, and veterinary pathologists have
tended to refer to the latter cell as 'chromatolytic' while the former change is termed the
'axonal reaction' (Summers et al, 1995). The word chromatolysis in this thesis is used
merely to describe the morphology of the cell and not the aetiology of the loss of Nissl
staining.
Cytopathology is studied to determine the aetiopathogenesis of the disease, and thus
limit the numbei of potential insults. Individual neurons differ greatly from each other in
architecture, neurotransmitter release, state of functional activity and metabolic
requirements (Waggie et al, 1999), and information about specific shared features
unique to a pool of neurons making these neurons selectively vulnerable to a disease
may further narrow the field. The initial investigation of the cytopathology of central
neurons in EGS is the basis of this chapter.
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2. Neuronal Cell death
a) Introduction and literature review
An issue which appears fundamental to the study of central neuronal cytopathology in
EGS cases, is whether affected cells are dying or are likely to recover from the insult.
This very basic question requires an understanding of the two types of cell death that are
now recognised, apoptosis and necrosis.
Apoptosis, variously referred to as 'cell suicide' or 'programmed cell death', was
discussed in the literature as early as 1972 (Kerr et al,), replacing the previous concept
of 'necrobiosis' or 'single cell necrosis', however it did not receive a great deal of
scientific attention until the late 80s. To date there are over 35,000 publications on this
topic with around 600 papers referring to apoptosis published per month.
The basic process of apoptosis has been well reviewed (Raff, 1992; Schwartzman and
Cidlowski, 1993; Columbano, 1995; Levin, 1995; Vaux and Hacker, 1995; White,
1996). Classically, apoptosis occurs physiologically by a process encoded in the genome
in order to regulate numbers of cells during development, after hyperplasia, after cell
senescence, as a defence mechanism to limit the replication of intracellular parasites and
in respunse to oxidative stress (see Appendix 3).
Reactive oxygen species are hypothesised to be intimately involved in the process of
apoptosis, both in the induction phase and in the final degradation phase. Much
emphasis has been placed on the excitotoxic amino acid glutamate and its interaction
with N-methyl-D-aspartate (NMDA) type channels (Nicotera et al, 1997). It is
speculated that reactive oxygen species generated by glutamate, and opening of NMDA
activated calcium channels, induce an increase in mitochondrial permeability leading to
apoptosis (Kroemer et al, 1997) or, if exposed to high concentrations, a loss of
mitochondrial membrane potential and necrosis (Ankarcrona et al, 1995). A substantial
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amount of evidence now exits that excitotoxicity leads to acute necrosis and delayed
apoptosis (Pang and Geddes, 1997).
Apoptosis can also be induced pathologically following damage by chemicals,
microorganisms or ischaemia and is the mode of target cell death mediated by cytotoxic
T lymphocytes and natural killer cells. Apoptosis is an active process of cell destruction
of single cells characterised by a rapid course of early internucleosomal double-stranded
UNA fragmentation into 180 bp DNA fragments, chromatin aggregation, nuclear
pyknosis, cell shrinkage, and membrane blebbing. The cell eventually fragments into
membrane bound acidophilic globules (apoptotic bodies) often containing organelles and
nuclear material. These apparently provide a potent stimulus for phagocytosis by
phagocytic cells or even neighbouring epithelial, endothelial or tumour cells.
Inflammation is not elicited .
Details of the intracellular processes involved in apoptosis are probably still not
complete and the identity of obligate mediators remains controversial. Consistent though
is the cleavage of double stranded DNA into principally fragments with single base 3'
OH overhangs (Mundle et al, 1995). This feature is the basis of the standard in apoptosis
in situ detection techniques (Gavrieli et al, 1992; Ansari et al, 1993), terminal
dcuxynucleotidyl transferase (TdT) mediated UTP nick end labelling (TUNEL). This is
reported to be a rapid, sensitive, and reproducible in situ assay of DNA fragmentation
capable of detecting apoptosis in even very old formalin-fixed and paraffin embedded
material (Bardales et al, 1997). The procedure labels DNA strand breaks in apoptotic
cells with a non-isotopic reporter molecule (dUTP) in the presence of a DNA
polymerase such as TdT, with immunohistochemical identification of labelled DNA.
TdT is a template independent DNA polymerase adding deoxynucleotides to a 3'-OH
terminus on single stranded or double stranded DNA. The 3'-OH acceptor can be an
overhang, blunt or recessed end, although an overhang end is most efficient (Brown,
1991). Since apoptosis was originally defined by morphological criteria however, using
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either electron or light microscopy, these remain the gold standard for documentation of
apoptosis (Ankarcrona et al, 1995; Levin, 1995).
Necrosis (reviewed by (Buja et al, 1993; Schwartzman and Cidlowski, 1993;
Columbano, 1995; Nicotera et al, 1997; Perry et al, 1997) on the other hand generally
occurs in a group of adjacent cells and is characterised by the disappearance of
membrane pumping activities resulting in mitochondrial, endoplasmic reticulum and cell
swelling. Intense mitochondrial damage follows with rapid energy loss and electrolyte
changes including increases in magnesium, chloride, sodium and most significantly
calcium ions as well as potassium ion efflux. Lysosomes rupture causing cellular
disintegration and DNA is either not fragmented or nonspecifically degraded into a
continuous spectrum of sizes resulting in a diffuse smearing in gels. Membrane lysis
follows, releasing intracellular constituents that evoke an inflammatory reaction. Its is
typically a process associated with energy depletion but in some situations may be
prevented by inhibitors of protein synthesis (Popp et al, 1978). There are no specific
histochemical tests that identify necrosis but the early increased membrane penneability
can be exploited in living cells by dye exclusion methods.
'There is no field of basic cell biology and cell pathology that is more confusing and
more unintelligible than is the area of apoptosis versus necrosis' (Farber, 1994). The
search for the presence of apoptosis in diseased tissues has highlighted that, despite
fundamental appearing differences between the two modes of cell death, they can be
difficult to differentiate. Many tissues and pathogenic processes contain necrotic areas as
well as cells undergoing apoptosis (Columbano, 1995) in which case gel electrophoresis
may not be sensitive or specific enough to confirm the presence of apoptosis. This is
complicated by the fact that even apoptotic tissues will undergo secondary necrosis if the
phagocytic system is overwhelmed (Manjo and Joris, 1995; Perry et al, 1997) and the
finding that morphologically necrotic cells are also labelled using the TUNEL procedure
(Gold et al, 1994; Charriaut-Marlangue and Ben-Ari, 1995; Levin, 1995; Mundle et al,
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1995; Frankfurt et al, 1996; van Lookeren Campagne and Gill, 1996; Pang and Geddes,
1997). Necrotic or apoptotic cells may be differentiated by the difference in staining
intensity (Mundle et al, 1995), perhaps because apoptotic cells contain a higher
proportion of 3' overhangs, preferentially labelled by TdT.
Recent evidence of the existence of a morphological continuum of necrosis and
apoptosis confuses the issue even further since it contradicts the premise that the two
forms of cell death are distinct and mutually exclusive. Serum withdrawal from AKR-2B
mouse fibroblast cells activated a succession of events followed by time-lapse video
microscopy and electron microscopy (Simm et al, 1997) which were initially similar to
those defined as apoptosis, i.e. nuclear condensation and membrane blebbing. This
however was rapidly followed by cell lysis and disruption of mitochondria, both of
which are characteristic of necrosis. Plasma membrane blebbing and mitochondrial
damage in the absence of DNA fragmentation was also recorded after glutamate induced
cell death (Tan et al, 1998) while simultaneously apoptotic DNA laddering and
ultrastructural morphologic evidence of necrosis was found to occur in excitotoxic
neuronal death in neurons in the adult (Portera-Cailliau et al, 1997a) and immature
(Portera-Cailliau et al, 1997b) brain. It has also been suggested that DNA fragmentation
in certain brain regions in Alzheimer disease may reflect metabolic disturbances in the
premortem period, but that cell destruction is mediated through necrosis rather than
apoptosis (Stadelmann et al, 1998).
Nevertheless, it is thought that apoptosis may be involved in many acute and chronic
neurodegenerative diseases (Linnik, 1996) which would have implications for both the
pathophysiology and the development of therapeutic agents. Unfortunately it is difficult
to determine to what extent chronic neurodegenerative diseases involve neuronal
apoptosis due to the low rate of cell death and therefore the small percentage of cells
potentially undergoing apoptosis, the rapidity of apoptotic cell death with phagocytosis
and the nonspecificity of TUNEL techniques in differentiating end stage apoptosis from
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necrosis (Bredesen, 1995). Diseases such as Parkinson's disease have studies confirming
(Mochizuki et al, 1997) and refuting (Kosel et al, 1997) the presence of apoptotic
neurons. Similarly apoptosis may play a role in Alzheimer's disease but the value of
blocking it is not yet known (Barinaga, 1998). In amyotrophic lateral sclerosis (ALS)
however there is convincing in vitro (Alexianu et al, 1994), in vivo (Yoshiyama et al,
1994; Troost et al, 1995) and mouse model (Friedlander et al, 1997) evidence that
apoptosis is involved in the death of ventral horn lower motor neurons and glial cells.
One of the purposes of this study was to determine whether apoptosis plays a significant
role in the cell death of neurons in EGS, in the hope that the mechanism of cell death
may help determine the nature of the aetiologic agent. Unlike in the central tissues,
extensive histological evidence of cell death is found in postganglionic sympathetic
ganglia, and this tissue was used for the initial investigation. In the second phase the
technique was applied to central tissues. The apparent low specificity for apoptosis of
the TUNEL technique was acknowledged, in the final analysis however regardless of
what mode of cell death results in the DNA laddering, the TUNEL technique can be
used as a method to identify dying cells (Portera-Cailliau et al, 1997b) and this was the
principal goal when applied to central tissues.
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b) Materials and Methods
(i) Subjects
The initial investigation focused on sections of cranial cervical ganglia. Sections from
two AGS, six SGS, three CGS and seven control cases had TUNEL reagents applied to
them. More than one section was examined from the majority of cases at different times.
One positive control section of virally infected mouse brains, one section of sheep
thymus and at least one DNAse positive control slide was included in every run.
In the next phase, 16 sections of central tissues in which chromatolytic neurons were
present on H&E evaluation were included from ten EGS cases (Table 3-1). One section
of equine thymus was included as a positive control section for each run
(ii) Laboratory methods
In the first phase, DNA laddering in the cranial cervical ganglia sections was detected
using a standard TUNEL procedure. Five micron sections of formalin fixed paraffin
embedded tissue on Vectabond slides were deparaffinised in xylene, rinsed in 100%
ethanol and placed in 0.3% H202 in methanol at room temperature for 30 minutes. The
sections were hydrated to water through graded alcohols and permeabilised with
1% Triton-XlOO for 1.5 minutes. After rinsing in water the sections were digested in
10 pg/'ml proteinase K in 20 mM Tris and 2 mM CaCL, pH 7 for 20 minutes at 37°C
and placed in 0.01 M phosphate buffered saline (PBS). Positive control samples were
equilibrated with DNase 1 buffer (30 mM Tris pH 7.2; 140 mM sodium cacodylate;
4 mM MgCI2, 0.1 mM dithiothreitol) for 20 minutes at room temperature and incubated
for 30 minutes at 37nC in this buffer and 5 pg/ml DNase 1. All specimen were
equilibrated with TUNEL buffer (30 mM Tris pH 7.2; 140 mM sodium cacodylate; 1
mM cobalt chloride) for 20 minutes at room temperature and incubated with 0.6 units/pl
TdT enzyme (terminal deoxynucleotide transferase, Promega) and 20 pM Digoxigenin-
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11-dUTP (Boerhinger Mannheim) in TUNEL buffer for 2 hours at 37°C in a humidified
container. Sections were blocked with 3% normal goat serum and incubated with 1:100
sheep anti-digoxigenin peroxidase labelled Fab (fragment antigen binding) fragments
(Borhinger Mannheim). Negative control samples had either the TdT enzyme or the
digoxigenin labelled dUTP omitted. The sections were rinsed with PBS and
incorporated DIG-dUTP detected by reacting with 31 diaminobenzidine (Peroxidase
Substrate Table Set, Sigma Immuno Chemicals) for 20 minutes at room temperature.
The reaction was stopped by rinsing in distilled water. The sections were counterstained
with haematoxylin for 45 seconds, dehydrated and mounted.
In the second phase, the TUNEL procedure was applied to central tissues using a
commercial kit (ApopTag - plus, Oncor). Five pm sections were placed on
electrostatically charged slides (ProbeOn Plus, FisherBiotech) and deparaffmised in
xylene, rehydrated through graded alcohols and placed in 10 pg/ml proteinase
K/Tris/CaCl2 for 30 minutes at 37°C to facilitate penetration. After rinsing in water,
endogenous peroxidase activity was blocked with 3% hydrogen peroxide in water for
5 minutes. A positive control section was produced by incubating one tissue section in
DNase 1 buffer at room temperature for 20 minutes before incubating with 5 pg/ml
DNase 1 in buffer for 30 minutes at 37 0 C. After washing in PBS, all slides were
immersed briefly in equilibration buffer and subsequently were incubated with working
strength TdT Enzyme for 1 hour at 37° in a humid chamber. One negative control
section had the TdT enzyme omitted. The reaction was stopped using the Stop/Wash
Buffer, the sections were washed in PBS and had anti-digoxigenin peroxidase conjugate
applied for 30 minutes at room temperature. Sections were placed in PBS peroxidase




The TUNEL assay proved to be problematic in its reproducibility and much time was
spent trying to standardise and optimise the system. The results below refer only to those
experimental runs from on which negative controls were negative and positive control
sections, including mouse brain, thymus and DNAse treated sections, were labelled
(Figure 3-1)
In phase one, more than one cranial cervical ganglion section was included from the
majority of cases on each of the different runs. A few cranial cervical ganglion sections
from EGS and control sections had labelled nuclei on some experimental runs. These
usually appeared pyknotic (as opposed to open faced) and were in neurons with less
cytoplasm than other cells (Figure 3-2). Sections which included labelled neurons on
some sections but not on others had TUNEL reagent applied again in the second phase,
but with the exception of a few positive glial cells, none were subsequently positive.
In phase two no neurons from CNS sections were labelled. Microscopic examination of
sections confirmed that chromatolytic neurons with nuclei were present.
Table 3-1: Central tissue TUNEL procedure
Case # Diagnosis Structure on section
97/1032 SOS Nucleus CN V, XII & GVE X
95/387 SGS CI LMNs
96/396 SGS Nucleus CN III & V
96/291 SGS Nucleus III & VII
98/62 CGS C8 LMNs
97/376 CGS Nucleus CN VII, XII & GVE X
98/244 CGS L6 LMNs
98/264 CGS C8 LMNs
97/538 CGS Motor nucleus V
97/293 CGS Nucleus CN III
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The observation that large numbers of neurons in the cranial cervical ganglia of EGS
cases appeared to be dying in the absence of a marked inflammatory response
(Brownlee, 1965), initially suggested that apoptosis may be the principal form of cell
death. This was further supported by the suspicion that oxidative stress may contribute to
the aetiology of EGS, due to the disease being associated with climatically stressed
vegetation (B. McGorum, R(D)SVS, personal communication). The absence of overt
apoptotic bodies being noted on routine histological sections is not unusual even in the
presence of apoptosis, since TUNEL -positive cells are known to be cleared from the
CNS by phagocytosis within 2 hours (Wetts and Vaughn, 1998). Some practice is
needed to identify apoptotic bodies with the light microscope, and finding even
relatively few of them on histological sections of a tissue implies that quite extensive
'drop out' is taking place (Kerr et al, 1972).
Nevertheless, and despite the occasional TUNEL positive cell being evident, it is
reasonable to conclude that apoptosis is not a prominent form of cell death in EGS
postganglionic neurons. Further work has been unable to show that oxidative stress is a
significant component of the disease process in EGS (B. McGorum, R(D)SVS, personal
communication), and autonomic neurons have been shown to be relatively resistant to
excitotoxic cell death, which is thought to account for the lack of GVE neuronal
pathology in the presence of somatic LMN death in amyotrophic lateral sclerosis (Wetts
and Vaughn, 1998).
The TUNEL technique was applied to central tissues in order to label neurons that were
dying, regardless of the underlying process. The sensitivity of the technique is arguably
low, given that comparatively few chromatolytic central neurons with nuclei present on a
tissue section. This decreased the probability of the appropriate fragmented DNA being
present, particularly in view of the rapid removal of apoptotic cells. In addition, the
specificity of the presence of DNA laddering for cell death is now questioned; recent
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work has shown that there is evidence to suggest that TdT labelled cells may recover and
not undergo terminal apoptosis. 70 - 80% of nuclei in entorhinal cortex/hippocampal
formation in Alzheimer's disease show increased TdT labelling even early in the disease,
far exceeding the actual loss of cells observed cases with longer disease duration
(Cotman, 1998). The large number of cells with DNA fragmentation in some cases may
reflect metabolic disturbances in the pre-mortem period and not indicate impending cell
death (Stadelmann et al, 1998).
The lack of TUNEL staining in addition to the absence of histological evidence of
somatic neuronophagia or glial cell accumulations, strongly suggest that the
chromatolytic central neurons in EGS are capable of recovering. One could speculate
that a metabolic component of somatic LMNs is able to defend the cell from a terminal
insult of the putative EGS 'toxin', or that the CNS represents a 'protected' area able to
shield those neurons. The similarity in the distribution of neuronal pathology between
EGS and feline dysautonomia suggests that a very similar insult is involved in the
disease in those two species, however the death of central neurons described in the latter
(Pollin and Griffiths, 1987) may point away from that. The difference may represent a
species specific effect, alternatively the agent may be modified by the nature of the
putative source (Grass vs cat food??).
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3. UBIQUITIN EXPRESSION IN GRASS SICKNESS
a) Introduction and literature review
Numerous, round, argyrophilic, 5 - 15pm eosinophilic bodies are present in perineuronal
supporting tissue and in recesses in perikarya of normal and degenerate postganglionic
sympathetic neurons of EGS cases. These closely resemble Parkinsonian Lewy bodies
(Figure 3-3) and are present in the majority of chronic and subacute grass sickness
sympathetic ganglia and very occasionally in central neurons. Gilmour (1975) noted on
ultrastructural examination of EGS postganglionic sympathetic neurons that these
contained mitochondria and vacuoles in vesiculotubular material, and were surrounded
by a single limiting membrane and a sheath of satellite cell processes. It was proposed
that they represent dystrophic axons, as similar changes have been described in
experimental and infantile neuraxonal dystrophy in a number of structures including in
the soma of nuclei of CN III and VII and spinal cord LMNs (Cowen and Olmstead,
1963). That work found no histopathological indications of axonal spheroids in any
other central or peripheral structures in EGS, and it was proposed that these bodies may
more likely be similar to Parkinsonian Lewy bodies.
Lewy bodies are an obligate characteristic of Parkinson's disease, although they are also
occasionally found in multiple system atrophy, progressive supranuclear palsy,
amyotrophic lateral sclerosis, Alzheimer's disease, Down's syndrome, Lewy body
dementia and others. Two types are described: Classical (brainstem) and cortical (Lowe
etal, 1997).
Classical Lewy bodies are intraneuronal, rounded, 8-30 pm eosinophilic inclusions with
a hyaline core and a pale staining peripheral halo. In Parkinson's disease they are found
in the substantia nigra, locus ceruleus and thalamus, hypothalamus, substantia
innominata (basal forebrain nuclei) and parasympathetic nuclei of the vagus nerve. One
neuron may contain many Lewy bodies. The halo has not been fully characterised but
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associated with a granular electron-dense coating material and vesicular structures. It
contains ubiquitin and proteins involved in ubiquitin metabolism. The core contains
densely packed filaments associated with compacted granular material.
Figure 3-3. 'Lewy bodies'
A: Lewy inclusion body. Pigmented neuron substantia nigra. Parkinson's
disease.
B: 'Lewy body like' cytoplasmic compaction. Cranial cervical ganglion neuron.
Chronic Grass Sickness.
Cortical Lewy bodies are present in all cases cf idiopathic Parkinson's disease but often
only in small numbers. Larger numbers are associated with Lewy body dementia, which
may be a variant of Parkinson's disease. They are poorly defined structures without an
obvious halo, and may be angular. Ultrastiucturally cortical Lewy bodies are composed
of a felt like material of intermediate filaments associated with granular electron dense
material (Lowe et al, 1997).
In addition, Lewy bodies have also been described in the cell processes, bit only rarely
the perikarya, of sympathetic ganglia of Parkinsonian and multiple system atrophy cases
(Den Hartog Jager and Bethlem, 1960; Forno and Norville, 1976). Three types are
described: the classical Lewy body type in the neuronal ©ma (rare), a second type made
up of coarse, ill defined granules mixed with organelles and sometimes granulovesicular
and filamentous material circling the central core and thirdly, swellings in swollen
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vesicular and filamentous material circling the central core and thirdly, swellings in
swollen unmyelinated cell processes. 1'hese are made up of various mixtures of dense
material, filaments, membranous structures and dense core vesicles and, unlike classical
Lewy bodies, are often described as having an 'inside out' appearance with the less
electron dense material in the centre. Roessman et al (1971) interpreted these
'eosinophilic bodies' as axonal swellings in preganglionic terminals. They are
reminiscent of the structures described as dystrophic axons by Gilmour (1975).
Stressed cells show high levels of expression of a set of proteins which have cell-
organising and cytoprotective activities (Lowe and Mayer, 1990). They have been
repeatedly associated with neurodegenerative diseases, particularly with the cytoplasmic
inclusions which are pathognomonic for a number of them. Expression of these proteins
should give an indication of the level of stress undergone by the chromatolytic, but
otherwise often unremarkable, central neurons in grass sickness and may indicate how
closely the cytoplasmic compactions are to Parkinsonian Lewy bodies.
Ubiquitin is a member of a group of proteins known as 'Heat Shock Proteins', having
been discovered in cells responding to experimental heat shock. This response is an
important basic cellular mechanism with enables cells to survive environmental stresses.
Mutant strains ol yeasts with altered ubiquitin gene expression do not withstand heat or
toxic stresses that are non-lethal in normal strains (Finley et al, 1987) and work on a
stroke model of induced transient cerebral ischemia in rats indicates that cell survival
seems to depend on the degree of ubiquitin expression (Magnusson and Wieloch, 1989).
The function of ubiquitin in normal and stressed cells has been well reviewed (Lowe and
Mayer, 1990; Mayer et al, 1991; Muller and Schwartz, 1995) Ubiquitin is a 76 amino
acid basic protein which is amongst the most conserved gene products in evolution, with
only one amino acid differing in the structure of ubiquitin in nematodes and in
mammals. It has been shown to play an essential role in a wide variety of cellular
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functions ranging from the regulation of chromatin conformation and embryonic
development to programmed cell death and protein degradation.
Molecular and pathological findings indicate that ubiquitin may be pivotal in the cell
stress response in chronic neurodegenerative diseases. Ubiquitin is induced in cells as
part of the cell stress response and is a co-factor for ATP dependent non-lysosomal, and
possibly lysosomal (Dickson et al, 1990), proteolysis, using a complex set of enzymes
to finally covalently link ubiquitin to target proteins. These are then recognised and
degraded, releasing ubiquitin and peptides. Virtually all misfolded proteins that have
failed to find their partners undergo ubiquitination. Proteins tagged with four or more
ubiquitin molecules are targeted for destruction (Mezey et al, 1998). As such ubiquitin
appears to have been adapted as part of an intracellular surveillance system that can be
activated by altered, damaged, or foreign proteins and organelles, and its primary
function is believed to lie in the removal of these proteins in some eukaryotic cells.
The protein is also a component of filamentous inclusions, particularly those associated
with intermediate filaments, in the neurons of a number of neurodegenerative diseases
such as neurofibrillary tangles and granulovacuolar bodies in Alzheimer's disease as
well as Pick bodies in Pick's disease, punctate inclusions in equine motor neuron disease
(Kuwamura et al, 1994) and Lewy bodies in Parkinson's and diffuse Lewy body
diseases. Furthermore, a study using ubiquitin antibodies to detect the presence of
ubiquitin in a series of non-viral intracytoplasmic inclusions concluded that ubiquitin is
selectively present in non-membrane-bound filamentous inclusions such as Mallory,
Crooke, Lafora and amyloid bodies, as well as Rosenthal fibres and axons of giant
axonal neuropathy (Manetto et al, 1989).
In addition to their association with inclusion bodies, ubiquitinated proteins, or the
expression of a polyubiquitin gene, are also known to be substantially increased in
neurons in a variety of neurodegenerative diseases including Parkinson's disease,
Alzheimer's disease and amyotrophic lateral sclerosis (Heggie et al, 1989; Bergmann,
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1993), as well as in non-filamentous 'dot like structures' in normal brains (Dickson et al,
1990). Ubiquitinated inclusions in CNS LMNs in ALS are distinct from conventional
intermediate filament inclusions and may be highly disease specific as well as being
present in transgenic mouse models (Ince et al, 1998).
b) Materials and methods
(i) Subjects
The initial investigation focused on sections of cranial cervical ganglia from four acute,
two subacute, one chronic and two control cases. In the next phase, central neurons were
examined using sections from three areas of the brain stem which included the motor
nuclei of cranial nerves III, V and VII. Four sets were from cases of subacute grass
sickness and five from chronic cases, all with prominently chromatolytic neurons in two
or more of these nuclei on H&E evaluation. In addition, one longitudinal section of
spinal cord from a case of subacute grass sickness was used, principally because it was
known to contain a large number of affected lower motor neurons, many more than
could be examined in one section of brain stem. One horse with colic and one
orthopaedic case sci ved as negative control cases. Each run incorporated a control
positive section of human cortex with prominent corpora amylacea, and at least one
presumed positive control equine section of either caudal brainstem containing the
lateral cuneate nucleus from a case of equine degenerative myeloencephalopathy (EDM),
or spinal cord from a severe case of cervical vertebral malformation (CVM).
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(ii) Laboratory methods
Ubiquitin immunoreactivity was revealed using a standard avidin/biotin immunostaining
protocol. 5 pm sections on Vectabond (Vector Laboratories, Inc., CA) coated slides were
incubated in a 70° C oven for 30 minutes before being deparaffinised in xylene,
rehydrated through graded alcohols and placed in picric acid for 15 minutes to decrease
formalin complex background staining due to over-fixation. After rinsing in water,
endogenous peroxidase activity was blocked with 3% hydrogen peroxide in water for
15 minutes. Sections were incubated in 10% normal swine serum with added avidin
(Avidin/Biotin blocking kit, Vector Laboratories) for 15 minutes at room temperature in
a humid chamber. Pilot studies using primary antibody dilutions from 1:50 to 1:500
determined that 1:200 rabbit anti bovine ubiquitin (Biomeda) with added biotin,
preincubated in 2% normal horse serum (NHS) for 1 hour at 37°, was optimal, and this
was applied and the slides incubated for 30 minutes at room temperature. 1:200 non¬
immune rabbit serum (NRS), preincubated in 2% normal horse serum ,was applied to
cranial cervical ganglia negative control slides. Polyclonal Universal Negative Control
Serum (CPD, Llanberis) but no NHS preincubation or avidin/biotin blocking step was
used for negative control slides in central sections in subsequent studies. Biotinylated
1:200 swine anti rabbit immunoglobulin (DAKO) was applied as the secondary antibody
for 30 minutes at room temperature in a humid chamber and slides were incubated in the
ABC Reagent (StreptABComplex/HRP, DAKO) for 30 minutes at room temperature.
Sections were developed by incubating in a DAB (3,4,3',4'-tetra-amino biphenyl
hydrochloride) Substrate Kit (Vector Laboratories, Burlingame CA 94010) at room
temperature for 30 seconds and counterstaining with hematoxylin. Finally, the slides
were dehydrated in graded alcohols and three changes of xylene and mounted in
Permount (Fisher Scientific).
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Table 3-2: Subjects and sections examined for ubiquitin expression.
Case Number Diagnosis Structure of interest
96/291 SGS Nucleus of CN III, CN XII, GVE X,
96/396 SGS Nucleus of CN III, motor V, CN VII
97/1032 SGS Nucleus of motor V, CN VII, GVE X, CN
97/424 SGS $licleus of CN III, motor V, CN VII
97/293 CGS Nucleus of CN III, motor V, CN VII
97/313 CGS Nucleus of CN III, motor V, CN VII
97/376 CGS Nucleus of CN III, VII, GVE X, CN XII
97/538 CGS Nucleus of CN III, motor V,










Aged human Corpora amylacea
N96- 657 CVM Spinal cord axonal spheroids
N96-879 EDM Spinal cord axonal spheroids
N 96-542 EDM Spinal cord axonal spheroids
N96/847 EDM Spinal cord axonal spheroids
Negative Control
97/352 Orthopaedic Nucleus of CN III, motor V, CN VII
97/618 Colic Nucleus of CN III, V, VII, XII, GVE X
97/654 Hepatopathy CCG
96/500 CVM Spinal cord axonal spheroids
CCG = cranial cervical ganglion
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c) Results
The positive control human subependymal corpora amylacea stained dark brown in all
the ubiquitin runs with no non-specific binding elsewhere. The lateral cuneate nucleus
from one case of EDM contained several dark accumulations which may represent small
spheroid or axons. Compressed equine spinal cord sections did not contain many
prominently labelled spheroids but numerous astrocyte nuclei were labelled as well as a
number of the nuclei of alpha motor neurons.
Negative control sections from both horse and human negative control sections were
marked by high levels of non-specific staining when NRS was applied at the same
dilution as the diluent containing the primary antibody. No evidence of specific binding
of equine tissue was found using the commercial negative control product.
Numerous postganglionic sympathetic neuronal nuclei in both grass sickness and normal
control cases were labelled with the rabbit anti bovine ubiquitin. Most of these had an
'open faced' morphology. The cytoplasm of many neurons was also labelled, with or
without associated nuclear labelling. Degenerate neurons did not appear to be labelled
preferentially over normal appearing cells in grass sickness cases. 'Lewy body like'
structures, or cytoplasmic compactions to varying degrees, were occasionally labelled
but not consistently and not strongly (Figure 3-4).
In the central sections in both grass sickness and control cases the ependynral cells
around the mesencephalic aqueduct were often labelled, as were astrocyte nuclei. Small
accumulations of pigment were occasionally seen in the neuropil, not associated with
particular nuclei and not in greater quantities in grass sickness compared to control
cases. The was no significant cytoplasmic staining of neurons in the cranial nerve nuclei
under examination and the labelling of neuronal nuclei could not be differentiated from
similar staining in normal appearing somatic neurons in grass sickness or normal control
cases.
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Figure 3-4: 'Lewy body like' cytoplasmic compaction labelled with
ubiquitin (arrowhead) and unlabelled (arrow). Postganglionic sympathetic
neurons, cranial cervical ganglion, chronic grass sickness. Ubiquitin 1:200.
X 200.
d) Discussion
The results obtained were initially thought to include an un-interpretable amount of false
positive and false negative labelling due to the apparent absence of staining of axonal
spheroids, intense background staining of normal rabbit serum treated sections and
labelling of lower motor neuron and astrocyte nuclei. The lack of a known true positive
equine tissue was an additional obstacle to interpretation of the results.
The rabbit anti ubiquitin was supplied as part of a kit and the true concentration of
antibody relative to the concentration of immunoglobulins in NRS was unclear and
relatively high concentrations of NRS were initially applied to negative control sections
leading to a an unacceptably high level of background staining. This was probably due to
non-specitic rabbit anti horse and anti human interactions. The Avidin / Biotin blocking
and preincubation in normal horse serum steps were introduced to try to decrease non
specific rabbit anti horse, and avidin by endogenous biotin binding. Further discussion
with Biomeda revealed a much lower content of non-specitic immunoglobulins in the
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primary antibody than was initially understood, and a commercial negative control
product was subsequently applied to the central section.
Standard positive control tissues for ubiquitin work include either human corpora
amylacea, subpial or subependymal structures associated with ageing, or Parkinsonian
Lewy bodies. Since neither of these structures were available in horse tissues, alternative
structures likely to contain ubiquitinated proteins were sought. Axonal spheroids are
known to express ubiquitin epitopes in a variety of neurodegenerative (Lowe and Mayer,
1990; Moretto et al, 1993; Takahashi et al, 1997) and traumatic diseases including
compressed equine spinal cord (Jortner et al, 1996). The specific brainstem and spinal
cord nuclei from cases of EDM classically contains spheroids (Mayhew et al, 1977) as
do compressed segments of spinal cord from animals with cervical vertebral
malformation and sections from these were included as positive equine control tissues.
The lack of consistent labelling of axonal spheroids, and the strong staining of many
nuclei in this experiment however does not necessarily indicate non-specificity of the
ubiquitin antibodies for equine tissues, something that would be unexpected given the
great similarity of the ubiquitin molecule across species. Spheroids from cases of human
dysautonomia show reactivity with antisera to ubiquitin only when smaller than 30
microns, and it is speculated that larger spheroids containing degradative products of
neurofilament proteins may lose their immunoreactive epitopes (Moretto et al, 1993).
The small structures labelled in the region of the lateral cuneate in the EDM tissues may
represent similar smaller dystrophic axons. In addition, not all spheroids in the spinal
cord segments from horses with CVM were intensely labelled with ubiquitin in one
study (Jortner et al, 1996), but many were seen to demonstrate this protein in a more
consistent and intense fashion than seen in one control animal. In addition, nuclei have
been reported to be frequently labelled in human tissues expressing ubiquitin as well as
occasionally in neurons, Schwann cells and glial cells of normal CNS (Manetto et al,
1988; Dickson et al, 1990).
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The presence of heat shock proteins in other neurodegenerative diseases however has not
been explained (Lowe and Mayer, 1990; Mayer et al, 1991; Mezey et al, 1998). A recent
study looking for a number of stress proteins in the brain of Alzheimer disease patients
using non-quantitative immunohistochemistry, including alpha B-Crystallin, heat shock
protein (HSP) 27, HSP 65, HSP 70, HSP 90, and ubiquitin, concluded that a selective up
or down regulation of stress proteins in degenerating neurons could not be detected
(Stadelmann et al, 1998). The use of alpha B-Crystallin and heme oxygenase-1
antibodies was attempted in this study, but was abandoned as their specificities could not
be determined due to the lack of positive control tissues in this species. Proteins may be
ubiquitinated in an effort to degrade abnormal organelles or proteins, accumulated as
part of a pathologic process, or they may actually cause the neuronal death. Alternatively
they may initially be cytoprotective and, if this fails, become involved in a ubiquitin-
dependent protein catabolism which ultimately destroys the neurons (Mayer et al, 1991).
Similarly, the role of inclusion bodies is not understood, particularly since their
formation does not necessarily correlate with the expression of heat shock proteins
associated with various forms of cell stress such as cerebral ischaemia. Intermediate
filaments are the elements of cytoskeleton most sensitive to cell stress, and ubiquitinated
intermediate filament inclusion bodies may represent a failure ofprotein degradation
system, or may be result of an attempt to cocoon unwanted cellular material. The
inclusions may then become permanent or they may be slowly eliminated by a ubiquitin
coupled breakdown system.
It is likely that the argyrophilic inclusions described as dystrophic axons by Gilmour
(1975) represent the perikaryal structures resembling Lewy bodies which are commonly
seen in the sympathetic ganglia of subacute and chronic cases. The presence of a single
limiting membrane would differentiate them from classical Parkinsonian Lewy bodies,
which are not surrounded by a membrane (Lowe et al, 1997). The structures are only
variably argyrophilic in our laboratory (Figure 3-5), however that may be dependent on
75
described apparently extracellular Lewy bodies in the Parkinsonian autonomic nervous
system. He debated that these are likely to represent intracytoplasmic Lewy bodies
protruding slightly from the cytoplasm and appearing to be extracellular in some
sections, or a very large intracytoplasmic Lewy body filling the entire cell which finally
degenerates, giving rise to an extracellular body. Alternatively, they may come from
degenerated dendrites or neurites cut in transverse sections. The former two options may
be more likely based on the fact that some of these structures in grass sickness appear to
be placed firmly in the perikaryon, which would not be compatible with their description
as dystrophic axons. It is possible, if somewhat unlikely, that these structure are present
in both soma and axons. Closer examination of postganglionic sympathetic axonal
morphology may determine if this is the case.
Figure 3-5: Argyrophilic (arrowhead) and unstained (arrow) cytoplasmic
compactions. Labelled axon (star). Cranial cervical ganglion, Holmes Silver, x
200.
e) Conclusion
Ubiquitinated inclusion bodies are not a feature of Grass Sickness nor does there appear
to be a substantial increase in ubiquitin expression. More sensitive techniques, such as
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e) Conclusion
Ubiquitinated inclusion bodies are not a feature of Grass Sickness nor does there appear
to be a substantial increase in ubiquitin expression. More sensitive techniques, such as
quantitative in-situ hybridisation methods for evidence of differences in RNA
expression, may disclose subtle increases in expression of this heat shock protein in
chromatolytic central neurons from cases of EGS.
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4. NEUROFILAMENTS
a) Introduction and literature review
Neurons contain three major classes of cytoskeletal elements, microtubules,
microfilaments and neurofilaments, interconnected by protein bridges. Neurofilaments
are neuron-specific, stable, intermediate filaments and have been recognised for over
100 years due to their intense argyrophilia. The three protein subunits, light (L), medium
(M) and heavy (H), are assembled in the perikaryon and move down the axon, where
they fill most of the axoplasm, until they are degraded at the axon terminals. Their
function is still conjectural, but may contribute to the stability and rigidity of the axon
(Greenfield et al, 1988). Unlike in the soma, neurofilaments in axons are
phosphorylated. Phosphorylation ofneurofilaments begins in the cell body of central
neurons but increases markedly in the axon once the neurofilaments begin to be
transported (Manetto et al, 1988).
Soma which are chromatolytic secondary to axonal damage, accumulate phosphorylated
neurofilaments associated with the decrease in their outflow from the cell body into the
axon and the longer residence time in that region of the neuron (Manetto et al, 1988).
Alterations in the neuronal cytoskeletal architecture are one of the most generalised
neuropathologic changes in neurodegenerative disorders (Nicotera et al, 1997) and the
perikaryon is known to accumulate phosphorylated neurofilaments of a number of
neurodegenerative diseases including motor neuron disease in man (Munoz et al, 1988;
Sobue et al, 1990; Gonatas et al, 1992; Lowe et al, 1992; Takahashi et al, 1997; Ince et
al, 1998), Brittany spaniels (Cork et al, 1988; Price et al, 1996), rabbits and pigs (Cork
et al, 1988), cats (Shelton et al, 1998), and mice (Koliatsos et al, 1994), as well as in
other neurodegenerative diseases such as Werdnig-Hofftnann's disease, multiple system
atrophy (Sobue et al, 1990) and neuronal inclusions on Parkinson's and Alzheimer's
diseases (Manetto et al, 1988). It has been proposed that phosphorylation ofNF in ALS
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occurs prematurely and is associated with an impairment ofneurofilament transport
(Manetto et al, 1988).
Griffiths (1993) recorded marked disturbances in neurofilament proteins in
postganglionic sympathetic neurons in EGS. The purpose of the present study is to




24 sections of tissue containing the nucli of CN III, V, VII, XII or GVE X fromlO EGS
cases and three control animals were included.
(ii) Laboratory methods
Immunohistochemistry was performed by the peroxidase-anti peroxidase method.
Five pm sections on Vectabond (Vector Laboratories, Inc) coated slides were incubated
in a 70° C oven for 30 minutes before being deparaffinised in xylene, rehydrated 100%
alcohol and placed in Lugol's iodine followed by 5% sodium thiosulphate for one
minute to clear preservative precipitates and enhance staining. After rinsing in water,
endogenous peroxidase activity was blocked with 3% hydrogen peroxide in absolute
alcohol 15 minutes. Sections were rinsed in PBS. Sections were incubated in 10%
normal goat serum for two hours at room temperature in a humid chamber. Mouse
monoclonal anti-phosphorylated neurofilament H and M antibody (1:1500 SMI 31,
Affinity, Research Products Ltd) was applied overnight at 4°C. PBS was applied to a
negative control section in each run. Goat anti-Mouse IgG (Sigma Immuno Chemicals,
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(BDH Laboratory supplies, UK), incubated for five minutes, counterstained with
hematoxylin for 20 seconds and mounted.
c) Results
Axons and an occasional incidental spheroid were strongly positive in tissues from both
EGS cases and control animals. A few soma on sections from control animals had very
light stippled staining but none were strongly labelled. A number of GSE and GVE
neurons (usually -20%) showed intense cytoplasmic labelling of the soma (Figure3-6).
A proportion of them appeared to be chromatolytic, with a swollen soma and central
staining, but the majority were morphologically normal with diffuse labelling of the
cytoplasm.




The labelling of phosphorylated neurofilaments in the soma of central neurons is not
found in normal tissues. This is unlikely to be due to primary axonal disease since, as
presented in chapter 4, the peripheral nerve from nuclei with chromatolytic neurons do
not show evince of pathology. This suggests that premature phosphorylation is taking
place, which may be either the result or the cause of an axonal transport problem. Semi
quantitative work in ALS has shown a significant increase in the phosphorylation of
neurofilaments not only in the perikaryon but also in the proximal region of the axon
with an accompanying decrease in labelling of non-phosphorylated neurofilaments.
These data suggest that phosphorylation of neurofilaments occurs prematurely in the cell
body and proximal axons of patients with ALS thereby masking the nonphosphorylated
epitopes. It may be possible to differentiate a generalised neurofilament transport
problem in EGS from an unrelated defect resulting in inappropriate premature
phosphorylation, by assessing whether there is an accumulation of non-phosphorylated
neurofilaments as well. Immunohistochemical staining for non-phosphorylated
neurofilaments as well as acetylated and (3 tubulin was attempted in order to further
define a disorder in cytoskeletal structure, however the results were not conclusive,
potentially because of a lack of staining specificity.
The immunoreactivity of epitopes of phosphorylated neurofilaments in normal appearing
perikaryons poses the question of whether their presence in the soma precedes the
dissolution of the Nissl substance and chromatolysis, or is found in neurons that are
recovering. The absence of evidence of central neuronal cell death suggests that the latter
is possible. The proportion of chromatolytic neurons in all affected GSE and GVE
LMNs is 0.16 (Chapter 2), which is similar to the proportion of soma labelled for
phosphorylated neurofilaments in the majority of sections examined. Cases were noted
to have chromatolytic neurons over a large range of disease duration (1-76 days), and it
may well be that the process is dynamic, with some cells recovering and others
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exhibiting an increase in metabolic activity and chromatolysis. In the absence of an in-
vitrn model however this question may be very difficult to answer.
These results, in addition to the work done by Griffiths (1993), point to an alteration of
the neuronal cytoskeleton being part of the cytopathology of EGS. Further detailed
studies may implicate a group of agents responsible.
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5. ELECTRON MICROSCOPY
a) Introduction and literature review
Electron microscopic examination of material from EGS cases was initially performed
by Chandler (1967), focusing on intestinal sympathetic ganglia from three affected
horses. Considerable time had elapsed in some cases before fixation. The cytoplasm in
all neurons examined was abnormal with gross vacuolation being a prominent feature.
Vacuoles were up lo 4 jam in diameter, and were limited by a single, often incomplete
membrane with occasional fusion of adjacent vacuoles and a very low density content.
One case was marked by large numbers of dense structures, 0.25 - 0.3 prn in diameter,
with a circular profile, a double membrane and with a variable content. It was
speculated that these structures represented stages in development of the vacuolation. In
addition, altered mitochondria were observed, however the state of preservation must
hinder interpretation of subtle changes.
Gilmour (1975) was able to remove the cervicothoracic and middle cervical ganglion
within five minutes of euthanasia and noted nuclear pyknosis, cytoplasmic vacuolation
originating from granular endoplasmic reticulum and axonal dystrophy. There was an
apparent increase in microtubules but no normal rough endoplasmic reticulum was
evident. Mitochondria were similar to those seen on control grids. Round or oval
structures surrounded by a single limiting membrane and containing mitochondria,
membrane bound vacuoles and vesiculotubular material, were noted in the recesses of
neurons and in the satellite cell network (see chapter 3, section 4).
(Hodson el al, 1984c, Hodson, el al, 1997) observed marginated Nissl, crenated and
peripheral nuclei, dense bodies in vacuolated cytoplasm, and an increase in lysosomes in
neurons of the coeliacomesenteric ganglion. Unmyelinated axons within the ganglion
were observed to contain accumulations of vesicular material, neurofilaments and
mitochondria indicative of a disruption of axoplasmic flow. Some myelinated fibres
showed abnormalities of the myelin sheath in terms of lamellar stripping of myelin and
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vesiculation. Accumulations of dense bodies in Schwann cells were often seen, together
with dilated cyternae. Similar changes were also apparent in satellite cells. Dorsal root
ganglia were also examined and contained neurons which showed changes compatible
with classical chromatolysis. Overall the changes were suggested to be similar to
retrograde lesions following axonal pathology.
The ultrastructural appearance of central neurons in EGS have not been examined.
b) Materials and methods
(i) Subjects
Six horses with chronic grass sickness were euthanised with a mixture of
quinalbarbitone and cinchocaine (Somulose, Arnolds). The head was disarticulated and
the brain collected by sawing through the calvarium with an electric saw (PFZ 550 E,
Bosh). The smallest sections of tissue which could reasonably be cut from unfixed brain
(averaging 3 mm3), were removed from the caudal medulla oblongata just lateral to the
floor of the fourth ventricle. The average time take from euthanasia to immersion of the
tissues in fixative was just under 12 minutes.
(ii) Tissues
Tissues were processed by the Electron Microscope Unit, R(D)SVS. The specimens
were fixed in 3% glutaraldehyde in 0.1% sodium cacodylate buffer solution at pH 7.3 for
at least two hours at room temperature. After several washings with cacodylate buffer
solution, tissues were post-fixed with 1% osmium tetroxide in 0.1 M cacodylate buffer
solution at pH 7.3 for one hour at room temperature. Following dehydration in a graded
series of acetone solutions, the tissue was infiltrated and embedded in an Araldite resin
mixture. In order to orientate and select an area for the ultrastructural observations, semi-
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thin 1 pm sections were cut with glass knives, stained with 1% toluidine blue and
examined under the light microscope. Ultra-thin sections with silver gold interference
colour (approximately 70-80 nm in thickness) were cut on an OMU4-Reichert Ultracut
microtome and collected on 200 mesh grids. The sections were double stained in
saturated uranyl acetate in 50% methanol for 30 minutes followed by lead citrate in
water for 5 minutes. The areas selected for investigation included large neurons which
were expected to originate from the hypoglossal nucleus. The grids were examined and
photographed using a Philips CM 12 transmission electron microscope.
c) Results
The state of preservation was reasonable, as judged by the structure of central myelin
sheaths in which the dense lines and intraperiod lines could be differentiated (Figure 3-7)
and mitochondria, in which cristae could be identified (Figure 3-8).
The perikarya of normal appearing neurons were large and round or multipolar (Figure
3-9), with organelles and multiple dark lipofuscin granules containing a peripherally
located vacuole dispersed throughout the cytoplasm (Figure 3-10. Nuclei were
prominent and round, containing a large nucleolus and little heterochromatin. The Nissl
bodies consisted of discrete stacks of orderly arrays of nearly parallel, broad cisternae
with ribosonral rosettes attached to their outer surface and free clusters of ribosomes in
the surrounding cytoplasmic matrix. The Golgi complex was infrequently observed, but
when present it appeared normal.
Very few affected neurons were evident and only one was noted which included a
nucleus. The cytoplasm of abnormal neurons were characterised by an extensive loss of
membrane associated ribosomes the apparent replacement of stacks of Nissl substance
by finely granular material. Soma were large and round (Figure 3-11), with numerous
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mitochondria and lipofuscin granules distributed throughout the cytoplasm. The
mitochondria appeared increased in number, but due to the paucity of affected neurons
available this could not be substantiated. In one cell in which the nucleus was in the
plane of section, the nucleus were undergoing early karyorrhexis with a partial loss of
the nuclear membrane and clumping of heterochromatin (Figure 3-12). There was no




Figure 3-7: Transmission electron micrograph, central myelin sheath
X 160,000. DL - major dense line. IL- intraperiod line
Figure 3-8: Transmission electron micrograph, mitochondrion
X 45,000. Cr - cristae.
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Figure 3-9: Transmission electron micrograph, normal neuron containing
an open faced nucleus (arrow head) and multiple lipofuscin granules
(arrow) X 1000
Figure 3-10: Transmission electron micrograph, lipofuscin granule
X 45,000
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Figure 3-11: Transmission electron micrograph of a chromatolytic neuron,
CN XII, CGS.X 1000
CN XII, CGS.X 1000
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Figure 3-12: Transmission electron micrograph of the degenerating
nucleus of a chromatolytic neuron showing condensed chromatin
(arrowhead), a partial nuclear membrane (arrow) and nuclear fragments
(star). CN XII. X 10,000
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d) Discussion
The nucleus of CN XII was selected to be examined since almost 90% of horses with
chronic grass sickness were noted to have chromatolytic neurons in that nucleus, and it is
relatively easy to isolate. Nevertheless only very few chromatolytic neurons were
successfully identified. In part, problems arose because of the difficulty involved in
accurately trimming fresh brain, even when exceptionally sharp instruments were
employed. The lack of in-situ perfusion also invariably resulted in the creation of post¬
mortem artefacts, despite the active measures taken to decrease the time from death to
tissue collection. The brain of smaller animals is classically fixed by cannulating the
aorta and perfusing with large volumes of aldehyde fixatives but the technical
difficulties involved in performing this task in an animal the size of a horse however are
almost prohibitive (S. Hackett and J. Cummings, Cornell University, pers comm).
The ultrastructural changes associated with chromatolysis due to axon pathology in
central neurons have been well defined (Aldskogius, 1978; Thomas et al, 1993).
Depending on the duration and distance from the axon damage and the functional system
the neurons originate from, cytoplasmic changes have been noted to include the
disappearance of granular endoplasmic reticulum, proliferation of smooth endoplasmic
reticulum, focal mitochondrial aggregates and mitochondrial degeneration and increased
numbers of microtubules and neurofilaments. This is associated with nuclear
displacement, infoldings of the nuclear membrane, nucleolar condensation and
vacuolation and the appearance of intranuclear electron dense particles. The findings
have been interpreted as indications of disturbed protein metabolism, oxidative
metabolism and increased intraneuronal transport.
The hallmark of chromatolysis, dispersal of the Nissl substance, was the principal
criterion by which abnormal neurons were recognised. There was no evidence of
cytoplasmic inclusions or increased neurofilaments, in direct contrast to EMND
(Cummings et al, 1990). Mitochondria appeared relatively well preserved and not
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overtly degenerating but were not objectively quantified. The state of fixation, although
reasonable, did not allow for pragmatic statements to be made about the appearance of
other organelles such as lysosomes, autophagic vacuoles, or of further cytoskeletal
elements such as microtubules.
The accumulation of lipofuscin granules seen here is a common feature of ageing, with a
mean of 63% of anterior horn neurons containing lipofuscin in 91 year old humans
compared to 24% at age 1 7 (Thomas et al, 1993). Histochcmically lipofusciu is
heterogeneous and consists of lipids, proteins and carbohydrates, and ultrastructurally it
is composed of membrane-bound particles which contain mainly electron-dense
homogenous material with a granular appearance. Increased levels of lipofuscin are
found in diseases associated with alpha-tocopherol deficiency, including equine
degenerative myeloencephalopathy (Mayhew et al, 1978) and EMND, in which
prominent accumulations of endothelial lipopigment are found in the small vessels of the
spinal cord (Cummings et al, 1995) and retina (Riis et al, 1999). A large body of
evidence suggests that lipofuscin can be used as a marker of oxidative stress and ageing
(Sohal and Brunk, 1989) but lipofuscin levels have not been shown to increase in ALS
patients relative to control tissues (McHolm et al, 1984). Barlow (1969) noted lipofuscin
granules in EGS central tissues, however EGS cases are unlikely to be deficient in alpha-
tocopherol and lipopigment accumulations have not been noted in the CNS vascular
endothelium
The ultrastructural changes of central neurons in the nucleus of CN XII have been
described in cats with dysautonomia using in-situ fixation of the brain (Pollin and
Griffiths, 1987). Abnormal neurons were characterised by a dispersion of the Nissl
substance progressing to dilation of individual cisternae by an electron-dense floccular
material with those cisternae having lost the majority of their ribosomes. There was
proliferation of smooth endoplasmic reticulum in several neurones with an increased
number of morphologically normal mitochondria and lysosomes. The nuclei of affected
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neurones were eccentric with crenations of the nuclear envelope and in some cases
nucleolar changes. Neurons which appeared to be degenerating were also identified, and
these contained only smooth membranous profiles and vacuoles with occasional
lysosonres and mitochondria. Adjacent GVE X neurons were examined and in addition
to the changes noted in the somatic neurons these contained frequent, complex,
membranous stacks. It was not clear whether this is due to a difference in the severity of
the initial damage to centrally and peripherally situated neurons, or whether there is a
differing response to a similar insult in the two cell types.
Notably, no Golgi complexes, either normal or abnormal, were identified in any central
neuron in feline dysautonomia in which the Nissl substance was markedly disrupted.
The Golgi apparatus was similarly not recognisable in an ultrastructural study of
postganglionic sympathetic neurons in affected hares (Griffiths and Whitwell, 1993).
The Golgi complex is involved in important functions of processing and transport of
plasma membrane, lysosomal, and secreted proteins. Fragmentation and atrophy of the
Golgi apparatus of motor neurons has been detected with organelle specific antibodies in
approximately 30% of motor neurons in five ALS patients in one study (Gonatas et al,
1992), which suggests that the alteration of the Golgi apparatus is an early event in the
pathogenesis of the neuronal degeneration in ALS. The Golgi apparatus was not evident
in affected neurons in the present study, however it would be preferable to be able to
examine further affected central neurons in EGS, particularly if in-vivo fixation could be
employed.
In summary, the ultrastructure of chromatolytic central neurons of EGS cases indicates
that these neurons have a dispersed Nissl substance, no evidence of neuronal inclusions
and an apparent loss of Golgi apparatus. In contrast to evidence found on histopathology
and TUN EL staining, which indicates that there is no evidence of neuronal cell death in
central tissues from EGS cases, the presence of at least one pyknotic nucleus examined
suggests that some affected neurons may not be capable of recovering. Indeed, the
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presence of karyorrhexis in at least one nucleus suggests that apoptosis may after all be





1 INTRODUCTION TO PTOSIS IN EGS
Ptosis in EGS could reasonably be caused by combinations of pathology to the
structures that assist raising the upper eyelid (Figure 4-1). The principal muscle
elevating the upper eyelid under voluntary control is the levatorpalpebrae
superioris, a flat muscle situated almost entirely in the orbit, originating on the
pterygoid crest and terminating in a thin tendon in the upper lid. It is innervated by
CN III. Ptosis due to pathology to CN III is rarely seen in isolation, but can be
associated with focal pathology caused by retrobulbar masses, or more diffuse
diseases including polyneuritis cqui (Mayhew, 1989).
An additional skeletal muscle is the levator anguli oculi medialis (LAOM), a small
muscle lying on the frontal bone and inserting on the medial part of the upper lid
(Budras et al, 1994). The muscle is innervated by a branch of CN VII, the
auriculopalpebral nerve, and unlike in dogs (Braund, 1994), or in man (Adams and
Victor, 1993), facial nerve paresis in horses does result in ptosis (de Lahunta, 1986),
as that muscle does not appear to play a role in raising the eyelid of species other
than horses or cattle.
Resting tone of the eyelid is supplied by a smooth muscle, Midler's superior tarsal
muscle underlying the striated levator muscles of the eyelid. It is innervated by
postganglionic sympathetic axons from neurons in the cranial cervical ganglion. In
the dog this is a delicate fan-shaped muscle arising from the trochlear cartilage on the
medial wall of the orbit, inserting on the tarsus in the upper lid continuous with the
edge of the levator palpebrae superioris muscle (Evans, 1993). Midler's muscle has
also been referred to in the lower eyelid of the dog but does not appear to have been
described in either eyelid in the horse. In man the upper lid becomes ptotic by no
more than 2 to 3 mm when cervical sympathetic nerves are interrupted (Beard, 1983)
but in horses ptosis is one of the most constant and distinct features of Horner's
syndrome (Simoens et al, 1990). Since enophthalmos is not a feature of Homer's
syndrome in horses (Simoens et al, 1990), ptosis due to sympathetic denervation in
this species is likely to result from paresis of Midler's muscle.
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Ptosis in cases of EGS could reasonably be to due to paresis of the striated levator
palpebrae superioris or the levator anguli oculi medialis following dysfunction of
the chromatolytic neurons of CN III or VII (Chapter 2), or due to a of the loss of
sympathetic tone in Muller's muscle secondary to the pathology of neurons in the
cranial cervical ganglion. Assessing the structure and function of the individual
anatomical components is necessary to answer that question, and is the basis of this
chapter.
Mutter'3 mu3de
LAOM Levator palpebrae superioris
Figure 4-1: Periorbital region of the horse showing the position of
muscles raising upper eyelid. Left dorsolateral view.
LAOM = Levator anguli oculi medialis
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2. STUDIES ON THE EXPERIMENTAL INDUCTION OF
PTOSIS IN HORSES
a) Introduction
Ptosis is a relatively common clinical sign of a variety of neurological diseases. In
horses it has been noted in such diverse conditions as guttural pouch mycosis, equine
protozoal myeloncncephalitis, neck trauma, grass sickness, otitis media/interna,
cranial nerve (CN) V pathology with marked temporal and nrasseter muscle atrophy,
head tiauma and fractures of the tenrporohyoid bone, among others (Smith and
Mayhew, 1977; de Lahunta, 1983; Mayhew, 1989; Simoens et al, 1990; Cottrell et
al, 1999).
Earlier observations in these studies indicated that assessing the angle of the
eyelashes to the cornea was an effective way of determining the degree of ptosis in
equine cases of Homer's syndrome. This is likely to be due to a smooth muscle, not
Midler's muscle, which is mentioned rarely in the literature, the arrectores ciliorum,
bundles of smooth muscles which extend from the follicles of the eyelashes towards
the cartilaginous tarsal plate. These are absent in man but common in ruminants
(Gelatt, 1991) and horses (R.E. Habel, Cornell University, personal communication).
In these experiments the change in eyelash angles was used as a measure of change
in the degree of ptosis.
The precise appearance of ptosis in horses due to lesions at different sites has not
been documented, and was the basis of this study.
98
a) Materials and Methods
Six mature, healthy research ponies were used in this study (PIL 60/5641, PPL
60/1875). Five separate investigations, detailed below, were performed over three
days in a random order. A minimum of five hours was scheduled between
experiments to allow all clinical signs to recede.
The experiments were based on assessing the degree of ptosis by measuring the angle
between the eyelashes and a line drawn horizontally between the medial canthi of the
eyes (Figure 4-2). One eye was directly treated in each experiment with the untreated
eye serving as a control. The relative degree of ptosis was assessed by calculating the
difference in eyelash angles between the control eye and experimental the eye. Thus
a positive eyelash angle difference (Diff) indicated a greater relative degree ofptosis
in the experimental eye (Tx), whereas a negative eyelash angle difference indicated a
greater relative degree of ptosis in the control eye. In addition, a subjective visual
score of ptosis was made (0 = none, 1 = just evident, 2 = mild, 3 = moderate,
4 = pronounced).
1. Topical alpha-adrenergic agonists
Phenylephrine (500pl, 0.5%w/v Martindale) was applied to the conjunctiva of the
left or the right eye. Frontal photographs were taken 30 minutes later with a 1.4 M
pixel digital camera (Olympus D-600L) and the subjective ptosis score was noted.
Images were downloaded onto a computer and the angles of the eyelashes of both
eyes determined (Image-Pro Plus, Media Cybernetics), (Fig. 4-2).
2. Topical alpha-adrenergic agonists post sedation
Within five minutes of sedation with either 500 pg/lcg romifidine (Sedivet,
Boehringer Ingelheim) IV, 0.5mg/kg xylazine (Virbaxyl 10%, Virbac Ltd) IV or
50pg/kg acepromazine (ACP injection, C-Vet) IV, phenylephrine was applied to the
conjunctiva of one eye . The degree of sedation was noted and frontal photographs
were taken 30 minutes later and analysed as above for eyelash angle difference and
ptosis score.
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3. Vagosympathetic trunk anaesthesia
i) The jugular vein was digitally compressed in the cranial neck and a 40 mm 21G
needle inserted to its hub into the jugular groove in the caudal third of the neck and
positioned so that blood could not be aspirated. Ten ml of mepivacaine (Intra-
Epicaine, Arnolds), with or without 5ml bupivacaine hydrochloride (Marcain,
ASTRA Pharmaceuticals Ltd) was injected and the onset and character of clinical
signs noted. In three cases, (ponies 2, 4 and horse 6), a further 5 or 10 ml
mepivacaine was administered when no facial sweating or ptosis was noted within 30
minutes of initial administration. Frontal and lateral photographs were obtained when
clinical signs appeared most prominent, variably within 30 to 45 minutes of
administration of the last doses of local anaesthetic. Ptosis score and eyelash angles
were recorded.
ii) 5 ml of 0.5%w/v phenylephrine eyedrops were applied into one eye when ptosis
appeared most prominent and the ptosis score and eyelash angles was again recorded
at the time of any prominent change in eyelash angles, usually 30 to 45 minutes later.
4. Palpebral nerve anaesthesia
i) 500 pi of mepivacaine were infiltrated around the palpebral nerve at the level of
the zygomatic arch using a 16 mm 23 G needle and details of the onset and character
of the subsequent clinical signs were noted. A frontal photograph was taken when
clinical signs appeared very prominent and the ptosis score as well as the angle of the
eyelashes to a line drawn between the medial canthi of the eyes was measured as
before.
ii) 500 pi of 0.5%w/v phenylephrine eyedrops were then applied and eyelids assessed
as above 30 minutes later.
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5. Topical adrenergic antagonist
A volume of 500 pi of 0.5 % dapiprazole monohydrochloride (Glamidolongelini,
Angelini) was applied to the conjunctiva of one eye. The eyelids were assessed as
above when clinical signs appeared most prominent, usually within 30 minutes of
application.
Data were analysed using a statistical software package (SigmaStat, SPSS Science),
b) RESULTS
The eyelash angles determined for the treated eye, the control eye, and the difference
between them, as well as the ptosis score and further clinical observations for each
experiment are given in Tables 4-1 to 4-7.
The combined data were normally distributed but failed the equal variance test. A
Kruskal-Wallis one way analysis of variance on ranks was performed on the
difference in eyelash angles and a statistically significant (p = 0.045) difference
among experiments was detected. Data from individual experiments passed the equal
variance test and a student's t-test between the difference in eyelash angles before
and after phenylephrine treatments following vagosympathetic trunk anaesthesia
showed a significant difference (p = 0.03), indicating that the ocular sympathetic
agonist had substantially reversed the degree of ptosis. Eyelash angle differences, pre
and post phenylephrine administration, from animals with a palpebral nerve blockade
however were not significantly different from each other (p = 0.95), nor were the data
between phenylephrine treated and control sides in the absence of Horner's syndrome
or facial paresis (experiment 1). Summary statistics and p values for student's t-test
comparing experimental and control eye data for all experiments are given in
Table 4-8 and Figure 4-3.
The degree of sedation was scored as 'none' or 'mild' after acepromazine or xylazine
administration, and 'marked' to 'profound' after detomidine or romifidine sedation.
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There was no correlation (p = 0.68) between the ptosis score or eyelash angle
difference and the degree of sedation (experiment 2). The effect of topical adrenergic
agonists and antagonists on the pupil was assessed subjectively and no conspicuous
changes in diameter were noted.
There was a significant relationship between the differences in eyelash angles and the
ptosis score (Spearman Rank Order correlation, p <0.0001) for all experiments,
however the correlation was less significant (p = 0.02) when only the palpebral nerve
block (experiment 4i) was analysed.
Table 4-1: Experiment (1) Topical phenylephrine
Eyelash angles: Notes
Control Rx Diff Score
Pony 1 150 146 4 0 No pupil changes
Pony 2 140 133 7 0 No response at 30 minutes
Pony 3 112 118 -6 1 No pupil changes
Pony 4 128 142 -15 3 No pupil changes
Pony 5 152 154 -2 0 No pupil changes
Horse 6 119 118 1 0 No pupil changes
Table 4-2: Experiment (2) Topical phenylephrine post sedation
Eyelash angles: Degree of sedation
Sedative Control Rx Diff Score
Pony 1 Xyl 117 155 -38 3 Mild
Pony 2 Rom 129 147 -19 4 Marked
Pony 4 Det 112 160 -47 4 Marked
Pony 5 Det 122 137 -15 3 Profound
Horse 6 Det 107 124 -17 2 Profound
Pony 3 ACP 103 101 2 0 Mild
Pony 4 ACP 114 127 -13 3 None
Pony 5 ACP 114 127 -13 3 None
Horse 6 ACP 107 109 2 0 Mild
Xylazine (Xyl), detomidine (De ), romifidine (Ram), acepromazine (ACP).
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Fig 4-2. Frontal photograph of a horse with Horner's syndrome in the
right eye with position of defining lines used to measure the eyelash
angles
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Fig 4-3. Box and whisker plot summarising the eyelash angle
differences data for each investigation
Key: The ends of the boxes define the 25th and 75th percentiles with a line at
the median and error bars defining the 10th and 90th percentiles for
experiments A through E. Outliers are shown as •
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c) DISCUSSION
The measurement of eyelash angles from a frontal view is a novel approach for
assessing ptosis in equidae and circumvents the problem of simultaneously assessing
the palpebral fissure of both eyes. The eyelash angle differences correlated well with
the subjective ptosis score but the association was less marked when the ptosis was
due to somatic CN VII nerve blockade. This was predictable given that the
arrectores ciliorum is a smooth muscle inserting on the eyelashes. For the same
reason, phenylephrine did not have a significant effect on the palpcbrae uf eyes in
which there had been no compromise to sympathetic tone (experiments 1 and 4), but
significantly reversed the ptosis produced by blocking the vagosympathetic trunk
(experiment 3). The dilute concentration of phenylephrine used in this study was
shown in a pilot study to have a minimal effect when used in the normal eye of
horses with Homer's syndrome while still significantly reversing the ptosis in the
affected eye. The effect of the palpebral nerve block was determined by assessing the
menace response, in which the efferent pathway is mediated by CN VII. It is
clinically significant that the ptosis score of animals with a markedly reduced or
absent menace response secondary to blocking the facial nerve was modest or absent
in four of the six subjects, reinforcing the observation that suspected paresis of eyelid
muscles innervated by that nerve is best assessed by palpation rather than by
assessing the degree of ptosis. A thorough ocular examination should also ensure that
any change in the angle of the eyelashes is not due to pain oi enophthalmos.
Phenylephrine is a direct-acting adrenergic agonist, but unlike epinephrine and
norepinephrine it is a, receptor selective (Hoffman and Jefkowitz, 1996), and
therefore causes contraction of the smooth muscles of the eyelid. Dapiprazole on the
other hand specifically blocks a! adrenergic receptors (Valeri ct al, 1986) and is used
to reverse the mydriasis induced by sympathomimetic and parasympatholytic
compounds. Ptosis is a recognised side effect in the use of dapiprazole in a small
proportion of human patients (Wilcox et al, 1995), however the marked effect on the
equine eyelid was greater than expected and may be associated with the additional
presence of the arrectores ciliorum.
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The effect of sedation on phenylephrine response was evaluated in order to assess its
potential impact on the diagnostic use of alpha agonist eyedrops in clinical cases with
ptosis. Both phenothiazines and the a2 agonist drugs are known to have muscle
relaxation properties and this was borne out by the increased response of the eyelids
to phenylephrine in sedated animals. Phenothiazines interfere with the central actions
of catecholamines and peripherally block cholinergic, adrenergic and ganglionic
activity (Muir, 1991) by blocking postsynaptic a, receptors (Hoffman and Jefkowitz,
1996) leading to muscle relaxation. The a2 agonists such as xylazine and romifidine
bind cential and peripheral presynaptic inhibitory a2 receptors, hyperpolarising
neurons (Hedrick et al, 1995) and inhibiting norepinephrine release. Both a, and a2
receptors are stimulated peripherally by the a, agonist sedatives, however detomidine
has 100 times more a, affinity than xylazine (Muir, 1991). It is possible that in a
larger study detomidine would be found to have a lesser impact than xylazine on
palpebral paresis. The degree of ptosis in this study did not correlate with degree of
sedation, as exemplified by the acepromazine treated animals which did not appear to
be sedated but responded conspicuously to phenylephrine administration, suggesting
less effective sedative but greater muscle relaxation properties of a, receptors.
In small animal and humans patients, the presence of Horner's syndrome is
con finned clinically by evaluating pupillary responses to topical direct-acting
noradrenergic agonists (O'Brien, 1991). Horses have been shown to have a variable
or absent pupillary response both to sympathetic denervation and to topical
administration of sympathetic agonists (Smith and Mayhew, 1977; Hacker et al,
1987; Simocns et al, 1990; Gelatt et al, 1995) and this study was consequently not
designed to quantify the response of pupils. Subjective assessments of pupillary
responses throughout the current experiments however are in line with these previous
studies; namely pupillary responses to adreneigic agonist or antagonist eyedrops
were minimal if at all present, and only inconsistent miosis was noted on inducing
Horner's syndrome in these animals.
This study shows that ptosis is not an inevitable consequence of acute palpebral
nerve pathology and that a decrease in sympathetic tone causes paresis of the smooth
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This study shows that ptosis is not an inevitable consequence of acute palpebral
nerve pathology and that a decrease in sympathetic tone causes paresis of the smooth
musculature of the palpebra and eyelashes. Alpha agonist eyedrops are a useful
additional diagnostic test in detecting ptosis induced by sympathetic denervation in
unsedated horses.
109
3. CRANIAL NERVE III MORPHOLOGY
a) Introduction
Ptosis is evident in AGS cases of short duration and remains a prominent clinical
sign even in chronic cases after many weeks. If the cause of the ptosis is pathology to
the neurons of CN III, it is reasonable to expect alterations in the peripheral nerve
either because of primary axonal or myelin damage, or secondary to neuronal cell
death.
Chromatolysis is classically equated with a reaction due to axonal disruption
(Summers et al, 1995), which raises the question ofwhether the chromatolysis noted
in EGS brainstem LMNs is due to a primary axon pathology. Hodson, (1984b)
ultrastructurally examined myelinated preganglionic sympathetic fibres from EGS
cases and noted myelin lamellar stripping and vesiculation, in addition to
accumulations of dense bodies in Schwann cells. The changes were suggested to be
similar to retrograde lesions following axonal pathology. Gilmour (1975) described
changes resembling neuraxonal dystrophy of postganglionic sympathetic axons in the
stellate ganglion of EGS cases, and after observing accumulations of nor-adrenaline
in the abnormal structures in the axon tracts deduced that there is a primary axonal
lesion in grass sickness (Gilmour, 1976). The complete loss of Golgi apparatus
recognised by Griffiths (1993) in postganglionic sympathetic neurons however has
never been observed in somatic or visceral neurons after experimental axotomy.
Longitudinal 1pm semi-thin sections of carefully preserved oculomotor nerve from
EGS and control cases were examined to try to answer the question of whether
CN III pathology is a cause of ptosis in EGS, and to further assess whether somatic
LMN cell death is occurring in this disease.
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b) Materials and Methods
Oculomotor nerves were obtained from two control horses and three cases of EGS
(Table 4-9). The nerve was collected by removing the cap of the calvarium as soon as
possible after euthanasia, usually within 20 minutes, and severing CN III close to the
orbital fissure when removing the brain. The proximal portion of the nerve was cut
close to its origin at the base of the mesencephalon. Nerves were suspended in
3% glutaraldehyde in cacodylate buffer by fixing one end from the brim of a plastic
universal with a hypodermic needle, and weighting the nerve with a 0.4g weight
attached to a size 12 de-barbed fish hook. After four days the weights were removed
and the nerves kept immersed in the glutaraldehyde until further processing.
Tissues were processed by the Applied Neurobiology Group, University of Glasgow.
Samples were trimmed to remove the ends and washed in 0.1 M sodium cacodylate
buffer before post-fixing in 1% osmium teroxide in 1% potassium dichromate and
0.85% sodium chloride at pH 7.2 for 45 minutes. Samples were washed further in
sodium cacodylate, stained with toluidine blue for one minute, and dehydrated in
increasing concentrations of alcohol. Finally the tissues were infiltrated in increasing
concentrations epoxy resin (Araldite, Agar Scientific Ltd) in propylene oxide for a
total of 30 hours, infiltrated in Araldite Mix and Araldite Mix with accelerator
(AGAR Scientific) and embedded for 48 hours at 60°C in Araldite Mix with
Accelerator. Semi-thin 1 pm longitudinal and transverse sections were cut using an
ultramicrotome (Reichert OMU4 ULTRACUT, Leica UK Ltd) and mounted
routinely on one glass slide.
Sections were examined under a microscope for evidence of histopathology (Dyck
1993).
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Table 4-9: Subjects included in ptosis study
Case # Signalment Diagnosis Duration (days)
99/279 4 yo WB gelding CGS 5
99/330 4 yo Highland pony mare CGS 20
99/299 4 yo WB gelding SGS 5
98/820 3 yo WB mare CVM
98/738 9 yo Clydesdale gelding Orthopaedic
c) Results
The sections examined were judged to be well preserved. Axon material was variably
maintained depending on the section. Occasional axons were not truly longitudinal
but the majority could be adequately assessed while in the plane of section. Schmidt-
Lanterman incisures could be differentiated and indentations of myelin by fibroblast
and Schwann cell nuclei was evident. Nodes were difficult to distinguish and
occasional artefactual vacuoles were present. There was no evidence in any sections
of decreased myelin density, macrophage activity, myelin ovoids or disruption of
myelin above that which could be explained by artefact.
d) Discussion
Disorders of the peripheral nerve can be classified in terms of the components of the
neuron that is primarily affected, thus a primary loss of the neurons contributing
axons to the peripheral nerve is categorised as a neuronopathy, while pathology to
the axon may be due to primary axonopathy or secondary to a demyelinating
neuropathy (Thomas et al, 1993).
Alterations due to axonal degeneration are the basis of the classical wallerian
degeneration resulting in chaiacteristic lesions at histopathology, while changes due
to myelin pathology have been well defined in teased fibre studies (Dyck, 1993). A
detailed assessment of myelin pathology in EGS fibres would be optimised by the
use of a teased fibre protocol, however the process which is most likely to cause
peripheral nerve alteration in EGS is axonal degeneration following neuronal death.
The mechanism by which somas and their axons degenerate in neuronal degeneration
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is incompletely known (Dyck, 1993) but axonal pathology in sural nerve biopsies
from ALS patients has been described to include acute axonal degeneration, with
initial widespread "wrinkling" of myelin and uneven myelin thickness eventually
resulting in myelin degeneration into linear rows of myelin ovoids and balls (Dyck et
al, 1975; Sobue et al, 1981; Bradley et ai 1983). It seems likely that these are
secondary effects resulting from axonal degeneration caused by deterioration and loss
of somatic LMNs in the spinal cord (Perrie et al, 1993).
The absence of pathological changes evident in semi-thin sections in this study
strongly suggests that neuronal cell death or axon degeneration is not taking place in
the oculomotor nucleus of EGS cases. However, axonal histopathological changes
due to neuronopathy may be not be noted on histopathology as only a very low
proportion of abnormal fibres may be present (Dyck et al, 1975). The detection of
subtle pathological changes may require the use of morphometric techniques,
performed in the next section of work.
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4. CRANIAL NERVE III MORPHOMETRY
a) Introduction
This technique allows the appraisal of the diameter of axons, the myelin thickness
and fibre densities, as well as calculated derivatives, particularly the diameter
distribution of fibres and the ratio of the axon diameter (d) to the total myelinated
fibre diameter (D), the 'g' ratio. Loss of a specific functional or physiological group
of fibres can be expected to alter some or all of these parameters. While there is a
striking difference in fibre composition among nerves and a great variety in diameter
histograms among species, the median diameter and diameter peaks of a specific
nerve at a given level are remarkably consistent. Morphometric values are
sufficiently consistent to evaluate the class of neuron, the level within the neuron,
and the components (axon or myelin) affected (Dyck, 1993).The technique is well
established in some species, particularly man, in which a large amount of
comparative data on normal subjects are available.
Routine histopathologic evaluation in horses is restricted to specific diseases such as
equine motor neuron disease (Jackson et al, 1996) and idiopathic laryngeal
hemiplegia (Duncan et al, 1978). The recurrent laryngeal nerve of horses with
idiopathic laryngeal hemiplegia has been comprehensively assessed (Duncan et al,
1978; Duncan and Brook, 1985; Cahill and Goulden, 1986a), however evaluation of
the nerve in normal control horses (Lopez Plana et al, 1993) is hampered by the high
incidence of subclinical disease (Cook, 1988). The only comprehensive examination
of an equine peripheral nerve was undertaken by Wheeler (1987), who closely
examined a somatic sensory nerve, the lateral palmar nerve.
Comparison of oculomotor nerve data to other nerves necessitates the classification
of this cranial nerve as a peripheral nerve, an issue that is not without controversy in
the literature, as many authors classify cranial nerves separate from other nerves
particularly when applied to clinical disease (Anthoney, 1993). The evaluation of
general somatic efferent cranial nerves is usually limited to the facial nerve
(Fahrenkamp and Friede, 1987; Thurner et al, 1993) and very few studies in any
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species have quantitatively investigated the oculomotor nerve. One study evaluating
the the components of the nerve roots of the oculomotor nerves of ALS and recessive
bulbospinal muscular atrophy cases was unable to uncover any evidence of pathology
(Sobue et al, 1981). Bronson (1978), used the oculomotor nerves of rats to evaluate
the use of light and electron microscopic morphometric techniques and different
statistical tests performed on nerve data. The axon distribution was found to be
bimodal, and formal methods of dividing the distribution into component normally
distributed parts were used to derive the mean diameters of the upper and lower
peaks. Large and small classes of axons in the oculomotor nerve were also noted in a
further study designed to examine morphometric axon-myelin relationships, however
diameter summary data were not provided (Fraher, 1989).
This study was designed to evaluate axon and fibre diameters and distribution curves
in the oculomotor nerve of control and EGS cases in order to detect evidence of
pathology in the principal nerve responsible for innervation of the levator palpebrae
superioris.
b) Materials and Methods
(i) Case material
Oculomotoi nerves (CN III) were collected from 26 LGS cases and control horses in
1997 and 1998. Samples from 13 cases were processed to semi-thin (1 pm) sections
and the eight highest quality sections were chosen for morphometry (Table 4-10).
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Table 4-10: Experimental animals
Case # Signalment Diagnosis Duration (days)
98/179 4 yo Connemara female CGS 35
98/264 4 yo TBx gelding CGS 16
98/303 6 yo Cob gelding SGS 3
98/401 9 yo Arab x female SGS 5
98/263 1 yo TB female AGS 1
98/365 6 yo Irish Draft female Colic
98/677 5 yo TBx gelding Oesophageal sliiclure
98/699 3 yo Pony x male Strangulated scrotal hernia
(iii) Tissue materials and Methods
The nerve was collected by removing the cap of the calvarium as soon as possible
after euthanasia, usually within 20 minutes, and CN III was severed close to the
orbital fissure when removing the brain. The proximal portion of the nerve was cut
close to its origin at the base of the mesencephalon and stretched onto a piece of
cardboard and immersed in 4% formalin for between one and three days.
Tissues were processed by the Electron Microscope Unit, R(D)SVS. Samples were
washed in 0. IM sodium cacodylate buffer three times for 20 minutes each and
postfixed in 1% osmium tetroxide in 0.1 M sodium cacodylate buffer for 45 minutes.
This standard method resulted in inadequate fixation of the centre of the nerve, and it
was found that initial fixation of the nerve in 1% osmium tetroxide, with further
immersion of 2mm thick pieces of nerve for 40 minutes, improved axonal
di fferentiation in some of the samples by allowing the fixative to penetrate through
the myelin sheathes. Samples were then washed three times in distilled water, stained
with toluidine blue for 30 seconds and dehydrated through increasing concentrations
of ethanol. After placing in a 50:50 Araldite/dodecanyl succinic anhydrate (DDSP)
mixture (AGAR Scientific) three times in dry apparatus, they were left overnight at
60°C. The following day they were infiltrated in Araldite Mix and Araldite Mix with
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accelerator (AGAR Scientific) for 60 minutes each before finally embedding for 48
hours at 60°C in Araldite Mix with accelerator. Semi-thin (1 pm) transverse sections
were cut using an ultramicrotome (Reichert OMU4 ULTRACUT, Leica UK ltd) and
up to six sections were mounted on one glass slide. Addition of a coverslip using
Permount was found to decrease diffraction under light microscopy.
(iv) Quantitative studies
Semi-thin sections of nerve were magnified to x 400 and captured from a microscope
(Nikon Optiphot-2) through an attached analogical RGB videocamera (TK 1070E,
JVC). Images were digitised with a frame grabber (Snapper-24, Data Cell) connected
to a computer. The diameters of fibres and axons were measured with the help of a
computerised image analysis system (Image-Pro Plus, Media Cybernetics), calibrated
using a slide micrometer. The resolution was set to 1024 x 768 pixels and the
corresponding yield was 3.56 pm/pixel. A variation on systematic random sampling
of squares (Mayhew and Sharrna, 1984) was used to obtain a systematic random
pattern of fields covering each montage. The first field was chosen at one extreme of
the section and a repeating pattern was chosen to cover the section (see Figure 4-4).
The pattern chosen allowed at least 600 fibres per sample to be measured for the first
five samples and greater than 300 for three further samples after analysis of the initial
data. The repeatability was verified by counting one section twice on different days
using this system but with a different starting co-ordinate, to result in two
independent and non overlapping observations.
Figure 4-4: Systematic random sampling of axons from semi-thin
sections of nerve
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Myelinated fibres and their axons in each field were outlined individually on a
digital graphics tablet (Ultraslate, Coopertina). Tangentially sectioned or artificially
changed fibres were excluded from the analysis. After separating automatically
linked outlines, the diameter of a circle of the equivalent area was derived for each
measurement. Axon and fibre outline data were paired by sorting the grid coordinates
of the centre of the perimeters in Excel (Microsoft Inc). Statistical software (C-stat,
Oxford Scientific) was employed to determine the relationship between axon and
fibre diameters in samples from grass sickness and control cases. Fibres were not
measured if they appeared crcnatcd or deformed. Descriptive statistics were
calculated and diameter distributions were determined and plotted graphically. The g
- ratios, indicating the thickness of the myelin sheath relative to the diameter of the
axon, were derived from axonal and myelinated fibre diameter data as follows:
g ratio = axonal diameter (d)
fibre diameter (D)
c) Results
The fixation of material appeared not be optimal, however it was judged to be
adequate for purposes of the present study (Figure 4-5). A median of 531 fibres were
counted per sample (range 310 to 706). Median fibre and axon diameters and g -
ratios of the oculomotor nerve of three control and five EGS cases are shown in
Table 4-10. The g - ratio data were normally distributed and mean and standard
deviations are presented (Figure 4-6). Scatter plots with a simple regression line
relating fibre diameters to axon diameters for total EGS and control data are shown
in Figure 4-7. Fibre and axon diameter distribution histograms for individual sample
and summed control and EGS data are given in Figure 4-8 to 4-11. The fibre
diameter distribution graphs were bimodal in shape with the peak of the lower mode
visually assessed at 4 pm and the upper mode at 13 pm for both the summed control
and the EGS data. The upper mode was much more difficult to identify in the axon
distribution curves and was unimodal in some cases, particularly when the combined
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control data are considered. The g - ratios from control and EGS cases however
appeared to represent a single population (Figure 4-12).
Figure 4-5: CN III, semi-thin transverse section, SGS.
The field contains numerous myelinated fibres of a range of diameters,
outlined by densely stained myelin sheaths. A Schwann cell nucleus (n), a







Figure 4-6: g - ratio diameter distributions (%) (all data).
Table 4-11: Median values (minimum, maximum) for fibre diameter,
axon diameter and the ratio of axon to fibre diameter, mean value of g -
ratio (± standard deviation)






98 677 Control 684 10.2(1.5-20.1) 5.3 (0.6-15.4) 0.56(0.10)
98 699 Control 706 10.2 (1.7 - 19.1) 4.8 (0.6-13.5) 0.50(0.10)
98 365 Control 320 10.4 (2.1 - 22.2) 4.7 (0.9-12.4) 0.53 (0.11)
Total control 1710 10.3 5.0 0.53 (0.11)
98 263 AGS 628 8.9 (2.4-20.6) 4.4 (0.7-14.1) 0.50 (0.09)
98 264 CGS 628 10.7(2.7-22.3) 5.3(1.2-16.3) 0.54 (0.08)
98 179 CGS 661 9.0(2.4-20.8) 4.4(0.7-16.3) 0.51 (0.09)
98 401 SGS 310 9.9(1.8-19.0) 4.2 (1.0-14.7) 0.47 (0.10)
98 303 SGS 311 9.8(1.9-19.2) 4.3 (0.8-14.6) 0.48 (0.11)
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Figure 4-7: Scatter plot with simple regression line relating fibre
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Figure 4-9: CN III fibre and axon diameter distributions (%). EGS cases
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Figure 4-10: CN III fibre (left) and axon (right) diameter distributions
(%). All data, control animals.
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Figure 4-11: CN III fibre (left) and axon (right) diameter distributions















A number of fixatives have been recommended to preserve nerves for morphometry
including differing concentrations of glutaraldehyde (Duncan et al, 1978; Cahill and
Goulden, 1986a; Vita et al, 1992), glutaraldehyde and paraformaldehyde (Fraher,
1989; Wheeler, 1991) and formalin (Braund et al, 1982b). The latter was chosen with
advice from that author but did not result in optimal fixation of the myelin sheathes
and precluded analysis of unmyelinated fibre diameters. Axons have been shown to
have a greater diameter in paranodal regions, thus paranodal fibres, as well as
severely crenated fibres were excluded from the analysis (Braund et al, 1982b). The
state of fixation prevented the categorical identification, and exclusion, of Schmidt-
Lanterman incisures, however these have been noted to account for less than 1% of
all fibres (Mayhew and Sharma, 1984) and have a minimal effect on external fibre
diameters (Jacobs and Love, 1985). The number of fibres counted per sample in this
study is in line with the sample size recommended in the literature (Braund et al,
1982b; Wheeler, 1991) and the systematic random sampling of squares method for
counting fibres has been shown to be highly efficient and to give sampling trial
results which are less than 1% different to absolute counts (Mayhew and Sharma,
1984). Density of axons was not assessed due to the considerable variability in both
density and number of myelinated fibres found at a given level of a specific nerve
(Dyck, 1993) and with different processing methods (Wheeler, 1987).
Fibre diameter data primarily appeared to have a bimodal distribution, which
formally precludes the use of parametric statistical techniques. Dividing bimodal data
into two normally distributed components is feasible in some cases (Bronson et al,
1978) but did not result in appropriate distributions for this data. The most
commonly biopsied human nerve, the sural nerve, has a bimodal distribution (Jacobs
and Love, 1985; Dyck, 1993), as have equine lateral palmar nerves (Wheeler and
Plummer, 1989) and rat oculomotor nerves (Bronson et al, 1978). Biimodal
distributions are a characteristic of nerves such as feline trochlear and abducens
nerves (Hildebrand et al, 1988), human facial nerves (Thurner et al, 1993), canine
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nerves (Hildebrand et al, 1988), human facial nerves (Thurner et al, 1993), canine
medial articular nerve (O'Connor et al, 1982) and equine (Duncan et al, 1991b;
Lopez Plana et al, 1993) and canine (Braund et al, 1982b) distal laryngeal nerves.
Proximal portions of the recurrent laryngeal nerve and the vagus on the other hand
have a unimodal distribution (Braund et al, 1988b), and canine peroneal and ulnar
nerve frequency distributions were found to be unimodal at birth and bimodal at 3-6
months old (Braund et a\, 1982b), emphasising the importance of controlling for the
specific biopsy site and the age of the subject.
Neurodegenerative diseases characteristically result in a loss of distinct fibre
populations (Sobue et al, 1981; Hanyu et al, 1982; Bradley et al, 1983; Cahill and
Goulden, 1986a; Atsumi and Miyaatake, 1987; Rosales et al, 1988; Braund et al,
1994), shifting the median and modal peak diameter values. The very similar median
and equivalent modal and peak diameter values of EGS and control fibres in this
study indicate that they are unlikely to be based on different fibre size populations.
The median diameters of fibres in this study is similar to that found by Duncan
(1991b) in an analysis of distal equine recurrent laryngeal nerve, and the modal peak
diameters correspond to those determined in the equine lateral palmar nerves
(Wheeler and Plummer, 1989). Median fibre diameters however are significantly
larger than the mean diameters obtained from human and rat samples of the
oculomotor nerve (Bardosi et al, 1990).
g - ratios can be a sensitive means to indicate the presence of peripheral neuropathy;
high g - ratios being associated with regeneration (Beuche and Friede, 1985) while
abnormally low g - ratios are a feature axonal atrophy (Jacobs and Love, 1985), as
exemplified by uraemic neuropathy (Dyck, 1993). The most reliable way to
determine g - ratios is by counting myelin lamellae using ultrastructural techniques,
but it is satisfactory to calculate them by measuring axon and fibre diameters (Vita et
al, 1992). The g - ratios of the same nerve can vary greatly between species (Bardosi
et al, 1990), and within one species can differ significantly even between fibre
classes of nerves that are closely similar in respect of morphological class, central
origin, peripheral distribution and function (Fraher, 1989). The g - ratio values
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determined in this study are within the limits of normal values found in adult human
sural nerve biopsies (Jacobs and Love, 1985). The g - ratios of human and rat
oculomotor nerve fibres (Fahrenkamp and Friede, 1987; Bardosi et al, 1990) can be
grouped into two main populations, differing in their relative myelin sheath
thicknesses. The general relationship of g - ratios and fibre size is unclear however,
with different studies finding that g - ratios increase, decrease or remain unchanged
with increases in axon diameters (Thomas et al, 1997). Grouping of g - ratios was not
apparent in this study however, suggesting that the ratio of myelin to fibre diameters
was constant in both control and EGS samples. This provides further indirect
evidence that axonal atrophy (and thus neuronal death) or hypertrophy is not taking
place in CN III axons in EGS cases and that pathology of CN III is not the cause of
ptosis in EGS cases.
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5. MORPHOMETRY OF THE EQUINE LEVATOR ANGULI
OCULI MEDIALTS MUSCLE
a) Introduction and Literature Review
The levator anguli oculi medialis (LAOM) muscle (Figure 4-1) is a thin, small
muscle which arises over the root of the zygomatic process and spreads out in the
upper eyelid, blending in with the orbicularis oculi. It is innervated by the
auriculopalpebral branch of cranial nerve VII and assists raising the upper eyelid of
cquids (Getty, 1975). Paresis of the LAOM following pathology to (JN Vll would be
shown to be a cause of ptosis in EGS cases if changes compatible with denervation
were demonstrated in that muscle.
The muscle is subdivided into fascicles by a well defined collagen layer called the
perimysium. Individual muscle fibres are multinucleate syncytia surrounded by a cell
membrane, the sarcolemma, and are separated from one another by a network of fine
collagen fibres, the endomysium (Dubowitz, 1985; Loughlin, 1993).
Individual fibres are divided into three fibre types with distinct metabolic and
functional features. Type I fibres arc characterised by a relatively strong aerobic
capacity, are associated with sustained activity and are well represented in postural
muscles. Type II fibres are involved in rapid, powerful movements and are
subdivided into Type IIA fibres, which have been found to be more glycolytic with
strong aerobic and moderate-to-strong anaerobic capacity, and Type KB fibres which
are characterised by a relatively low aerobic and a relatively high anaerobic capacity.
The histochemical differentiation of fibres into two main types, as well as at least
two subtypes of Type II fibres, is based on adenosine triphosphatase (ATPase)
reactivity with ATPase substrate under acidic and alkaline preincubation to inactivate
different ATPase systems. The ATPase enzyme catalyses the reaction ATP + H20 —>
ADP + orthophosphates + energy. The tissue is incubated in a solution containing
ATP and calcium at pH 9.4, splitting off the terminal phosphate from ATP if the
ATPase is active. The phosphate immediately combines with calcium to form
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insoluble calcium phosphate which is deposited at the site of the enzyme activity.
The addition of cobalt chloride solution forms cobalt phosphate which is turned into
black cobaltous sulphide by a reaction with ammonium sulphide. The ATPase
present in various muscle fibres is highly dependent upon the influence of pH and the
reaction can be used to demonstrate distinct fibre types by preincubating the tissue at
different pH values. The ATPase enzyme has been found to be more reliable than
other enzyme systems for fibre typing in diverse physiological and pathological
states (Dubowitz, 1985; Braund, 1991; Loughlin, 1993)
The appearance of muscle pathology secondary to denervation, and the use of
qualitative and quantitative diagnostic methods have been well reviewed (Dubowitz,
1985; Loughlin, 1993). Although the changes are not specific for denervation
(Johnson et al, 1973b), classical histopathological signs include the presence of
angular fibres, greater than 3% of fibres containing internal nuclei, small or large
group atrophy and somal changes including pyknotic nuclear clumps and pale
staining hyaline (necrotic) fibres.
More subtle changes may only be disclosed by the complementary use of quantitative
methods. The combination of denervation and compensatory increase in work load
by remaining fibres commonly results in muscle fibre diameters alterations,
frequently shown only by an increase in range of sizes without an associated change
in mean diameters. The fibre size variability coefficient, defined as the fibre size
data standard deviation x 1000 divided by the mean fibre diameter, is considered to
be abnormal if it exceeds 250 (Dubowitz, 1985; Loughlin, 1993) to 300 (Braund,
1991). This does not appear to have been substantiated in equids.
A further use of quantitative methods is in the analysis of fibre type arrangements
and fibre type grouping. A reinnervated muscle fibre will become the fibre type of
the motor unit which adopts it (Dubowitz, 1970), leading to a loss of random
arrangement of fibre types. Assuming that Types I and II fibres are arranged
randomly throughout a muscle, the number of fibres of one type which may be found
lying in contact with each other in normal muscle is related to the proportions of the
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two main fibre types. A muscle is considered to be enclosed if, in transverse section,
it is completely surrounded by fibres of its own histochemical type. This usually only
occurs if at least five fibres of the same type are together (Jennekens et al, 1971). The
proportion of enclosed fibres will increase as the proportion of that fibre type in
muscle rises, but remains at a relatively low prevalence until greater than 70% of
fibres in a muscle are of one type (Loughlin, 1993). The distribution of fibre types is
random in the great majority of muscles (Johnson et al, 1973a) and a number of
statistical models have been devised to calculate the expected number of enclosed
fibres (Johnson ei al, 1973b; Loughlin, 1993). A representative computer simulation
designed to model fibre type grouping was proposed (Lexell et al, 1983).
Increasingly it has become clear that that morphological and morphometric changes
must be interpreted in the light of a sound appreciation of the range of nonnal
variation. The pathological features of denervation and reinnervation can, to a lesser
extent, also be observed in control subjects (Iwasaki et al, 1991) and considerable
variation in mean diameters, coefficients of variation, distribution and proportions of
fibre types have been found associated with variables such as the specific muscle
examined (Jennekens et al, 1971), depth of biopsy within a specified muscle (Mahon
et al, 1984; van den Hoven et al, 1985b), gender (Moore et al, 1971; Loughlin,
1993), age (Moore et al, 1971; Essen et al, 1980; Lexell and Downham, 1991;
Loughlin, 1993) and duration of fixation (Moore et al, 1971).
The technique for histochemical detennination of equine muscle fibre types and the
metabolic profiles of healthy equine gluteus medius muscle has been described
(Llodgson et al, 1983; van den Hoven et al, 1985a). Fibre characteristics and enzyme
activities were determined for the gluteus, semitendinosus, vastus lateralis and
triceps brachii muscles of a large number of Standardbred trotters of different ages,
focusing on the proportion of fibre types and the histochemical staining
characteristics. In all the muscles examined, Type II fibres predominated (69 - 87%)
and, with the exception of the vastus lateralis, was age related (Essen et al, 1980).
Further work concluded that large differences existed in the same zone of individual
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muscles and it was concluded that results obtained by biopsies of muscles must be
interpreted with caution (van den Hoven et al, 1985b).
Very little work, however, has determined values for fibre diameter, variability and
fibre type grouping data. The majority of work on equine muscle has focused on a
few specific diseases such as EMND (Valentine et al, 1998) and particularly
idiopathic laryngeal hemiplegia (ILH) (Duncan et al, 1977). The inteipretation of
histopathological changes of the intrinsic musculature of the equine larynx in horses
affected with ILH (Cahill and Goulden, 1986b; Duncan et al, 1991a), clinically
normal horses (Gunn, 1972), foetal horses (Gunn, 1973; Harrison et al, 1992) and
particularly distal limb muscles of ILH and control cases (Gunn, 1972; Cahill and
Goulden, 1986b; Kannegieter, 1989) has been impeded by a lack of sufficient data on
the normal morphometry of equine muscle fibres.
Neither the LAOM muscle nor its analogue in the bovine, the frontalis muscle, have
been examined in detail. The purpose of this study was to assess the normal
histology, morphometry and fibre size variability of the LAOM and to determine
fibre type grouping in terms of random and non-random arrangements to disclose any
subtle evidence of neurogenic pathology in EGS cases.
b) Materials and Methods
The LAOM was collected from four adult horses with no clinical evidence of facial
nerve or LAOM pathology, and six horses with a confirmed diagnosis of EGS (Table
4-12). A transverse section of the muscle was dissected as soon as possible after
euthanasia, adhered to a cork carrier and frozen immediately in isopentane in dry ice
to a tempeiature of -96°C. After freezing the blocks were stored at -80°C until
analysis, at which time 8 urn thick transverse serial sections were cut onto Biobond
coated glass slides (British Biocell International, Cardiff, UK) and allowed to air dry.
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Table 4-12: Subjects included in LAOM morphometry study
ID Diagnosis Days affected Signalment
98 339 AGS 5 15 yo Connemara mare
98 372 AGS 2 16 yo TB mare
98 401 SGS 6 9 yo Arab x mare
98 443 AGS 3 4 yo TB gelding
98 461 AGS 3 2 yo TB gelding
99 279 CGS 12 3 yo Welsh gelding
98/365 Colic 6 yo Irish Draft mare
98/738 Orthopaedic 7 yo Clydesdale gelding
98/820 CVM 1 yo WB maie
99/522 Colic 18 yo Arab x mare
(i) Histology
One cryostat section for each sample was stained with hematoxylin and eosin and
examined for histopathological evidence of denervation including the presence of
angular fibres, small group atrophy and internal nuclei. Nuclei were defined as
internal if they were further than two nuclear diameters from the cell wall. The
number of muscle fibres per fascicle was quantified in tissue sections from control
animals.
(ii) Enzyme histochemistry
Individual fibre types were demonstrated using calcium activated myofibrillar
ATPase. Pilot studies in our laboratory have found better segregation of Type IIA
and IIB fibres at pH 4.3 rather than pH 4.6 recommended in the literature (Dubowitz,
1985). Sections were fixed in cacodylate buffered formalin for two minutes and
rinsed in distilled water before being incubated in acetate buffer at pH 4.3 for 15
minutes. After rinsing in distilled water, sections were immersed in freshly prepared
37°C ATPase incubation solution containing ATP disodium salt and calcium
chloride in tris acetate buffer at pH 9.4. Sections were incubated for between 20 and
30 minutes and then rinsed in distilled water, immersed in 2% cobalt chloride for 2
minutes, rinsed again and developed in fresh 1% ammonium sulphide before being
mounted routinely. This technique results in Type 1 fibres being stained dark brown,
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while Type IIA fibres are pale and Type IIB fibres have intermediate staining






Figure 4-13: Transverse section LAOM ATPase histochemistry. pH 4.3,
CGS
(iii) Quantitative techniques
Sections were magnified to lOOx, captured from a microscope, digitised, and the
images downloaded onto a personal computer. Morphometry was performed with the
help of a calibrated computerised image analysis system (Image-Pro Plus, Media
Cybernectics).
Four or five fields containing only transverse sections of fibres were chosen to cover
the whole section and including a minimum of 350 and a maximum of 600 fibres.
Fibres were manually outlined using a digital graphics tablet (Ultraslate, CalComp
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Technology, Inc.) and divided into Type I, Type IIA and Type IIB fibres using
histogram based segmentation after contrast enhancement. All fibres in a field which
were not touching the edge were included and the area, number and diameter of
fibres was recorded. Descriptive statistics were calculated and diameter distributions
were determined and plotted graphically. The fibre size variability coefficient was
calculated as
fibre size data standard deviation x 1000
mean fibre diameter
The data were visually assessed and the distribution judged to be approaching
normality (Figure 4-14). Students t-test and analysis of variance techniques were
applied when appropriate. Non parametric techniques were used on proportion data




Figure 4-14: Fibre diameter frequency histogram, all data
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(iv) Fibre type grouping
All fields included in the quantitative fibre type analysis were re-examined and the
number of enclosed fibres noted. An enclosed fibre was defined as one that was
enclosed by fibres of the same type along its major surfaces, excluding the corners.
To determine fibre type grouping in terms of random and non-random arrangements,
a model by Lexell (1983) was used to calculate the expected number of enclosed
fibres. Briefly, the model assumes a binomial distribution of the number of enclosed
tibres and the expected numbei of enclosed fibres for a particular fibre type is equal
to MP , where M equals the number of internal points in a field, assuming that each
fibres has six neighbours, and P is the proportion of fibres that are of a particular
fibre type. M is the largest integer less than n - 2 x V nn where n is the number of
fibres of a specified type. The proportion of the most commonly occurring fibre type
was determined for control or EGS samples and P substituted accordingly.
c) RESULTS
(i) Histology
No signs of denervation were noted in tissue sections from control or EGS cases.
Specifically there was no evidence of groups of angular atrophied fibres, multiple
internal nuclei, proliferated sarcolemmal nuclei or inflammatory cells. A single
internal nucleus was found in an occasional fibre. Fibres with multiple internal
nuclei, or split fibres, were very rare and angular fibres were not noted. Muscle
spindles were not observed. Thirty eight randomly chosen fascicles in control tissues
yielded a mean of 163 (+/- 72) fibres per fascicle.
(ii) Proportion of fibre types
The total number and proportions of Type 1,1IA and IIB fibres are given in Table
4-13, Table 4-14 and Figure 4-15. ANOVA on ranks and pairwise multiple
comparison procedures indicated that the proportion of Type IIA fibres was
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significantly smaller than the proportion of Type IIB fibres in both EGS (p<0.001)
and control samples (p - 0.04). There was no significant difference between type I
fibres and Type IIA or I1B fibres in EGS or control cases. Within the same fibre type
there was no significant difference between EGS and control animals (Rank sum t-
test, all p > 0.2).
Table 4-13: EGS LAOM fibre numbers (proportion) by fibre type
ID Total # Type I (prop) Type IIA (prop) Type IIB (prop)
98/443 607 198 (0.33) 114(0.19) 295 (0.49)
98/339 462 138 (0.43) 62 (0.13) 202 (0.44)
98/372 361 91 (0.25) 37(0.10) 233 (0.65)
98/401 345 96 (0.23) 84 (0.24) 165 (0.48)
98/461 526 158 (0.30) 93 (0.18) 275 (0.52)
98/279 431 106 (0.25) 55 (0.13) 270 (0.63)
All 2732 787 (0.29) 445 (0.16) 1440 (0.53)
Table 4-14: Control LAOM fibre numbers (proportion) by fibre type
ID Total # Type I (prop) Type IIA (prop) Type IIB (prop)
99/522 603 157 (0.26) 127 (0.20) 319 (0.53)
98/820 540 164 (0.30) 54(0.10) 322 (0.60)
98/365 407 83 (0.20) 64 (0.16) 260 (0.64)
98/738 469 166 (0.35) 44 (0.09) 259 (0.55)






Figure 4-15: Proportions of fibre types in control and EGS cases.
Median plus 95% CI
(iii) Fibre diameters
The summed diameter distributions by fibre type for EGS and control horses are
given in Table 4-15. Summary statistics are shown in Figure 4-16. The mean
diameters of Type I (p = 0.004), Type IIA (p = <0.001) and Type IIB (p = 0.003)
fibres were statistically significantly different between EGS and control horses. Fibre
size variability coefficient data are given in Table 4-16.
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EGS LAOM 31.0 (8.49) 44.1(12.24) 41.21(13.89)
Control LAOM 29.7 (8.53) 41.1 (10.05) 39.6 (13.03)
Table 4-16: Fibre size variability coefficient
Type I Type IIA Type IIB
Control 287 246 328
EGS 274 277 337
Cntrl EGS Cntrl EGS Cntrl EGS
Type I TypellA Type MB
Figure 4-16: Diameter distributions by fibre type.
Mean plus standard deviation
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(iv) Fibre type grouping
Type IIB fibres represented the highest proportion of fibres present and were the only
type in which enclosed fibres were noted. The proportion (P) of Type IIB fibres
determined in EGS and control cases was substituted accordingly. The number of
enclosed fibres noted, and the number of enclosed fibres expected using the statistical
model are shown in Table 4-17. The number of expected and calculated enclosed
fibres were not significantly different when control (p = 0.343) or EGS (p = 0.15)
data were compared. There was no significant difference (Rank Sum ANOVA
p = 0.272) between any of the samples when data for all fields in all samples was
compared.
Table 4-17: Number of expected and actual enclosed fibres
ID n M Number expected Number actual
98/522 Cntrl 319 256 5 2
98/820 Cntrl 322 258 5 10
98/365 Cntrl 260 203 4 7
98/738 Cntrl 259 202 4 9
98/443 EGS 295 234 3 2
98/339 EGS 202 152 2 2
98/372 EGS 233 179 2 12
98/401 EGS 165 119 1 2
98/461 EGS 275 216 3 3
99/279 EGS 270 212 2 10
n = number of fibres counted. M = model number internal points in a field.
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(v) Internal nuclei
The number of fibres on the section with internal or multiple nuclei was assessed.
The fascicles present on that section were counted and the total number of fibres
present was calculated using the mean number of sections per fascicle determined
(Table 4-18). A median of 0.1% of all fibres contained at least one internal nucleus.
Multiple internal nuclei were very rarely noted. There was no significant difference
(p = 0.9) between the proportion of internal nuclei in control and EGS fibres.
Table 4-18 Proportion of fibres with internal nuclei, estimating the
number of fibres per section from the estimated mean number of
fibres/fascicle
Nucleated No. of Estimated Proportion of fibres
fibres fascicles no. of fibres with internal nuclei
98/365 control 45 6 10,000 0.005
98/522 control 14 8 13,000 0.001
98/738 control 30 11 18,000 0.002
98/820 control 13 7 11,000 0.001
98/372 EGS 19 11 18,000 0.001
98/401 EGS 60 10 16,000 0.004
98/339 EGS 71 10 16,000 0.004
98/461 EGS 20 10 16,000 0.001
98/502 EGS 17 11 18,000 0.001
d) Discussion
There was no histopathological evidence of neurogenic atrophy in any of the EGS
tissues examined. The duration of clinical disease was arguably very short for a
number of the acute cases examined, however the severity of enteric and ganglionic
neuronal pathology in that group of cases implies that the disease process has been
ongoing for significantly longer time than suggested by the presence of clinical signs.
Morphologic signs compatible with the neurogenic atrophy however would have
been expected in sections from the CGS case if denervation of the muscle had
occurred.
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The median figure of 0.1% of fibres with internal nuclei is small compared to quoted
data (Braund et al, 1988a; Braund, 1991) (Dubowitz, 1985; Loughlin, 1993) and is
notable in that a ten fold increase in incidence in internal nuclei may be a sign of
significant pathology in this muscle, but would lie well within the nonnal range in
the muscles more commonly examined. The difference may lie in the fact that
muscles usually chosen for biopsy, and hence histopathological examination, are
active postural or locomotion muscles which may be subject to greater stresses than
the LAOM.
The predominance of Type II fibres in the LAOM is not unexpected in view of the
high proportion of that fibre type in locomotory muscles (Valentine et al, 1998).
Indeed it has been suggested that the act of blinking may be one of the best examples
of phasic activity and the orbicularis oculi, the main eyelid muscle innervated by the
facial nerve, contains a high proportion of Type II fibres (Johnson et al, 1973a).
The diameters and frequency distributions of Type I and Type II fibres vary among
different muscles and are also influenced by factors such as age, gender, nutritional
status and degree of physical activity (Loughlin, 1993), further emphasising the
importance of specific data being available for each muscle examined. Essen (1980)
as a general rule suggested that Type IIA fibres are usually 1.5 to 2 times larger than
Type I fibres, which is in agreement with this data. The total nnmher of fibres
examined in this study compares favourably with the 150-200 fibres per case which
is accepted tu give a reproducible and consistent value for mean diameters and
standard deviations (Jennekens et al, 1971; Dubowitz, 1985; Loughlin, 1993).
Control mean fibre diameter data were statistically significantly different to data
from EGS cases, however in light of the small actual difference (Figure 4-16) is
unlikely to be biologically significant.
In many instances an increase in range of sizes is a more sensitive indicator of
myopathies than a change in mean diameters (Loughlin, 1993), nevertheless
artefactual variation may account for the minor differences in fibre size variability
coefficient noted in these data. Mahon (1984) found considerable variations in the
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proportions of fibre types and mean fibre size between individuals in duplicate
needle biopsies from the quadricepsfemoris muscle from healthy, age matched
human males. Within individuals, comparisons of samples taken at a reference site
with samples obtained from deeper, more proximal or contralateral sites also often
showed significant differences in fibre size and suggests that caution is necessary
when interpreting apparent changes in such values. Data for fibre diameters from
both control and EGS cases were slightly greater than the suggested maximum in
normal humans (Dubowitz, 1985; Loughlin, 1993), however the observation that the
variability coefficient for the same muscle in dogs alters with the size of subject
(Braund, 1991) implies that further work on horses is required before these figures
are more stringently interpreted.
The presence of fibre type grouping is contingent on reinnervation having taken
place, which is dependent on the capacity of the unaffected motorneurons to
reinnervate adjacent denervated muscle fibres. This varies between specific
neurodegenerative diseases (Telerman-Toppet and Coers, 1978), and fibre type
grouping does not appear to be a feature of a prominent equine neurodegenerative
disease, EMND (B. Valentine, Oregon State University, personal communication).
The presence of uniform fibre type grouping however, may not be justified as a
definite index of reinnervation, for example if replacement fibres are innervated by
collateral sprouting or if innervation is initiated by axons of both types (Johnson et
al, 1973b). Nevertheless, the lack of fibre type grouping in the LAOM from EGS
cases provides evidence that denervation followed by reinnervation has not taken
place.
The lack of evidence of LAOM denervation does not categorically rule out that
paresis of the LAOM is occurring, however purely functional pathology to the lower
motor neuron soma or axon is extremely rare. A number of toxins such as the
ionophore antibiotics, numerous chemotherapeutic agents, heavy metals and
pesticides (Innes and Saunders, 1962) are associated with peripheral neuropathy, but
would he expected to produce generalised clinical signs and structural
neuropathology, with subsequent neurogenic atrophy of innervated muscles. Toxins
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affecting presynaptic neuromuscular transmission produce paresis, however these are
not generally associated with a somal reaction and would be expected to cause
generalised paresis. Similarly, acquired metabolic diseases are not expected to target
nuclei with such extreme specificity.
In conclusion the results of this study suggest strongly that CN VII neuronal cell
death is not occurring and is not the cause of ptosis in EGS.
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6. ELECTROMYOGRAPHIC EVALUATION OF BLINK
REFLEX LATENCIES
a) Introduction
Neuronal death in neurodegenerative disorders may be preceded by periods of
neuronal dysfunction (Waggie et al, 1999), and electrodiagnostics can be used to
provide detailed information about the function of the neurologic system by
recording spontaneous and induced cell electrical activities (Andrews and Fenner,
198'/).
The blink reflex is a contraction of the orbicularis oculi muscle due to reflexly
activated motorneurons of the facial nerve, and is used in human medicine to study
the integrity of trigeminal and facial nerve function for the evaluation of peripheral
neuropathies and pontine and rostral medullary syndromes (Kimura, 1992). The
reflex pathway includes the supraorbital nerve branch of cranial nerve V, which
synapses with the nucleus of cranial nerve VII in the rostral medulla. Efferent
impulses reach the orbicularis oculi muscle through the facial nerve, giving an early
ipsilateral oligosynaptic response designated Rl. Later ipsilateral and bilateral R2
responses are thought to represent afferent impulses entering the pons through the
trigeminal nerve, descending in the spinal trigeminal tract along the dorsolateral
brain stem to at least the second cervical spinal cord segment before ascending to
make connections with the ipsilateral and contralateral facial nuclei (Eekhof et al,
1996). The R2 response can be abolished with severe cranial spinal cord lesions
(Nukes et al, 1995). A third R3 response can be observed, and is significantly related
to pain sensation in man (Rossi and Vignocchi, 1993). The Rl response is more
stable than the ipsilateral or contralateral R2 responses, and is suitable for studies of
the function of the afferent and efferent pathways (Kimura, 1992) .
Blink reflex latencies were studied in EGS cases to try to assess integrity of neurons
in CN VII supplying the auriculopalpebral branch of the facial nerve, the same nerve
that innervates the levator anguli oculi rnediulis.
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b) Materials and Methods
Blink reflex latencies were determined in 17 EGS cases and 19 unaffected horses.
Control animals were either experimental ponies or animals in the hospital having
electrodiagnostic tests done for other reasons.
Compound motor action potentials (CMAPs) were recorded after stimulating the
supraorbital nerve by tapping the zygomatic process with an external triggering
hammer. This triggered an electrodiagnostic unit (Neurostar MS92B, Medelec Ltd,
Old Woking, UK) and the resulting evoked compound muscle action potentials were
recorded from the ipsilateral orbicularis oculi muscle by a needle electrode inserted
subcutaneously in the lower eyelid. The reference electrode was sited over the
ipsilateral facial crest and the ground electrode was inserted into the musculature of
the cranial neck. These sites were chosen as those which consistently give a smooth,
repeatable waveform. The electrodes were connected to the signal averaging
equipment via a prc-amplifier (PA92B, Medelec Ltd, Old Woking, UK) that was
attached to the subject's head collar. Ipsilateral recordings were made on averaged
successive stimulations, the number of tracings included in the average differing
between subjects. A sweep of 100 ms was recorded with the amplitude set at lOOpV
per division, low frequency filter set at 2 Hz and high frequency filter at 10 kHz. The
electromyographically recorded responses consist of polyphasic early R1 response in
the orbicularis oculi muscle and, variably, a late R2 response.
Each subject was measured to obtain an estimate of the length of the reflex pathway.
The measurements were taken with a flexible steel tape measure from the stimulus
site to the base of the ear, and from there to the recording electrode inserted into the
orbicularis oculi.
Latency was defined as the time interval (msec) between the start of recording by the
triggering hammer to the initial deviation from baseline in the positive direction, and
separately to the apex of the positive peak of R1. In a few control cases data for the
initial deviation from the baseline was not measured. In cases which had an inverted
trace with a major negative peak, negative reflections from baseline and negative
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peak latencies were measured. If the peak reflex latencies were different for separate
traces, the visual median between peaks was determined and noted. Data were
excluded if the initial deviation from baseline could not be recorded due to artefact
secondary to environmental electrical activity or muscle movement. Latency
velocities were calculated by dividing the measured distances by the latency.
c) Results
Stable and repeatable R1 responses were obtained with little apparent increase in
latency due to habituation (Figuie 4-17). R2 responses were inconsistently observed
and R3 responses were never noted. Estimated lengths of the reflex pathway, the
latency of the initial deviation from the baseline and to the peak of Rl, and the
calculated reflex latency velocities of control and EGS subjects are given in Table 4-
19 and Table 4-20. Summary data are shown in Table 4-21 and Table 4-22.
All data passed formal normality tests. There were no significant differences between
control subject and EGS case mean latencies of the deviations from the baseline
(p = 0.87), peak latencies (p = 0.47) or reflex latency velocities (p = 0.32). There
was no correlation between the estimated length of the pathway and the peak latency
(p = 0.4), or the latency of the deviation from the baseline (p = 0.6).
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Sweep duration 100 ms 99/895
Amplitude SOOpV/division Contro| (Lymphangitis)
10 yo TB mare
Figure 4-17: Recording from the ipsilateral orbicularis oculi muscle
showing R1 response and R2 responses
D = deviation from the baseline latency, P = peak latency, N = number of
averaged sweeps
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Table 4-19: Blink reflex data control animals
Latencies (m.sec1) Reflex latency velocity (ms)





1 0.29 6.0 10.0 48.3 29.0
2 0.34 7.0 16.0 48.6 21.3
3 0.37 10.4 15.0 35.6 24.7
4 0.28 6.5 11.5 43.1 24.3
5 0.23 8.5 15.0 27.1 15.3
6 0.32 11.0 17.0 29.1 18.8
7 0.28 9.0 12.5 31.1 22.4
8 0.3 12.0 25.0
9 0.25 9.0 27.9
10 0.25 12.4 20.2
11 0.27 11.6 23.3
12 0.26 11.6 22.4
13 0.26 13.2 19.7
14 0.37 6.4 9.6 57.8 38.5
15 0.36 6.0 13.2 60.0 27.3
16 0.33 4.8 19.6 68.8 16.8
17 0.30 4.4 20.0 68.2 15.0
18 0.22 10.0 14.0 22.0 15.7
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Table 4-20: Blink reflex data EGS cases
Latencies (ms) Reflex latency velocity
(m.sec')





97/363 0.23 6.5 10.5 35.4 21.9
97/528 0.23 8.0 16.0 28.8 14.4
97/987 0.37 7.0 13.0 52.9 28.5
98/244 0.28 7.0 10.4 40.0 26.9
98/408 0.28 3.2 12.0 87.5 23.3
98/431 0.23 7.0 10.0 32.9 23.0
98/448 0.2/ 13.0 14.5 20.8 18.6
98/501 0.25 9.0 14.0 27.8 17.9
98/502 0.31 11.5 14.5 27.0 21.4
98/540 0.24 10.0 13.0 24.0 18.5
98/877 0.27 5.2 10.0 51.9 27.0
97/834 0.27 5.0 11.0 54.0 24.5
98/335 0.23 7.2 17.0 31.9 13.5
Table 4-21: Control horse blink reflex results summary
Mean SI)
L (m) 0.29 0.05
Deviation from baseline (ms) 7.5 2.22
Peak (ms) 13.5 3.13
Peak reflex latency velocity (m.sec ') 45.0 16.3
Deviation from baseline
reflex latency velocity (m.sec ')
22.64 5.84
N=18
Table 4-22: EGS blink reflex results summary
Mean SI)
L (m) 0.27 0.04
Deviation from baseline (ms) 7.7 2.69
Peak (ms) 12.8 2.34
Peak reflex latency velocity (m.sec"1) 40.0 18.1
Deviation from baseline





Mean peak R1 latencies determined in this study were 5 ras shorter than others
reported in horses (Anor et al, 1996; Ahor et al, 1999). A difference in latencies can
be expected however since the latter studies evoked the response using electrical
stimulation sited over the supraorbital nerve, and recorded the CMAP with surface
electrodes. The more direct stimulation of the afferent limb of the reflex in that study
however, may have been expected to result in shorter latencies.
Blink reflex latencies are assessed in man without attention to the size of the subject
(Kimura, 1992). Since the size of the head varied greatly between ponies and horses
in this study, latency velocities were calculated in order to standardise the technique
for different sizes of animals. However there was no correlation between latencies
and estimated lengths of the pathway, which substantiates the sole use of latencies in
equids as applied in other studies (Anor et al, 1996; 1999).
A CMAP is the result of many muscle fibres being concurrently active. Large axonal
fibres, responsible for the latency of the deviation from the baseline (Anor et al,
1999), are capable of discharging at a faster rate than small fibres as shown by the
faster initial deviation from the baseline reflex latency velocities. Latencies may be
normal during early phases of axonal or myelin damage (Sims, 1994), however the
reduction in the number of innervated motor units should result in a decrease in
observed amplitude and increased duration of the CMAP (Aminoff, 1999), and
ideally the duration and amplitude of the CMAPs in this study would be determined.
In line with conclusions in the literature however (Aminoff, 1999), the amplitude of
the R1 response were noted to vary greatly between subjects in this study and thus
were not quantified.
The lack of a statistical difference between EGS and control animal latencies of the
deviation from baseline or peak of the CMAP is strong evidence of an intact pathway
in EGS cases, and indicates that a CN VII functional deficit is not involved in ptosis
in EGS cases.
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7. PHENYLEPHRINE EYEDROPS AS A DIAGNOSTIC TEST IN
EQUINE GRASS SICKNESS
a) Introduction
In light of the severe pathology seen in the cranial cervical ganglia of EGS cases, it
was hypothesised that the ptosis seen in these animals is predominantly due to
sympathetic denervation. Neuronal damage in the cranial cervical ganglion of EGS
cases is extensive (Pogson et al, 1992), but morphometric techniques to assess axonal
degeneration of postganglionic sympathetic fibres, as well as being technically
difficult (Gibbels, 1989; Wheeler and Plummer, 1989) would not determine if there
is a functional effect on eyelid tone. Ptosis in horses due to sympathetic denervation
was shown to be reversible with alpha agonist eyedrops (chapter 4 section 2) and the
administration of 10% phenylephrine eyedrops to horses with EGS was found to
result in a dramatic reduction of ptosis, lasting for several hours. 10% phenylephrine
however, the concentration used in the diagnosis of Horner's syndrome in small
animals and humans, also resulted in marked effects on the eyelids of control horses.
A pilot study determined the optimal concentration of phenylephrine and the time
required to elicit a significant decrease in ptosis EGS cases, while giving the least
increase in eyelash angle of normal control horses.
The current quantitative study was performed to establish whether ptosis in EGS
cases is a manifestation of Horner's syndrome and to determine if this technique has
potential as a simple, non-invasive, inexpensive pre-mortem diagnostic test for grass
sickness.
b) Materials and Methods
Twenty-three EGS cases and 12 horses with other diagnoses were included in this
study (Table 4-23). Control animals were chosen as horses that might have had EGS
but subsequently were found to have other diseases. Phenylephrine (Phenylephrine
10% w/v, Martindale), diluted to 0.5% with normal saline, and 0.5 ml of this stock
was applied to the conjunctiva of one eye and the subjective size of the palpebral
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fissure and angle of the eyelashes to the cornea was evaluated 30 minutes later by
comparing the treated and control eyes. Frontal photographs were taken using a 1.4
Mega pixel digital camera (Olympus D-600L) and analysed using a computerised
image analysis system (Image-Pro Plus, Media Cybernetics). The difference in
angles of the eyelashes to a line drawn between the medial canthi of the eyes were
measured. Data were analysed with the help of statistical software (SigmaStat, SPSS
Science).
c) Results
Phenylephrine administration resulted in marked reduction of ptosis in EGS cases
and had a minimal effect on control animals (Figure 4-18). The signalment, clinical
syndrome, days affected (EGS cases) and the difference in eyelash angles of horses
included in this study are shown in Table 4-23. A negative eyelash angle difference
indicates a smaller palpebral fissure size in the treated eye. Summary statistics are
shown in Figure 4-19. The data were normally distributed and there was a significant
difference between the eyelash angle differences of EGS cases and control horses
(p < 0.001), but within the control animal group there was no significant difference
(p = 0.14) between orthopaedic cases (horses 1-4) and 'sick' animals (5 - 12). A
One way ANOVA found no significant difference between AGS, SGS or CGS
groups (p = 0.71).
There was no significant correlation (Pearson Product Moment Correlation:
p = 0.25) between the effect of phenylephrine on the difference in eyelash angle in
EGS cases and the number of days the horse was affected on the day the test was
performed (median 6 days, range 1 - 65).
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Table 4-23: Animals included in the study and the difference in eyelash
angle between eyes after administration of 0.5% phenylephrine into one
eye.




1 16 yo TB mare Orthopaedic -18
2 9 yo Welsh gelding Orthopaedic 21
3 7 yo TB x gelding Orthopaedic -8
4 11 yo gelding Orthopaedic 3
5 6 yo TB x TR mare Choke 21
6 10 yo Cob x mare Colic 9
7 7 yo Cob gelding Colic 3
8 11 yo Cob mare Colic 10
9 7 yo WB gelding Colic -5
10 7 yo TB x mare Colic 34
11 3 yo Highland mare Botulism 25
12 3 yo WB gelding Dysphagia 22
13 4 yo Cob gelding AGS 1 12
14 4 yo TB x mare AGS 1 36
15 8 yo TB x mare AGS 2 22
16 1 yo Highland filly AGS 2 24
17 2 yo WB stallion AGS 2 32
18 10 TB x stallion SGS 3 48
19 3 yo TB mare SGS 3 57
20 9 yo Highland mare SGS 4 11
21 4 yo ID x mare CGS 4 21
22 4 yo WB gelding SGS 5 32
23 9 yo Cob gelding SGS 6 25
24 5 yo Pony gelding CGS 6 28
25 5 yo Pony gelding SGS 7 35
26 3 yo Cob gelding CGS 7 66
27 1 yo TB x mare CGS 8 50
28 4 yo Highland mare CGS 11 32
29 7 yo Highland gelding CGS 12 26
30 6 yo Eriskay gelding CGS 16 33
31 3 yo TB x gelding CGS 17 63
32 16 yo Cob gelding CGS 30 9
33 3 yo Cob stallion CGS 30 40
34 8 yo Highland mare CGS 61 18





























Figure 4-19: Difference in eyelash angles summary data
Key: The ends of the boxes define the 25th and 75th percentiles with a line at the
median and error bars defining the I0lh and 90m percentiles.ah
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d) Discussion
The current technique of using topical ophthalmic alpha-adrenergic agonist drugs in
clinical cases with ptosis represents a novel approach to the differentiation of
autonomic and somatic nerve dysfunction. Smooth muscle contraction is principally
effected by a, receptor activation, which would be effected to a far lesser degree via
Midler's muscle in EGS cases due to the substantial reduction of postganglionic
sympathetic neurons in the cranial cervical ganglion. Phenylephrine is a direct acting
adrenergic agonist, but unlike epinephrine and norepinephrine is a selective a,
agonist drug that activates P receptors only at much higher concentrations (Hoffman
and Jefkowitz, 1996). For interpretation of this test it is critical to ensure that animals
have not been sedated, even several hours previously, since sedation will lead to
increased responses (Chapter 4, section 2) and this may have inadvertently occurred
in some of the control animals in this study.
The lack of association between either severity or duration of EGS with response to
topical phenylephrine is perhaps unexpected since continued lack of receptor
stimulation might be anticipated to result in receptor hypersensitivity (Kurvers et al,
1996) and an increased response. Since ptosis appears not to persist in long term
recovered EGS cases it may be that reinnervation by surviving neurons, or a return to
function by recovering neurons, may provide sufficient a adrenergic tone in cases
with longer duration of disease. Due to the small numbers of acute and subacute
cases in the current experiment the result should be interpreted cautiously.
For this population there was a 25% overlap between the highest responding control
animals and lowest responding EGS cases, so if an eyelash angle of 22° was taken as
the cut off point between test positive and test negative animals, a specificity and
sensitivity of 75% would be calculated. Of more practical benefit perhaps is the
finding that only 15% of EGS cases responded at or below the mean response for
control animals and wc have found the technique a valuable addition to the diagnosis
of suspect EGS cases. Results must of course be assessed in context of other clinical
signs but we have been particularly impressed by the ability of the technique to point
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out the presence of ptosis in animals which on first examination do not appear to
show this very important clinical sign.
The significant difference in response to phenylephrine eyedrops between control
animals and EGS cases confirms that the major or sole cause of ptosis in EGS is
sympathetic neuronal dysfunction, and more importantly that this technique is a
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1. Introduction to rhinitis sicca in EGS
Rhinitis sicca, or drying of the nasal membranes resulting in crusting of a mucoid or
mucopurulent discharge on the nasal passages, is a common clinical sign in subacute
and particularly chronic cases of EGS (Milne, 1991) and feline dysautonomia
(Griffiths et al, 1982). Rhinitis sicca can appear to be distressing to the animal and
severe signs are associated with a very poor prognosis (Milne et al, 1994). It is
speculated that the rhinitis is associated with a lack of nasal secretions, but the
underlying cytopalhology has not been investigated.
The nasal fluid, a secretory product of the nasal mucosa, is involved in the
humidification and warming of inspired air, the protection of the underlying
respiratory epithelium and the removal of inhaled pollutants. The nasal mucosa is
innervated by an intricate network of sympathetic and parasympathetic nerve fibres.
Sympathetic axons originate in the cranial cervical ganglion, from which fibres run
into the plexus of the carotid artery before joining the petrosal and vidian nerves
innervating the nasal mucosa. Preganglionic parasympathetic fibres arise from the
GVE nucleus of CN VII, joining the petrosal nerve to synapse with neurons in the
sphenopalatine ganglion and in microganglia deep within the nasal mucosa (Klaassen
et al, 1988). Sympathetic neurons in the cranial cervical ganglion (Obel, 1955), and
paiasympathctic neurons in the sphenopalatine ganglion (personal observation) show
severe pathology in EGS.
Retrograde neuronal labeling of the rostro-lateral part of the nasal mucosa of rats
additionally labeled neurons in the parasympathetic otic ganglion, and a large
proportion of neurons in the ipsilateral trigeminal ganglion, containing neurons in
the general somatic afferent (GSA) system, indicating that the latter is an important
source of innervation of the nasal mucosa (Grunditz et al, 1994). The first order
sensory neurons in the mesencephalic nucleus of V were not noted to be
chromatolytic in EGS cases (chapter 2) but the same category of neuron in the
trigeminal ganglion was often chromatolytic, with a very uneven distribution. The
trigeminal ganglion has not been examined in detail in EGS cases, and pathology to
this structure may give a further basis for the rhinitis sicca of EGS cases.
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2. MORPHOMETRY OF TRIGEMINAL GANGLION AND
NUCLEUS OF MESENCEPHALIC V NEURONS
a) Introduction
This study emanated from the observation that some transverse sections of trigeminal
ganglion (TG) appeared to be severely affected, whereas other sections contained a
minimal number of chromatolytic neurons. On examining longitudinal sections
however, this appeared to depend on the number of small neurons on the field.
Prominent clustering of neurons by cell sizes was occurring and sections in which the
majority of neurons were smaller appeared to he more severely affected.
Mesencephalic V neurons (the only primary afferent neurons in CNS) were not noted
to be chromatolytic in sections of 56 grass sickness cases examined with the
exception of two individual achromatic neurons. This study was undertaken to
determine if a relationship existed between the presence of chromatolysis and
neuronal size.
b) Materials and Methods
(ii) Case material
Midbrain sections and/or trigeminal ganglia from 12 grass sickness cases and three
control horses were chosen at random from those collected between 1996 to 1998.
See Table 5-1.
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Table 5-1: Subjects and tissues examined, Trigeminal ganglion
morphometry
Case # Signalment Diagnosis Duration
(days)
Samples
96/425 10 yo Pony female AGS 2 Midbrain
98/443 4 yo TB gelding AGS 3 Midbrain
97/428 5 yo Irish Draft gelding AGS 2 Midbrain
97/517 3 yo TB female AGS 2 Midbrain
97/293 2 yo Highland pony female CGS 21 Midbrain
97/313 4 yo TB female CGS 11 Midbrain
97/348 5 yo Welsh x gelding CGS 15 Midbrain, TG
97/453 5 yo Connemara female AGS 2 TG
98/277 2 yo Clydesdale female AGS 1 TG
98/461 2 yo TB gelding AGS 3 TG
98/303 6 yo Cob gelding SGS 3 TG
98/563 8 yo Highland pony female SGS 3 TG
97/1116 14 yo TB gelding Respiratory TG
97/618 7 yo Clydesdale female Colic Midbrain
98/295 8 yo TB gelding Orthopaedic TG
Key: TG = trigeminal ganglion
(iii) Tissue materials and methods
The trigeminal ganglion was excised from the caudal portion of the canal of the
trigeminal nerve on the floor of the calvarium and placed in 4% neutral buffered
formaldehyde. After at least one week, longitudinal sections of trigeminal ganglion
and a section of brain at the level of the caudal colliculus were blocked for
processing. Sections were processed as outlined in chapter two, section 2. b.
(iv) Quantitative studies
Sections were captured from a microscope (Nikon Optiphot-2) through an attached
analogical RGB videocamera (TK 1070E, JVC). Images were digitised with a frame
grabber (Snapper-24, Data Cell) connected to a personal computer. The diameters of
neurons was measured with the help of a computerised image analysis system
(Image-Pro Plus, Media Cybernectics), calibrated using a slide micrometer. The




Groups of mesencephalic V neurons around the mesencephalic aqueduct were
identified and magnified to x 40. Between two and four fields were captured to
include the majority or all of the neurons on that section of brainstem. All cells that
approached standard size (ie not including those which were sectioned at the very
edge of the cell), whether or not they included nuclei, were outlined individually on
a digital graphics tablet (Ultraslate, CalComp Technology, Inc). Descriptive statistics
were calculated and diameter distributions were determined and plotted graphically
(SigmaStat and SigmaPlot, SPSS Scientific).
Trigeminal ganglion
Due to the prominent clustering of cell sizes within each longitudinal section, one
field was chosen for morphometry which contained mainly large neurons and another
field in which neurons were mainly small neurons. Slides were magnified to x 40.
Cells were outlined as above. Measurement data for each field in each case was
obtained for chromatolytic and normal neurons in control and grass sickness cases .
c) Results
Total neuronal number or density could not he ascertained due to the quantitative
methodology used but no qualitative decrease of neurons in EGS cases was noted and
no nodules ofNageotte were evident. Combined data had a normal appearing
distribution but failed the equal variance test. Individual EGS data (p=0.11) and
control data (p=0.06) were not significantly different from each other. Mean diameter
summary data for EGS and control trigeminal ganglion and mesencephalic V neurons
are given in Table 5-2 and Table 5-3. Data is given to one decimal place to be in
agreement with the accuracy of the measurement technique.
163
Chromatolytic TG neurons from EGS cases had the smallest mean diameters.
Diameter data had a large range (control data, 24 - 72 pm) and large associated
standard deviations. There was a statistically significant difference (ANOVA on
ranks, p<0.001) in collective neuronal diameter data from control TG neurons,
normal appearing EGS TG neurons, chromatolytic EGS TG neurons, control and
EGS mesencephalic V neurons. Pairwise multiple comparison procedures (Dunn's
method) indicated that all the groups had statistically significantly different diameter
data from each other with the exception of EGS and control mesencephalic V
neurons.
Table 5-2: Trigeminal ganglion neuronal diameter summary data
Number of neurons Mean diameter (SD)
Normal Chromatolytic Normal Chromatolytic
Control cases 348 N/A 33 (11.7) N/A
EGS 1034 296 44 (13.7) 29 (7.5)
Mean diameter measurements given in micrometers
SD = standard deviation
N/A = not applicable, no chromatolytic neurons
Table 5-3: Mesencephalic V neuron diameter summary data
Number of neurons Mean diameter (SD)
Control cases 38 56 (12.3)
EGS 255 48 (13.4)
Mean diameter measurements given in micrometers
SD = standard deviation
d) Discussion
Neuronal clustering by size was too extensive to allow a simple random sampling
technique to be used, however counting of all neurons on two microscope fields
resulted in sufficient data being collected to make the study statistically meaningful.
The data of individual cases within control EGS groups were not significantly
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different from each other, confirming that the morphometric methods used resulted in
rcpeatable estimates of the sizes of neuronal cell bodies being studied. Neurons were
counted whether or not they included a nucleus (underestimating cell sizes) since the
presence of peripheral nuclei in chromatolytic neurons would not have permitted
consistent measurements of nonnal and chromatolytic neurons to be taken.
Dorsal root ganglion neurons have been divided into three types of cells (A, B, C) on
the basis of size, the distribution of organelles and electrophysiological
chaiacteristies (Rambourg et al, 1981; Wang et al, 1993a). Type A cells are large
neurons in which Nissl bodies are evenly distributed throughout the perikaryon.
Type B cells are smaller, with concentric zonation of organelles, and type C cells are
the smallest, containing small, poorly demarcated Nissl bodies and a juxtanuclear
Golgi apparatus. It is likely that equine dorsal root ganglion neurons can be similarly
categorised by size, and this study suggests that the classification influences neuronal
sensitivity to the putative EGS insult with potentially class A neurons being
relatively more resistant.
In conclusion, the qualitative observation that smaller neurons were preferentially
chromatolytic was quantitatively substantiated. The following section attempts to
establish whether a specific marker could be used to differentiate large and small
trigeminal neurons
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3. Calcitonin Gene Related Peptide expression in neurons
from the trigeminal ganglion and mesencephalic V
nucleus
e) Introduction
Further to the investigation showing a predilection for chromatolysis by small
neurons of the trigeminal ganglion of grass sickness cases, as well as the absence of
chromatolysis in the large neurons comprising the mesencephalic trigeminal nucleus,
a marker differentiating large and small trigeminal neurons was suught to further
distinguish those neurons likely to show morphological or functional changes in
EGS.
In addition to the classical neurotransmitters, an ever growing list of neuroactive
peptides are recognised which modulate pre or post synaptic transmission or may use
the peptide as a sole neurotransmitter. Calcitonin Gene Related Peptide (CGRP) is a
37 - amino-acid peptide expressed principally in spinal motor neurons and sensory
neurons in the trigeminal and spinal dorsal root ganglia, as well as in
parasympathetic ganglia and some central nuclei including the oculomotor nucleus
and nuclei of CN VI, VII and XII (Silverman and Kruger, 1989; Thompson et al,
1995; Cooper et al, 1996). CGRP is present in sensory neurons and is a prominent
peptide in somatic motor neurons (Thompson et al, 1995). From double labelling
experiments it is known that nasal mucosal nerve fibres containing CGRP emanate
exclusively from the trigeminal ganglion (Zhao and Tao, 1994). This is despite
CGRP being present in other ganglia, such as the parasympathetic sphenopalatine
ganglion (Grunditz et al, 1994). Distinct expression of CGRP by trigeminal neurons
of different sizes, or by neurons in the mesencephalic nucleus of CN V, would be
notable. In addition, there is growing evidence that the expiession of CGRP is
decreased in the nasal mucosa of EGS cases (Corcoran, work in progress) and it is
therefore to relevant determine whether there is an association between affected
(chromatolytic) and CGRP expressing neurons by comparison of morphometric data.
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b) Materials and methods
(v) Subjects and tissues
Transverse or longitudinal sections of formalin fixed, paraffin embedded trigeminal
ganglia from fourteen horses (two acute, four subacute and two chronic EGS cases
and six control animals) were included (Table 5-4). One section from each ganglion
had been assessed histologically to record the degree of chromatolysis.
Sections of formalin fixed, paraffin embedded mesencephalon containing a number
of mesencephalic V nucleus neurons, usually at the level of the attachment of the
rostral medullary velum or in the same plane as the origin of CN III, were obtained
from one acute, two subacute, one chronic grass sickness and one control case. Most
of the horses were different individuals than those used for the previous study, but all
the grass sickness cases had chromatolytic trigeminal ganglia neurons on histological
examination.
Table 5-4: Subjects for trigeminal ganglion and mesencephalic
trigeminal nucleus CGRP immunohistochemistry studies
Horse ID Diagnosis Duration (days) Samples
98/374 AGS 2 TG
98/417 AGS 6 TG
98/443 AGS 3 Mesencephalon
97/428 AGS 2 Mesencephalon
95/425 SGS 3 TG, Mesencephalon
95/582 SGS 3 TG
96/291 SGS 6 TG
98/563 SGS 3 TG
96/475 CGS 19 TG
97/313 CGS 11 Mesencephalon
97/348 CGS 15 TG, Mesencephalon
97/155 Colic N/A TG
97/263 Colic N/A TG
97/618 Colic N/A Mesencephalon
97/654 Colic N/A TG
98/204 Orthopaedic N/A TG
98/210 Orthopaedic N/A TG
98/387 GME N/A TG
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(ii) Laboratory methods
Indirect immunoperoxidase staining was performed using a two step indirect
inimunoperoxidase technique and the MicroProbe system (Fisher Scientific).Tissues
were collected and processed to paraffin blocks as previously described. Five pm
sections, placed on electrostatically charged slides (ProbeOn Plus, FisherBiotech),
were dewaxed in xylene and a graded series of decreasing percentage alcohols and
transferred from 70% ethanol to 0.5% H2O2 in methanol for 10 minutes to block
endogenous peroxidase. Sections were incubated in 10% normal goat serum (Vector
Laboratories) for 30 minutes at room temperature in a humid chamber before being
incubated with polyclonal rabbit anti synthetic rat CGRP (Serotec Ltd) for 1 hour at
37°C. One section from each tissue was incubated with polyclonal universal negative
control scrum (DPC Llanberis) was included in each run as a negative control. 1:100
Goat anti Rabbit immunoglobulin conjugated to HRP (Sigma Immuno Chemicals)
was applied as the secondary antibody for 30 minutes at room temperature in a
humid chamber. Sections were developed by using a DAB substrate kit (Vector
Laboratories) at room temperature for ten minutes and counterstained with
hematoxylin. Finally, the slides were dehydrated in graded alcohols and three
changes of xylene and mounted in Permount (Fisher Scientific).
(iii) Quantitative Methods
Sections were magnified to x 100 and captured, outlined and the diameter measured
by image analysis software as for the trigeminal ganglion morphometry study (page
162). A variation on systematic random sampling of squares (Mayhew and Sharma,
1984) was used to obtain a systematic random pattern of fields covering each
montage. The first field was chosen at one extreme of the section and all neurons not
touching the side of the field were outlined. Between six and nine fields were chosen
to cover the section until at least 100 cells had been outlined. In order to avoid
measuring fields that were not stained adequately, only fields in which there was at
least one positive immunoreactive cell were included. Individual cells were divided
into positive or negative categories and outlined separately: In order to prevent the
inclusion of artefactually stained cells, only cells that appeared to have positive
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staining throughout the cell were included as 'positive'. Similarly, cells were labelled
as 'negative' only if they did not show any positive staining. A few cells which did
not match these criteria were not included. Measurement data was obtained for
labelled and unlabelled neurons in control and grass sickness cases and analysed
using statistical software (Excell, Microsoft Inc and C-Stat, Oxford Scientific).
Having outlined the neurons, captured fields were reloaded and the proportion of
positive staining cells which stained intensely positive was assessed. Intensely
staining cells were categorised separately as 'strong positive' cells. In order to add an
element of objectivity, the degree of immunoreactivity was defined as a range of
colour intensities using the image analysis system. However, since the background
staining and light intensity differed from section to section, a degree of operator
assessment was still required.
c) Results
CGRP immunoreactive cells (CGRP-IR) in trigeminal ganglia exhibited a granular
diffuse cytoplasmic brown staining, with a range of staining intensities (Figure 5-1).
No convincing CGRP expression was seen in any mesencephalic nucleus of V
neurons but in very few neurons pale, patchy staining was seen associated with the
soma. Careful observation of a number of trigeminal ganglia sections suggested that
the CGRP-IR cells were in many cases smaller than unlabelled cells. It also appeared
that EGS tissues contained fewer strongly labelled neurons than control tissues
(Figure 5-2 and Figure 5-3). The results from quantitation of many sections for each
case are presented in Table 5-5.
The majority of summed EGS and control diameter data for labelled and unlabelled
neurons had a normal appearing distribution but failed the equal variance test.
Statistical tests (ANOVA on ranks, Dunn's multiple comparison procedure, p<0.01)
confirmed that positive staining neurons were smaller than unlabelled neurons both
in EGS and control tissues, and that the diameter data for EGS and control unlabelled
neurons were not significantly different from each other. CGRP-IR neurons were
169
generally larger in EGS than in control tissues. EGS cases had a larger proportion of
positively labelled neurons but a much smaller proportion of strongly labelled cells
than did control cases (Table 5-6).
Diameter data for unlabelled cells and EGS and control labelled neurons were
compared to diameter data obtained for normal and chromatolytic TG neurons from
EGS cases in the previous section. All the groups were significantly different from
each other (ANOVA on ranks, p<0.001, Dunn's multiple comparison procedure).
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Table 5-5: TG CGRP individual subject immunoreactivity and diameter
morphometry
Horse Diagnosis Number Mean (SD) Number Mean (SD) Prop
Negative Negative Positive Positive Str pos
97/155 Control 30 38.3 (8.7) 67 37 (7.6) 0.66
97/263 Control 49 41.6(8.7) 63 35 (6.4) 0.17
97/654 Control 53 47.0(13.8) 89 23 (11.7) 0.85
98/204 Control 76 47.5 (11.2) 79 331 (6.6) 0.73
98/210 Control 57 44.1 (10.6) 61 34 (5.0) 0.66
98/387 Control 45 52.6 (9.9) 56 37(6.1) 0.55
98/374 AGS 44 48.3 (13.7) 61 34(6.8) 0.61
98 417 AGS 65 41.3 (12.7) 43 36 (6.2) 0.12
95/425 SGS 47 44.1 (11.2) 65 35 (8.6) 0.15
95/582 SGS 48 47.6(12.8) 54 32(8.1) 0.09
96/291 SGS 33 49.0(13.4) 75 39(8.3) 0.04
98/563 SGS 47 50.8 (12.6) 62 42(11.5) 0.05
96/475 CGS 51 45.2 (11.6) 48 38 (7.5) 0.21
97/348 CGS 73 49.0(13.6) 34 38 (9.4) 0.26
N = Number included
Negative = no staining
Positive = immunoreactivity
Prop Str pos = proportion of CGRP-IR cells showing strong immunoreactivity
Mean diameter measurements in micrometers. Standard deviations are
given in perentheses.
Table 5-6: TG neuron CGRP EGS and control subject summary data
Mean (SD) Percentage of neurons
Negative Positive Neg Pos Str pos
EGS 47 (12.8) 37 (8.8) 19 81 13%
Control 46(11.5) 32 (9.3) 43 57 64%
Str. pos = strongly positive staining neurons given as a proportion of positive
neurons
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Figure 5-1: Control trigeminal ganglion, anti CGRP
immunohistochemistry showing the variation in cellular staining. One
cell is a strong positive (arrow), x 400.
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Figure 5-2: Control Trigeminal ganylion. x100.
Figure 5-3 :Trigeminal ganglion, Chronic Grass Sickness, x 100
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d) Discussion
Morphometric data from all groups examined indicates that CGRP is expressed
preferentially by smaller neurons in the equine trigeminal ganglion. This agrees with
data from laboratory animals in which CGRP is expressed throughout the trigeminal
ganglion but is confined to neurons smaller than 50 pm, with the majority of cells
labelled in pigs and cats being smaller than 30 pm in diameter (Lazarov, 1995;
Aigner et al, 1997). These published morphometric results are similar to the 32 pm
mean diameter of CGRP-IR trigeminal ganglion neurons observed here in control
horses, and places equine CGRP-IR neurons into the category of type B neurons
[mean diameter in pigs = 20 -50 pm, Aigner, 1997 #576], It is likely that strong
positive equine CGRP-IR trigeminal neurons (mean diameter 28 pm) would fall into
the type C category (mean diameter <20 pm) if it were adjusted for the larger size of
equine neurons. In order for the results to be comparable to the TG morphometry
study, cells were outlined regardless of whether or not they contained a nucleus. This
could have resulted in bias towards small positive cells since these are easier to
identify than small negatively stained cells. Being aware of this however, a
concerted effort was made to include negative cells equally.
CGRP has been of considerable interest in providing a specific and prevalent marker
for type B sensory ganglion neurons (Silverman and Kruger, 1989). Studies in
laboratory animals focusing on CGRP-IR in dorsal root ganglia have concluded that
CGRP-IR somata are most frequently associated with high-threshold
mechanosensitive, presumably nociceptive, afferent neurons. CGRP however can be
expressed not only in nociceptive but also in many other types of primary afferent
neurons, the condition being that the conduction velocity is slow , <2.5 m/s, and/or
the cell soma small, <40pm diameter (Hoheisel et al, 1994). However, there is no
neuropeptide marker known at present that can be considered typical for a particular
type of afferent unit [Hoheisel, 1994 #581, or can be correlated in any exclusive
manner with any pathological states (Cooper et al, 1996).
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It is interesting that this study, and others, have been unable to find CGRP-IR
neurons in the mesencephalic trigeminal nucleus (Lazarov, 1995; Lazarov and
Chouchkov, 1996). MTN neurons are singled out by being the only primary afferent
neurons in CNS and as such might be expected to express CGRP. MTN neurons are
thought to process proprioceptive information from masticatory and extrinsic eye
muscles and periodontal ligament fibres but very little is known about their
neurochemical organisation (Lazarov, 1995). The nucleus is composed of large and
medium sized pseudounipolar primary afferent neurons as well as many smaller
multipolar MTN neurons. In studies using immunocytochemical retrograde tracing
techniques, immunoreactivity could not be detected in cell bodies against any ten
neuropeptides, including CGRP (Lazarov and Chouchkov, 1996).
Unlike classical neurotransmitters which are synthesised at the synapse, neuropeptide
synthesis is limited to the cell soma, from where it is transported down the axon
(Cooper et al, 1996). Thus, despite the concentrations of any given peptide in the
brain being maximally two to three orders of magnitude lower than classical
neurotransmitters (Cooper et al, 1996), CGRP producing neurons should be
immunoreactive at the level of the soma. The very occasional association of
mesencephalic V neurons with pale CGRP immunoreactivity in this study may be
explained by the electron microscopic observation that CGRP expressing perisomatic
fibres in the mesencephalon, probably derived principally from the brainstem
reticular formation and the spinal trigeminal nucleus, can be in direct apposition to
perikarya of unstained large cells (Lazarov and Chouchkov, 1996). Some of these
CGRP expressing fibres make synaptic contacts with mesencephalic V cell bodies
and dendrites. Since the faint staining was seen throughout the soma however, it is
possible that very few equine MTN neurons, and therefore probably also laboratory
animal MTN neurons, do express CGRP.
Although there was a great deal of individual variation, TG ganglia from control
horses had significantly fewer CGRP-IR neurons but a greater proportion of strongly
immunoreactive neurons than did EGS cases. Furthermore, CGRP-IR neurons which
were present in EGS ganglia (p<0.0001) were significantly larger than in control
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ganglia while there was no significant difference in the size of unstained EGS and
control TG neurons (p=0.24). Neuropeptides have long been considered to act as
neurotransmitters or neuromodulators but in addition they may potentiate the action
of acetylcholine by increasing the number of receptors on the postsynaptic membrane
(Thompson et al, 1995). In this way they may contribute to a variety of regulatory
and trophic neuronal functions (Lazarov, 1995). CGRP levels in motor neurons
increase after axotomy (Wang et al, 1993b; Thompson et al, 1995), suggesting a role
for this peptide in the response of neurons to injury and in regeneration. Based on the
available data one can formulate the hypothesis that CGRP expression by additional,
larger diameter, trigeminal neurons in Equine Grass Sickness is due to a similar
mechanism, and that a smaller proportion of EGS neurons are strongly
immunoreactive as a number of them have become chromatolytic.
The observation that the diameters of normal trigeminal neurons are larger than
chromatolytic neurons, and that small EGS neurons are more likely to be
chromatolytic may suggest that CGRP expressing neurons are preferentially targeted
in EGS. This is supported by the observation that mesencephalic V neurons neither
express CGRP nor are chromatolytic in EGS cases. It is tempting to correlate the
decrease in CGRP expression with clinical signs shown by EGS cases and a
prominent candidate is rhinitis sicca, which is so commonly seen in chronic EGS
cases. CGRP often co-localises with substance P and both substance P and CGRP
have vasodilator functions, it has been known for many years that antidromic
stimulation of afferents produces a vasodilator response (Cooper et al, 1996),
increases capillary permeability and augments the secretion of submucous glands
(Zhao and Tao, 1994). This efferent role of some of these peptidergic afferent axons
may also be inferred from their specific distributions. Sites involved in regulating
access to and sensitivity of sense organs fn external stimuli (e.g. cochlear and
vestibular hair cells, taste bud orifices, and main olfactory epithelium) are heavily
innervated by peptidergic neurons and may serve versatile roles in response to
noxious chemical stimuli, permitting sensory axon modulation of autonomic neuron
activity and triggering of protective reflexes (Silverman and Kruger, 1989).
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Dysfunction of any of these at the level of the nasal mucosa, but particularly a
decrease in secretion of submucous glands, is a very reasonable pathogenesis for an
alteration in the mucosa resulting in rhinitis sicca.
CGRP is also known to have an impact on gastric motility, and the response of spinal
sensory neuron terminals in the celiac and cranial mesenteric ganglia to noxious
stimuli are believed to partly mediate postoperative ileus. CGRP is generally
associated with inhibition of gastric motility, but a chronic alteration in these
extraspinal intestinogastric inhibitory reflexes could reasonably lead to a paradoxical
decrease in gastric motility, such as may be seen in EGS cases. Initial work detailing
CGRP changes in the gastrointestinal tract of EGS cases is supportive of this
hypothesis (Kitamura, Obihiro University, Japan, work in progress).
In conclusion, CGRP-IR neurons in the equine TG ganglion are smaller than
unreactive cells, and chromatolytic neurons in EGS are smaller than normal
appearing neurons. This is the first study to correlate neuronal susceptibility to the
agent responsible for EGS with a neuronal marker. It suggests that CGRP expressing
neurons may be specifically targeted in EGS, and that dysfunction of CGRP






This work achieved the objective of the study and quantified the histopathology of the
CNS of equine grass sickness cases, initiated the investigation of the CNS cytopathology
and evaluated the neuroanatomic basis of selected clinical signs.
Equine Grass Sickness cases ultimately are euthanised because of dysfunction of the
gastrointestinal system, and research efforts have understandably focused on the
autonomic nervous system. The recognition that EGS is a multiple system disease with a
highly specific somatic component however, may direct the emphasis towards finding an
aetiologic agent selective for neurons in the GVE, GSE and GSA systems. The
distribution of CNS lesions is so specific that there can be little doubt that domestic
carnivores with dysautonomia share a common aetiologic process, further narrowing the
field of possible causes. Indeed it is reasonable to expect any species affected with this
disease to have similar CNS changes, and thus it is very likely that hares (personal
observation) are affected but the diagnosis in one llama (Kik and van der Haage, 1999),
which was reported to have none of the appropriate central changes, may be in doubt.
The results of this study agree with Barlow's observation (1969) that central pathology
may be a specific part of the pathology of grass sickness but disagree with the conclusion
that the extent is in direct proportion to the duration of clinical illness and is not a
primary feature of the disease. CNS pathology was found in 90% of AGS cases in this
study, many of which had only been showing clinical signs for a matter of hours. This
strongly suggests that Gilmour's hypothesis (1973) is correct and damage to central
tissues occurs coincidentally with alimentary pathology.
The suggestion that the causative agent of EGS may reach neurons by retrograde axonal
transport (Griffiths et al, 1994) should be questioned in light of these results. Although
it is probable that the onset of cytopathology greatly precedes the expression of clinical
signs, and that a retrograde axonal transport rate for toxins of ~180 mm/day (Stockel et
al. 1975) may allow central pathology to occur at the same time as the onset of enteric
clinical signs, it is unlikely that the resulting pathology could be that neuroanatomically
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specific. The route of exposure of the axons of CN III, IV and VI to the agent is
particularly difficult to imagine.
The study of equine cytopathology is greatly impeded by the lack of specific reagents or
positive control tissues for that species. It was hoped that antigens well conserved
throughout evolution, such as ubiquitin, would be recognised by rodent specific
antibodies, but the lack of known positive staining equine CNS tissues made it extremely
difficult to validate the histochemical techniques. Staining for further heat stress proteins
such as alpha B crystallin, detected in chromatolytic neurons in human
neurodegenerative diseases (Lowe et al, 1992), was attempted repeatedly but the results
could not be interpreted despite the use of equine eye lens tissue on positive control
sections. The procedures reported in this study all had specific staining in positive
control tissues from other species, and no staining in negative control tissues in which
the histochemical agents or antibodies had not been applied.
The observation that smaller dorsal root ganglion neurons expressing CGRP become
chromatolytic in EGS may indicate that neurons expressing that neuropeptide are
particularly sensitive to the pathogenic agent. This is supported by the fact that CGRP is
specifically present in the somatic efferent and afferent neurons (Grunditz et al, 1994;
Thompson et al, 1995; Cooper et al, 1996) which become chromatolytic in EGS. It is
reasonable to suppose however that CGRP expression is only acting as a marker for a
specific subset of neurons, and further work allowing the classification of equine neurons
into categories such as those described by Aigner (1997) may be profitable. A number of
neurochemical substances including substance P, somatostatin, fluoride resistant acid
phosphatase, 5-hydroxytryptamine, glutamate and aspartate (Kai-Kai, 1989; Tracey et al,
1991) are also localised to small and intermediate diameter neurons in rodent ganglia and
may indicate that a factor such as metabolic activity makes neurons susceptible to EGS.
CGRP expression was investigated in central GSE LMNs and was also found to be
decreased in chromatolytic EGS neurons. On reflection however the specificity of a
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change in neuropeptide expression in chromatolytic neurons was to be expected. Nissl
granules are made of rough endoplasmic reticulum and free polyribosomes, and are the
site of synthesis of cytoskeletal elements and proteins such as the neuropeptide
neurotransmitters containing signal sequences (Kleinsmith and Kish, 1995; Waggie et al,
1999). Chromatolysis is associated with a dispersal in Nissl substance (Bodian and
Mellors, 1945) and an increase in RNA content of the nucleus (Thomas et al, 1993)
allowing free polyribosomes to produce proteins necessary for neuronal repair such as
regrowth of an axon (Aldskogius, 1978). Since the production of neuropeptide
neurotransmitters requires the ribosome to adhere to the endoplasmic reticulum
membrane, and arc arguably a non-essential product for an injured cell, it would be
reasonable to expect CGRP expression, along with many other proteins, to be down-
regulated. A more direct approach to try to determine whether chromatolytic neurons are
CGRP expressing cells under normal circumstances would be to evaluate the level of
CGRP RNA expression using in situ RT-PCR techniques (Kleinsmith and Kish, 1995).
The use of the TUNEL technique did not reveal any evidence of central neuronal cell
death regardless of whether or not DNA laddering is taken to be a specific marker for
apoptosis. This was further supported by the fact that there was no evidence of fibre type
grouping in a muscle innervated by CN VII, or a functional deficit of CN V or VII, or
pathology to CN III axons. Additionally, the brain of one horse presented for euthanasia
several years after recovering from EGS (Doxey et al, 2000) was carefully examined and
had no central evidence of cell loss or glial scarring (unpublished observations). This
conclusion differs from observations made by Pollin and Griffiths (1987) and encourages
further scrutiny of central tissues in species with dysautonomia similar to EGS.
In direct disagreement to the above was finding a nucleus by electron microscopy which
appeared to be breaking into apoptotic bodies. Neuronal DNA fragmentation has been
reported in both the canine and human brains in normal ageing [Borras, 2000 #795], and
finding one apoptotic neuron may not be a reflection of the disease process per se,
particularly in the absence of any further evidence of central neuronal cell death. Specific
and powerful new markers for apoptotic neurons such as endogenous caspase-3
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breakdown products (Natha et al, 2000) could be applied in the future. However their use
has the same limitations encountered in the TUNEL procedure, namely the short time
interval available to find cells in the process of undergoing apoptosis and the relatively
few large equine LMNs with nuclei present on each tissue section.
The observation that chromatolytic and normal appearing neuronal soma contain
phosphorylated neurofilaments suggests that abnormal axonal transport is a feature of
central EGS pathology. Labelled neurons with normal appearing Nissl substance may
either be recovering, or could be accumulating phosphorylated neurofilaments prior to
chromatolysis being evident. Reduced transport of selective cargoes of slow transport,
especially tubulin, can be detected months before neurodegeneration in ALS, and
represents the earliest detectable abnormality (Williamson and Cleveland, 1999). The
recognition that EGS pathology includes a defect in axonal transport demands further
work to investigate whether the impairment occurs in neurons other than the LMNs
investigated in this study, as well as trying to determine the nature of the deficit.
The loss of a recognizable Golgi structure noted by Griffiths (1993) is a feature which
should be examined in CNS neurons. Lectin histochemical identification of Golgi
apparatus in central EGS tissues was attempted on several occasions with different
batches of agents and with expert assistance, but was discontinued when the technique
did not result in consistent labelling of equine control tissues. Neurons with dispersed
Nissl substance examined by electron microscopy did not have an appreciable Golgi
apparatus, however the preservation was compromised to the extent that comparable
organelles in normal appearing neurons were also not clearly defined. It is unlikely that
the required tissues can be harvested in less time than accomplished in this study, and the
process of aortic transfusion in the horse is challenging. Golgi apparatus specific
antibodies are available for use in other species (Gonatas et al, 1992), and it would be
worth establishing whether the Golgi apparatus epitopes are conserved enough for the
antibodies to label the organelle in equine tissues.
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The absence of inclusion bodies evident in affected neurons by electron microscopy,
answers the question of whether EMND and EGS are extreme expressions of one
disease, posed by the workshop on equine neurodegenerative diseases (Hahn et al, 1997).
Chromatolytic LMNs in EMND are characterised by inclusions composed of aggregated
vesicular residues of membranous organelle degradation and marginated derivatives of
endoplasmic reticulum (Cummings et al, 1993), and there can be little question that this
places EGS into a separate categoiy. Similar findings to those in EGS in the central
neurons of cats (Pollin and Griffiths, 1987) however, provides further evidence that a
common aetiologic agent should be sought.
These initial cytopathological findings are the basis for further work, not only to narrow
the field of potential aetiologic agents but also to act as a guide for the changes which
can be expected to be found in cultured equine neurons (N. Hudson, R(D)SVS, work in
progress) exposed to the appropriate agent in vitro.
The determination of the specific appearance of ptosis in the horse secondary to different
insults is relevant in the evaluation of clinical cases. The marked reduction of ptosis
secondary to sympathetic denervation with the application of a topical alpha adrenergic
agonist, should enable the anatomic location of the lesion to be more accurately
determined. In addition, the pathway of the postganglionic sympathetic fibres to the
eyelid in the horse is incompletely understood and the ability to recognise sympathetic
dysfunction secondary to specific insults may provide functional anatomic data. The
technique may also prove useful in the diagnosis of botulism, a disease marked by a
muscle paresis secondary to a functional denervation.
The use of alpha adrenergic eyedrops as a simple adjunct diagnostic test for EGS is
proving to be a useful technique when applied appropriately. Further data must be
collected from stressed and exhausted patients and those in pain but not suffering from
EGS to determine the specificity, but clinicians at the R(D)SVS are now routinely
applying phenylephrine to suspect cases and to date the test has proved to be very
sensitive. Its use in very early or even subclinical cases remains to be investigated, but
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interestingly a marked positive response was obtained from one animal which had
suffered from EGS several years previously, suggesting that smooth muscle tone of the
eyelid, and thus the innervation, had never returned to normal.
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Postscript
I used to think I knew, I knew ;
But now I must confess :
The more I know, I know, I know,
I know, I know the less.
Greig, J.S. Acute "Grass Disease": an interpretation of the clinical symptoms.
Veterinary Record. 8, 31, 1928.
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EMND and related disorders (1997) IV
Editorial Prologue
The impetus behind this workshop was the recent recognition in
Switzerland of clinical cases of equine grass sickness (EGS) and
equine motor neuron disease (EMND) that appeared to display a
spectrum of neuronal pathologies. Some horses presented with
pure enteric and brainstem lesions (classic EGS pathology),
others showed only the typical somatic lower motor neuron
changes (classic EMND pathology), while a few 'combination
cases' appeared to have the clinical signs and pathological
changes consistent with both diseases. Interest in human
neurology has been raised by what have been termed 'overlap'
syndromes of distinct neurodegenerative diseases and it was
speculated that these equine diseases, traditionally separated by
clinical signs and geographic location, may be similarly related.
Equine grass sickness was recently demonstrated to be very
similar or identical to the disease 'mal seco', known in Patagonia
for many decades. The recognition was long overdue and opened
up potential new avenues of investigation. The presence of EGS
in two such very different environments as Europe and Patagonia
and its conspicuous absence from the USA may well hold a key
as to its cause.
Some of the clinical as well as the light microscopic neuronal
lesions of EGS appear identical to those of EMND despite the
difference in the principle target populations of neurons affected.
The diametrically different correlation of disease incidence and
access to grass in these two diseases also merits further
investigation particularly in the light of evidence of oxidative
injury being a component in EMND.
Could it be that EGS and EMND represent opposite extremes
of a more generalised neurodegenerative process in effect in the
Swiss cases? Ultrastructural comparisons between affected
somatic neurons in EMND and autonomic neurons from EGS
cases may yield further evidence of this process.
Horses with EMND have been observed to have lower serum
alpha-tocopherol concentrations than on-farm control horses
raising the possibility of a connection to equine degenerative
myeloencephalopathy (EDM), occurring usually in much
younger equids. Histopathological findings such as the florid
neuraxonal dystrophy associated with EDM as well as the
widespread lipopigment accumulation found in both EMND and
EDM, may be related to the age at which an antioxidant-deficient
state was initiated; animals destined to develop EDM having
subnormal circulating alpha-tocopherol concentrations at a much
younger age than that of the EMND cases examined.
The striking clinical resemblance of EMND to the sporadic
form of amyotrophic lateral sclerosis (ALS) in humans and the
absence of a suitable spontaneous syndrome in other species
opens up the potential that this disease could serve as a model for
the human disorder. This should encourage the search for a
common trigger in both diseases and the pursuit of lines of
investigation fruitful in ALS, such as the potential role of
excitatory neurotransmitters, antioxidants and enteroviruses.
The existence of pathological changes compatible with EGS
and EMND in the same animal, the realisation that EGS and mal
seco are probably the same disease and the evidence that
antioxidants play a role not only in EDM but also in EMND blur
accepted boundaries of disease identification. The purpose of the
workshop was to assemble an international panel of experts to
compare the clinical features, neuropathology, epidemiology and
pathogenesis of these fascinating equine disorders. This refereed
supplement is a synopsis of the presentations and subsequent
discussions at the workshop.
The Editors
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97/424 SGS 3 5 Highland Mare
98/303 SGS 3 6 Cob Gelding
98/401 SGS 5 9 Arab x Mare
98/563 SGS 3 8 Highland Mare
95/359 CGS 14 8 Coloured Gelding
96/475 CGS 10 18 Pony Gelding
97/150 CGS 76 7 Thoroughbred x Mare
97/293 CGS 21 2 Highland Mare
97/313 CGS 11 4 Thoroughbred x Mare
97/348 CGS 15 5 Welsh x Gelding
97/376 CGS 18 4 Clydesdale Mare
97/538 CGS 10 4 Thoroughbred x Mare
97/605 CGS 17 3 Welsh pony Gelding
98/179 CGS 35 4 Connemara Mare
98/244 CGS 21 7 Highland Mare
98/264 CGS 16 4 Thoroughbred x Gelding
98/502 CGS 26 5 Connemara x Gelding
98/62 CGS 7 1 Anglo Arab Mare
476/98 Open 1 Thoroughbred Gelding
97/1011 Orthopaedic 8 Thoroughbred Gelding
97/1116 Respiratory 14 Thoroughbred Gelding
97/352 Orthopaedic 1 Welsh cob Mare
97/618 Colic 7 Clydesdale Mare
98/204 Orthopaedic 2 Highland Mare
98/210 Orthopaedic 7 Thoroughbred Mare
98/251 Respiratory 6 Thoroughbred Gelding
98/261 Orthopaedic 5 Irish Draft Gelding
98/295 Orthopaedic 8 Thoroughbred Gelding
98/365 Colic 6 Irish Draft Mare
98/418 Colic 6 Thoroughbred Mare
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Guest Editorial
Equine Neurodegenerative Diseases—Stressed Neurons and
other Radical Ideas
It is almost impossible these days to avoid the sub¬
ject of 'oxidative stress' when reading about the
aetiology, pathogenesis or treatment of acute and
chronic neurodegenerative diseases, particularly
in human medicine. This emerging field clearly
demonstrates to neophytes why 'chemistry' has
always been a prerequisite for entry into veterinary
school and serves to remind us of the staggering
complexity of metabolic interactions required for
life.
The term 'degenerative diseases' implies that
there is no clear knowledge of the cause and
pathogenesis of the diseases in question. These
diseases tend to be symmetrical and involve
degeneration of selective groups of neurons that
may be functionally or anatomically related. Typi¬
cally, the pathological process is one of slow invol¬
ution of cell bodies without any intense inflamma¬
tory reaction. Oxidative damage is now thought to
be a potential contributor to the pathogenesis of
these illnesses with substantial evidence accumu¬
lating in Parkinson's disease, Alzheimer's disease
and amyotrophic lateral sclerosis (human motor
neurone disease). The paper by de la Rua-
Domenech et al. in this issue of the Journal associ¬
ates a prominent equine neurodegenerative dis¬
ease, equine motor neuron disease (EMND), with
the dietaiy deficiency of an important antioxi¬
dant, a-tocopherol.
All aerobic organisms are continually exposed
to oxidative stress The use of oxygen as a final
electron acceptor produces more energy per mol¬
ecule of glucose, but carries a high cost due to the
concomitant production of reactive oxygen spec¬
ies (ROS). These ROS include non-radical oxygen
derivatives such as hydrogen peroxide (ELCb) in
addition to the oxygen-centred free radicals such
as superoxide radical (02~), nitric oxide (NO-)
and the highly reactive hvdroxyl radical (OH-). A
free radical is defined as any species capable of
1090-0233/97/060173-02/$ 12- 00/0
independent existence that contains one or more
unpaired electrons. In an effort to complete its
own electron orbitals by extracting an electron
from a neighbouring molecule however, a further
free radical can be generated, potentially leading
to a chain reaction. Transition metals such as iron
and copper, whose release is facilitated by trauma
and other forms of cytotoxicity, promote these
reactions due to their loosely bound electrons.
The extent of damage done by oxidative stress is
considerable, including derangements of cell
metabolism, I)NA breakage, protease and nucle¬
ase activation and peroxidation of lipids.
Neurons appear to be at particular risk of free
radical damage by mechanisms that are not
entirely understood. Neurons are deficient in
some protective components such as catalase, glut¬
athione peroxidase and vitamin E while being sub¬
jected to free radical attack, including that pro¬
duced by the product of oxidation of the
neurotransmitter dopamine and by the induction
of NO synthase after peripheral nerve injury and
chronic central nervous system (CNS) inflam¬
mation. Motor neurons are particularly suscep¬
tible by having high energy requirements associ¬
ated with the maintenance of long axons and by
the additional fluxes of NO induced when the
brain adapts to motor neuron injury by rearrang¬
ing synapses with other neurons. In addition, the
high concentration of polyunsaturated fatty acids,
in neuronal cell membranes makes these cells par¬
ticularly prone to lipid peroxidation. This process
is accelerated by transition metals, such as iron,
that accumulates in the globus pallidus and sub¬
stantia nigra (containing target neurons in Alzhei¬
mer's disease), as well as being present in CSF.
Luckily, several antioxidant defence mechan¬
isms are in place, including the segregation of the
majority of oxidation-reduction reactions occur¬
ring within mitochondria, the binding of tran-
© 1997 Bailliere Tindall
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sition metals to proteins, and the existence of
chain-breaking antioxidants such as superoxide
dismutase (SOD) and glutathione peroxidase.
Finally, and of importance in the context of
EMND, the active component of vitamin E, a-toc-
opherol, is the major lipid soluble antioxidant and
has a high reactivity with organic peroxyl radicals
derived from lipid oxidation.
In reality, things are rather more complicated
of course, and the obvious solution of removing
transition metals and adding antioxidants is
unlikely to be the answer to oxidative stress-
induced diseases. Many ROS have important bio¬
logical functions, the messenger roles of nitric
oxide being one example. Metal ion chelators
similarly are not useful in the long-term due to the
important physiological function of iron and
because the chelates themselves are able to cata¬
lyse free radical reactions, a problem shared by
most antioxidants ('radicals beget radicals'). Fur¬
thermore, hydroxvl radical scavengers, such as
mannitol, ethanol and dimethyl sulphoxide, react
by diffusion-controlled rates. So for a molecule to
scavenge OH- in vivo it must be present at higher
concentrations than surrounding biological mol¬
ecules. This probably (unfortunately) means that
for ethanol to do one any good, one has to get
well and truly 'pickled'! It is possible that increas¬
ing SOD activity is actually damaging, due to the
hydrogen peroxide produced during dismutation
of superoxide, and the therapeutic use of antioxi¬
dants such as SOD and tocopherols have been dis¬
appointing.
Increased ROS formation has been implicated
in many human diseases but has not yet been pro¬
ven to play the major pathologic role in any of
them. As de la Rua-Domenech et al. point out, it is
unclear whether the decreased serum a-tocoph-
erol concentration and oxidative injury have a
causative role in EMND or are epiphenomena or
consequences of the disease. To prove that ROS
species are important in a particular disease it has
to be shown that ROS are formed at the site of pri¬
mary injury, that removal of ROS or prevention of
their formation has beneficial effects and that
direct application of ROS at concentrations found
in vivo leproduccs all or most of the primary
injury. This is going to be one of the challenges in
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